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Abstract 
The neuronal pathways used by general anaesthetics in order to cause loss of consciousness 
(LOC) are unknown. There is conflicting evidence as to whether anaesthetics exert their 
effects cortically or subcortically, possibly via sleep promoting pathways. Studies 
investigating the mechanisms underlying both natural sleep and anaesthetic-induced LOC 
have converged on the thalamus and neocortex, with their respective roles in instigating LOC 
being unclear.  
In this thesis, local field potentials were recorded from multiple thalamic and cortical nuclei 
in rats during transitions into natural sleep and anaesthetic-induced LOC using propofol and 
dexmedetomidine. Morlet wavelet analysis was used to visualise the time varying power 
spectra with high temporal resolution. Whilst anaesthetic specific changes occurred, 
reductions in frequency and increases in power within the 10-64Hz range of oscillations were 
observed occurring at, or immediately preceding, transitions into natural sleep and 
anaesthetic-induced LOC. These changes occurred within the central medial thalamus 
(CMT), a higher-order thalamic nucleus, prior to both the neocortex and a primary thalamic 
nucleus during transitions into natural sleep and propofol-induced LOC. For 
dexmedetomidine-induced LOC, these changes occurred simultaneously in all nuclei. 
However, following dexmedetomidine administration, a delta (1-4Hz) oscillation was 
induced. This oscillation reduced in frequency abruptly at the LOC point, accompanied by a 
sudden phase change between the CMT and all other nuclei. These results are in agreement 
with natural sleep and anaesthetic-induced LOC being initiated subcortically, with the CMT 
acting as a key mediator. Additionally, phase and spectral similarities between 
dexmedetomidine anaesthesia and natural sleep are consistent with dexmedetomidine 
utilising sleep pathways, whilst propofol only exhibits sleep-like characteristics during the 
recovery phase.  
Finally, a prototype device developed in-house capable of wirelessly transmitting six 
electrophysiological signals for 25 hours from rats is characterised. Further development for 
recording from unrestrained mice is outlined. 
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1.1 Consciousness: A Fundamental Question in Neuroscience 
Consciousness is one of the great unsolved mysteries in science and philosophy, its 
definition, neurobiological basis, and the reasons for its reversible loss in the form of natural 
sleep and general anaesthesia are all the subject of continuous research and debate.  
Consciousness has only recently warranted investigations from a scientific standpoint, having 
been a primarily philosophical study for centuries (Seth, 2010). How consciousness is defined 
could provoke endless discussion, given that different degrees of consciousness exist. One 
framework suggests that primary consciousness is the ability to combine sensory information 
with motor activity and long term memory in order to construct a multimodal depiction of the 
present upon which instantaneous and intentional action can be undertaken, whereas a limited 
number of animals possess higher-order conscious characteristics such as a narrative 
recollection of personal history, future plans (unrelated to the immediate environment), and 
consciousness of self (Edelman, 2003). This begs the surprising question as to whether 
animals possessing primary consciousness are truly conscious; with the scientific community 
recently declaring so, as signified by the 2012 Cambridge Declaration on Consciousness 
(Low, 2012) and experimental work (Mashour and Alkire, 2013). Thus, the definition for 
primary consciousness will be used as the definition of consciousness for this thesis. 
One question central to the scientific study of consciousness is identifying the minimum set 
of brain structures and the nature of their interactions required firstly for consciousness, and 
secondly the neuronal correlates of a specific conscious experience, termed the neural 
correlates of consciousness (Crick and Koch, 1990). These are two separate fundamental 
questions that are being studied in different ways. Neural correlates of consciousness are 
typically examined via investigation of the visual system responding to a stimulus (Rees et 
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al., 2002), whereas neural correlates of the level of consciousness (e.g. conscious vs 
unconscious or awake vs asleep) have predominately used neuroimaging techniques to study 
the whole brain in order to identify the basic set of structures and their interactions required 
for a basic level of consciousness sufficient to react to external stimuli, without any stimuli 
being present at that time, to exist. This typically consists of using neuroimaging techniques 
to identify the brain areas showing differences in metabolism and functional connectivity 
across consciousness transitions from wake to natural sleep (Hofle et al., 1997) and 
anaesthetic-induced loss of consciousness (LOC) (Hofle et al., 1997, Langsjo et al., 2012, 
Lewis et al., 2012). Additionally, data from clinical patients suffering from disorders of 
consciousness following traumatic brain injury (Giacino et al., 2014), provide some insights. 
The results of these studies have typically converged on an interconnected set of structures 
thought to facilitate consciousness, the thalamus and cortex. Current thinking (Alkire, 2008) 
and research (Ferrarelli et al., 2010, Imas et al., 2005) suggest that the mechanism underlying 
the unconscious state is the inability of information to transfer between different cortical 
nuclei, termed a loss of functional cortical connectivity. The extent to which this is mediated 
by the thalamus is debated (Fuller et al., 2011, Sherman et al., 2006), with 
electrophysiological recordings attempting to identify the temporal relationship between 
thalamic and cortical nuclei across LOC producing contradictory results (Gervasoni et al., 
2004, Hwang et al., 2010, Magnin et al., 2010, Velly et al., 2007). 
In this thesis an in vivo electrophysiological investigation has been undertaken attempting to 
clarify the temporal dynamics between the thalamus and cortex across loss of consciousness 
transitions. This study records from primary and higher-order thalamocortical circuits during 
both transitions into natural sleep and anaesthetic-induced LOC in order to discover whether 
the mechanism underlying LOC is conserved across the two types of transition, thus 
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indicating whether general anaesthetics, whose effects on neural networks are relatively 
unknown (Franks, 2008), induce their effects by acting upon endogenous sleep promoting 
neuronal pathways. This introductory chapter will firstly introduce the historical background 
surrounding mechanisms of anaesthetic action, before discussing sleep pathways and their 
possible modulation by anaesthetics. Following this, current methods of measuring brain 
activity and the oscillatory aspects of the thalamocortical system will be introduced before 
describing the proposed thalamocortical mechanism underlying the unconscious state. 
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1.2 General Anaesthetics 
Although the use of general anaesthetics is commonplace in modern medicine, the discovery 
of the ability to perform surgical procedures without the patient having conscious perception 
of pain was of enormous consequence for the time. Prior to the first widely reported use of an 
anaesthetic, ether, in 1846 by Dr William Morton (Bigelow, 1846), surgery was an 
unpleasant procedure of last resort, causing great pain and distress to the patient, with the 
surgeon having to operate with great speed. The scope of possible procedures was limited and 
mortality rates were high. The introduction of anaesthesia coupled with the development of 
antisepsis by Lister in the 1860’s, enabled more complex surgeries to occur on an immobile 
patient with less emphasis on speed and a greater chance of survival. Over time, through 
clinical experience, general anaesthesia has evolved into an extremely safe practice, with 
anaesthetists being able to choose the most suitable form of anaesthesia from a range of 
anaesthetics that have evolved over the past 168 years (Wilkinson, 2014). Despite this wealth 
of clinical experience, how anaesthetics exert their actions on the central nervous system in 
order to cause LOC is not fully understood.  
In the decades following 1846, the wide variety of structural and chemical differences 
between substances exhibiting anaesthetic properties resulted in scientists looking for a 
shared characteristic that could then be attributable to a mechanism of action (Weir, 2006). At 
the beginning of the 20
th
 century two scientists in Germany and Switzerland, Meyer and 
Overton, independently reported that the potency of an anaesthetic directly correlated with its 
oil/water partition coefficient (Meyer, 1899, Overton, 1901). This held true for a large 
number of anaesthetics, and thus led to the hypothesis that anaesthetics exert their effects on 
the lipid bilayer that constituted the cell membrane of nerves. The striking correlation 
between anaesthetic potency and oil/water partition coefficient made this hypothesis difficult 
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to dismiss for a number of years, despite a number of exceptions. For example 
octaflouropropane (Miller et al., 1972), and the fact that increasing the solubility of long 
chain alcohols and alkanes through the addition of additional groups onto homologous chains 
does not increase their anaesthetic potency beyond a certain point, known as “cut-off” 
(Mullins, 1954). Additionally, attempts to explain how direct anaesthetic action on lipid 
bilayers caused loss of consciousness faltered. By the late 70’s, there were four differing lipid 
based theories; anaesthetics increased lipid bilayer fluidity, anaesthetics induce a solid to 
liquid phase change within the bilayers, anaesthetics increase the lipid bilayer membrane 
dimensions and anaesthetics induce an increase in the cation permeability of lipid bilayers. 
Upon examining these theories on an individual basis several shortcomings were identified. 
Evidence supporting these theories typically examined lipid bilayers under the influence of 
anaesthetic doses that were of little clinical relevance and a number of proposed changes to 
the properties of lipid bilayers caused by anaesthetics, could also be induced by subtle 
changes of temperature, which can occur naturally within the animal without causing it to 
lose consciousness (Franks and Lieb, 1982). Most importantly these theories did not fully 
explain how the proposed changes in the lipid bilayers resulted in a dysfunctional membrane 
protein, which was the agreed end result of all theories (Franks, 2006). During the same 
period, a number of experiments had started to investigate the action of anaesthetics directly 
on proteins, and the first conclusive demonstration came in 1984 by Franks and Lieb, who 
discovered that the light output of an isolated pure protein, firefly luciferase, could be 
inhibited by a range of anaesthetics. The concentrations required to inhibit 50% of the 
luciferase were near identical to the ED50 (median effective dose) concentrations causing 
LOC in animals. Additionally, it was reported that the anaesthetics tested competed with the 
substrate molecule, luciferin, thus leading to the suggestion that anaesthetics not only act on 
receptors, but that their action involves competing with endogenous ligands for binding to the 
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receptor (Franks and Lieb, 1984). Following this, research into anaesthetic actions on 
proteins focussed on identifying which protein targets are responsible for loss of 
consciousness (Franks and Lieb, 1994), whilst the discovery that the stereoisomers of 
isoflurane, despite having the same effects on pure lipid bilayers (Franks and Lieb, 1991), 
had differing anaesthetic potencies both in vivo (Harris et al., 1992) and in vitro (Franks and 
Lieb, 1991), cast further doubt on lipid based theories. 
Currently, anaesthetics have been shown to exert effects on a limited number of receptors and 
channels, the most studied of which is the GABAA (γ-aminobutyric acid type A) receptor. 
Additionally, NMDA (N-methyl D-aspartate) receptors and two-pore-domain potassium 
channels (2PK) have been identified as anaesthetic targets (Rudolph and Antkowiak, 2004, 
Franks, 2008). 
GABAA receptors have been thought of as anaesthetic targets since the late 1970’s 
(Macdonald and Barker, 1978). The receptors are found throughout the CNS and with the 
exception of xenon (de Sousa et al., 2000), butane and cyclopropane, the effects of 
endogenous GABA on GABAA receptors are enhanced by almost all anaesthetics, resulting in 
additional GABA-induced chloride ion influx into the cell. At higher anaesthetic 
concentrations, direct activation of the GABAA receptor occurs. The receptor consists of five 
subunits, and 19 possible receptor subunits have been identified. Within the brain 60% of all 
GABAA subunits comprise of α1β2γ2 subunits, 15% consist of α2β3γ2 and 10-15% consists 
of α3βnγ2 (Rudolph and Antkowiak, 2004). The development of genetic engineering 
techniques allow the use of gene knockout, knock in and point mutations to explore the 
relative role of each subunit with regards to anaesthetic sensitivity. Although knockouts are 
not considered universally successful due to possible compensatory mechanisms (Rudolph 
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and Mohler, 2004) δ subunit knockout mice exhibit reduced sleep time in response to 
neurosteroids alphaxalone and pregnanolone, but not other anaesthetics (Mihalek et al., 
1999). β3 subunit knockout mice attenuated the ability of enflurane and halothane to remove 
response to noxious stimuli, an indicator of a surgical plane of anaesthesia being reached, 
whilst the sleep time measured with etomidate and midazolam was also reduced (Quinlan et 
al., 1998). Point mutations on the α subunit reduce the effects of volatile anaesthetics, but 
have little effect on intravenous agents (Krasowski et al., 1998), whilst mutations on the β 
subunit have been shown in vivo to reduce the ability of propofol, etomidate (Reynolds et al., 
2003, Jurd et al., 2002) and pentobarbital (Zeller et al., 2007) to induce loss of righting reflex 
(LORR), which is the accepted rodent correlate of LOC. Finally mice with a double knock-in 
in the α1 subunit displayed an unchanged GABA sensitivity yet reductions are observed in the 
ability of the volatile anaesthetics, isoflurane and enflurane, to induce LORR in mice (Sonner 
et al., 2007). 
NMDA receptors and 2PK channels are also anaesthetic targets, although the contribution of 
these to anaesthetic-induced LOC are less well characterised. 2PK channels, first identified in 
the pond snail (Franks and Lieb, 1988), were subsequently shown to exhibit sensitivity to 
volatile anaesthetics in mammals (Goldstein et al., 2001). 2PK channels function in 
homomeric or heteromeric dimers, and there are 15 subunits within the mammalian branch of 
this family (Goldstein et al., 2005). Of these subunits, five are opened by volatile 
anaesthetics, although their sensitivity to differing anaesthetics varies across classes. They are 
TREK1, TREK2, TASK1, TASK3 and TRESK. In contrast, 2PK channels have not been 
observed to exhibit sensitivity to any clinically relevant intravenous anaesthetic (Franks, 
2008). Opening of 2PK channels by anaesthetics typically results in inhibition of the cell 
(Sirois et al., 2000, Ries and Puil, 1999), although whether excitation or inhibition occurs 
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following the opening of presynaptic 2PK channels (Westphalen et al., 2007) is dependent on 
the nature of the synapse. 
In general knockouts of anaesthetic sensitive 2PK channels in mice reduce sensitivity to 
halogenated anaesthetics (Lazarenko et al., 2010, Heurteaux et al., 2004). However, level of 
reduction in anaesthetic sensitivity observed in vivo is dependent on the subunit type knocked 
out and the halogenated anaesthetic used (Chae et al., 2010, Lazarenko et al., 2010). The in 
vivo level of subtype and anaesthetic specific reductions in sensitivity are assessed by testing 
at different behavioural endpoints. These endpoints are: a reduction in locomotion during 
sedation, LORR, or loss of response to noxious stimuli. Not all knockout experiments test 
across all three behavioural endpoints, thus complete subtype knockout data tested across a 
range of anaesthetics is lacking (for review see (Steinberg et al., in press)).  
NMDA receptors, located both presynaptically and postsynaptically at glutamate synapses 
are also anaesthetic targets (Flohr et al., 1998). The receptor consists of four subunits, two 
compulsory NR1 subunits and two of four NR2 subtypes or two NR3 subtypes, thus it is the 
combination of NR2 and NR3 subunits that are the determinants of the receptors functional 
heterogeneity (Paoletti et al., 2013). Inhalational anaesthetics have been reported to inhibit 
NMDA receptors (de Sousa et al., 2000). The anaesthetic gas xenon, is currently of particular 
interest as it exerts its neuroprotective effects at the NMDA receptor (Harris et al., 2013). 
Mutations of both the NR1 and NR2A subunit reduce the anaesthetic sensitivity of the 
NMDA receptor although like manipulations of GABAA and 2PK receptors, the effects vary 
for different anaesthetic agents (Ogata et al., 2006),. At high concentrations, selective NMDA 
antagonists will cause sedation and LOC (Carter, 1995), however at these concentrations 
antagonist selectivity may be removed (Lingenhöhl and Pozza, 1998). Thus, whilst NMDA 
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receptor antagonism has a role to play in exerting the effects of xenon and to a lesser extent, 
other volatile anaesthetics, LOC is induced by additional effects on other molecular targets 
(Franks, 2008). 
Despite advances in the understanding of molecular and cellular mechanisms of anaesthetic 
action, how anaesthetics exert their effects on neuronal pathways is unknown. Knowledge of 
receptor locations provide clues as to which neuronal pathways are affected, yet further 
investigation is required to confirm which pathways are involved in LOC and whether these 
pathways are endogenous sleep pathways within the brain. Proposed neuronal pathways 
underlying sleep and the possible pathways of general anaesthesia are discussed in the 
following chapter. 
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1.3 Endogenous Sleep Pathways  
The neuronal pathways regulating sleep are located within the brainstem and hypothalamus. 
The reciprocal interactions between wake promoting, NREM sleep promoting and REM 
promoting nuclei within these areas are thought to govern transitions between wake and sleep 
states. Wake and NREM sleep promoting networks are outlined below and reviewed in full 
by Saper et al. (2010).  
Wake promoting networks are located within the midbrain and were first reported by 
Moruzzi and Magoun (1949), who described desynchronisation of the electroencephalogram 
(EEG), which correlates with behavioural alertness, being elicited following an electrical 
stimulation of this area in drowsy or lightly anaesthetised cats. This area contains a whole 
host of nuclei that release arousal promoting neurotransmitters into the forebrain and 
typically fire most actively in the waking animal. There are cholinergic projections from the 
pedunculopontine (PPN) and laterodorsal tegmental nucleus (LDT) (Satoh and Fibiger, 1986, 
Hallanger et al., 1987), noradrenergic projections from the locus coeruleus (LC) (Aston-Jones 
and Bloom, 1981), serotonergic projections from both dorsal (DRN) and median raphe nuclei 
(MRN) (Kocsis et al., 2006), dopaminergic neurons from the periaqueductal gray matter (Lu 
et al., 2006), histaminergic neurons from the tuberomammilliary nucleus (TMN) within the 
hypothalamus (Panula et al., 1989) and a glutamatergic set of projections from the 
precoeruleus (PC) and parabrachial (PB) nuclei (Saper and Loewy, 1980), whose importance 
in the maintenance of arousal was unknown at the time of the review but has recently been 
highlighted (Fuller et al., 2011). 
NREM (non-rapid eye movement) sleep promoting nuclei are located within the preoptic area 
(POA) of the hypothalamus and basal forebrain. A population of neurons within the 
INTRODUCTION 
24 
 
ventrolateral preoptic nucleus (VLPO) fire more rapidly during sleep than wakefulness 
(Szymusiak et al., 1998). VLPO contains inhibitory GABAergic and galaninergic projections 
to the TMN as well as other nuclei of the ascending arousal system including the, LC, raphe 
nuclei and PB nucleus. Reciprocal projections from these areas are also observed (Chou et 
al., 2002, Lu et al., 2006). The area surrounding VLPO also contains selective galaninergic 
projections to the DRN and LC (Sherin et al., 1998). Another well studied nuclei that exhibits 
increased firing during sleep is the median preoptic nucleus (MnPO) (Suntsova et al., 2002). 
Unlike VLPO neurons, which fire at sleep onset (Takahashi et al., 2009), elevated cFOS 
expression during sleep deprivation suggests that MnPO neurons fire prior to sleep and have 
a role in increasing sleep pressure (Gvilia et al., 2006). MnPO provides dense innervation of 
VLPO and although reciprocal projections to the brainstem arousal nuclei are observed 
(Saper and Levisohn, 1983, Uschakov et al., 2007), the nature of MnPO-brainstem arousal 
interactions is unknown (Saper et al., 2010). 
The observation that VLPO neurons are inhibited by neurotransmitters emanating from 
brainstem arousal nuclei, namely acetylcholine, norepinephrine, dopamine and serotonin 
(Gallopin et al., 2004, Gallopin et al., 2000), has led to the hypothesis that mutual inhibition 
between NREM sleep promoting and wake promoting nuclei controls switching between 
behavioural states- the Flip-Flop switch. Under this hypothesis, asymmetric inhibition will 
lead to rapid transitions between wake and sleep states, a characteristic favourable for 
survival in wild animals (Saper et al., 2010).  
In order to investigate to what extent anaesthetics can cause LOC exhibiting all features of a 
systemic dose through solely exerting their effects on these wake and NREM active nuclei; 
manipulation of individual brainstem targets, relevant to the molecular targets of the 
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respective anaesthetic has been undertaken via localised injection. The most notable example 
of this is probing the noradrenergic system through administration of dexmedetomidine into 
the LC. Systemically administered dexmedetomidine induces a sleep like state from which 
waking can be induced with sufficient stimulus (Kamibayashi and Maze, 2000). An 
enantiomer of medetomidine, dexmedetomidine is an α2- adrenergic receptor family agonist 
(Virtanen et al., 1988), of which, the α2A receptor is thought to be responsible for mediating 
its sedative and hypnotic effects (Lakhlani et al., 1997). The receptor exhibits the highest 
levels of expression within the LC (Wang et al., 1996), the largest source of brain 
noradrenaline (Foote et al., 1983). LC neurons are known to stop firing at the onset of NREM 
(Takahashi et al., 2010) and inhibition of LC neurons using locally administered 
dexmedetomidine causes LORR in rats (Correa-Sales et al., 1992). Systemic doses of 
dexmedetomidine have also been observed to cause effects upstream of the LC that are also 
observed during NREM sleep such as increases and decreases in c-Fos expression within the 
VLPO and TMN respectively (Nelson et al., 2003) and similar EEG (Bol et al., 1997), 
suggesting that dexmedetomidine causes LOC via an endogenous sleep pathway.  
In contrast to this, despite progress on the molecular level with GABAA receptors, it is not 
known how anaesthetics that exert their effects on these receptors act on the level of neuronal 
networks. For example, although injection of pentobarbital into an area within the brainstem, 
the mesopontine tegmentum, causes LORR in rats (Devor and Zalkind, 2001), the EEG 
recorded resembled sleep but did not contain spindle features that are stereotypical of 
pentobarbital recordings (Contreras et al., 1997). Thus, effects of systemic pentobarbital 
administration are not limited to the mesopontine tegmental area. Additionally, different 
anaesthetics appear to target GABAA receptors with different subunit compositions, which, 
while assumed to be ubiquitous, have varying distributions throughout the brain (Uusi-Oukari 
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and Korpi, 2010). Thus anaesthetics acting upon GABAA receptors may still exert effects on 
different pathways. Another example of an anaesthetic that exerts effects on GABAA 
receptors is propofol, however the EEG spectra exhibited by this anaesthetic is markedly 
different from that of pentobarbital and NREM sleep (Purdon et al., 2013), and experimental 
evidence has suggested that this anaesthetic induces LOC via preferential actions within the 
cortex as opposed to subcortically (Velly et al., 2007).  
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1.4 Studying The Brain: Neuroimaging And in vivo Electrophysiology Techniques 
Experiments seeking to study the neuronal pathways involved in sleep and anaesthesia utilise 
two primary techniques, neuroimaging and in vivo electrophysiology.  
Current neuroimaging experiments use blood-oxygen-level dependent functional magnetic 
resonance imaging (BOLD-fMRI) as opposed to previous nuclear techniques such as positron 
emission tomography (PET), as it is non-invasive and provides greater spatial and temporal 
resolution (Duyn, 2012). This technique measures the increase in blood flow supplying the 
oxygen required for increased neuronal activity, thought to correlate with both excitatory and 
inhibitory synaptic transmission. Thus, the exact nature of the underlying neuronal activity 
cannot be deduced using fMRI (Logothetis, 2008). Despite this BOLD-fMRI is an excellent 
tool for investigating the entire brain with excellent spatial resolution of up to 2mm (Shmuel 
et al., 2007). Identifying by correlation, the brain regions functionally involved in task 
evoked and resting brain activity. Correlation (Pearsons product moment correlation 
coefficient), can be calculated between all parts of the brain divided up into volumetric units 
called voxels. However to do this between each voxel is computationally intensive and 
produces vast quantities of data that would require additional analysis. Instead, the 
correlations are calculated between a selection of voxels known as a seed region, and the rest 
of the brain. The seed region is typically a relevant and specific anatomical feature, thus, 
changing correlations between the seed region and other parts of the brain across transitions 
in consciousness are used to identify relevant changes in functional connectivity. However, a 
change in correlation does not imply causation, and further analysis in the form of granger 
analysis, graph analysis or dynamic causal modelling is required in order to identify the 
nature of the relationship between two brain areas showing high levels of correlation (Duyn, 
2012). 
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Despite BOLD-fMRI enabling the identification of changes in functional connectivity within 
the entire brain, in addition to the inability to identify the exact nature of the underlying 
neural activity there are also other practical drawbacks. The temporal resolution of fMRI is 
limited to 2.3 – 5 seconds (de Zwart et al., 2005) and the subject must remain immobile 
during the scan to avoid artefacts. Owing to the noise generated by MRI equipment, it can be 
difficult to induce natural sleep transitions. These factors and the prohibitive cost make MRI 
unsuitable for lab based experimentation involving consciousness transitions. 
In vivo electrophysiological techniques measure the electrical activity of the brain on multiple 
scales, from global measurements such as the electroencephalogram (EEG) to single neuron 
(single-unit) recording. The advantage of using electrophysiological techniques is that the 
cellular mechanisms underlying the measurement are reasonably well understood. With its 
first reported use in humans published by Hans Berger in 1929 (Berger, 1929), EEG is the 
measurement of an oscillating potential taken from electrodes placed on the scalp. This 
voltage with respect to a ground reference is a measurement of the fluctuating extracellular 
field at the recording electrode. This extracellular field is comprised of all superimposed 
transmembrane currents, the largest source of which is synaptic activity (Buzsaki et al., 
2012). The amplitude of this measured voltage is reliant on two main factors, the spatial 
orientation of the contributing neurons, and the synchrony of their contributions to the 
extracellular field. In laminar structures, the current sources and sinks are respectively 
clustered, thus giving large measured potentials in comparison to neuron clusters with a 
random spatial orientation (Linden et al., 2011). The level of synchrony, typically brought 
about by large scale network oscillations, is also directly causal to the amplitude of the 
potential measured (Buzsaki et al., 2012). It is the frequency of these network oscillations, 
which strongly correlate with differing behavioural states of the subject that is of interest 
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when using the EEG, or other extracellular recording techniques. These frequency bands will 
be discussed in Section 1.5.  
With the temporal resolution of the EEG being of the millisecond scale, it is excellent for 
identifying changes occurring across consciousness transitions. However, the spatial 
resolution of EEG is poor. When using a single recording electrode measuring the potential 
against ground, the measurement is effectively a summation of global activity across the 
cortex (Buzsaki et al., 2012). Whilst useful for identifying behavioural states, EEG cannot be 
used for the study of individual nuclei within the cortex or subcortically. Current EEG 
techniques use multiple electrodes that are closely spaced in order to attempt to overcome 
this, and electrocorticograms (ECoG) place these electrodes below the distortion inducing 
skull, and have an improved spatial resolution of <5mm, in high density configurations 
(Blakely et al., 2008). 
In order to probe the extracellular currents subcortically, an electrode, typically in the form of 
a single high-impedance tungsten microwire, is inserted into the relevant structure, known as 
the local field potential (LFP). Recent data suggests that the LFP not only records local 
extracellular potentials, but volume conducted potentials from up to a centimetre away 
(Kajikawa and Schroeder, 2011a). Eradication of volume conducted potentials, which are 
also prevalent in EEG recordings, can be achieved by using a minimum of three closely 
spaced electrodes, and calculation of the second spatial derivative, called Current Source 
Density (CSD) analysis (Mitzdorf, 1985). However the extra instrumentation required makes 
this approach impractical for recording from multiple sites. A reasonable compromise that 
eradicates the majority of volume conducted potentials (Mitzdorf, 1985) is to use the first 
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spatial derivative, obtained by using closely spaced bipolar electrodes (Bollimunta et al., 
2008). 
Further techniques such as multi and single-unit recording can measure the occurrence of 
action potentials within small numbers of, or single neurons, and thus are the most direct 
measurements of neural activity. However, recordings from each area are normally 
performed with multi electrode arrays sampled at 25 kHz (Vyazovskiy et al., 2011), which, 
with the size of the recording arrays and current technology, places a limitation on the ability 
to record from multiple cortical and subcortical sites on a freely moving rodent. 
Each neuroimaging and in-vivo electrophysiology technique has its own benefits and 
drawbacks. BOLD- fMRI is an excellent technique for examining the brain and implicating 
groups of nuclei in consciousness, but has practical limitations and gives little information 
with regards to the underlying neural activity. Extracellular potential recordings such as EEG, 
ECoG, and LFP exhibit well characterised oscillation features in response to the conscious 
state of the subject and under general anaesthesia, and can record from a limited number of 
cortical and subcortical sites simultaneously, but are not a direct measurement of neuronal 
firing and do not have the spatial reach of BOLD-fMRI. Lastly, single-unit recordings 
provide the most precise depiction of neural activity, but there are practical issues 
surrounding simultaneous recording from multiple subcortical and cortical sites. Given that 
extracellular oscillations are excellent markers of sleep and general anaesthesia, the next 
chapter will examine the thalamocortical system, a set of nuclei that generate these 
oscillations and are implicated in the maintenance and breakdown of consciousness.  
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1.5 The Thalamocortical System: Oscillations during Sleep and Anaesthesia 
The main oscillations observed during sleep and general anaesthesia arise from the 
thalamocortical loop. The thalamocortical loop in its most basic form is a continuous 
feedback loop consisting of thalamus, cerebral cortex and reticular thalamus. There are 
reciprocal glutamatergic projections between thalamus and cortex, with both ascending 
thalamic and descending cortical projections branching to the reticular thalamus. The 
reticular thalamus in turn provides GABAergic input to the thalamus. Each of these three 
nuclei contain neurons that oscillate at an intrinsic rate, with their interactions governing the 
appearance of relevant frequencies being observed in the EEG at different times of sleep and 
under most general anaesthetics (Steriade, 2006). The main oscillations are the slow 
oscillation (0-1Hz), the delta oscillation (1-4Hz) and spindles (7-14Hz), which will now be 
discussed in turn. 
The slow oscillation is observed during natural sleep and under propofol, ketamine-xylazine 
and urethane anaesthesia (Massimini et al., 2004, Ni Mhuircheartaigh et al., 2013, Steriade et 
al., 1993b) Power within the slow oscillation band was originally attributed to the delta 
oscillation until the work of Steriade in the early 1990’s demonstrating a distinct low 
frequency oscillation exhibited by neocortical neurons in anaesthetised cats (Steriade et al., 
1993b). This oscillation consists of a distinct up (depolarised) state consisting of neuronal 
firing followed by down (hyperpolarised) states marked by quiescence. During the initial 
observations of the slow oscillation, additional recordings were undertaken of neurons within 
the reticular thalamus and thalamus where slow oscillations were observed and in the case of 
the reticular neurons, correlated with slow oscillations recorded from cortical EEG (Steriade 
et al., 1993a). However, following an additional in-vivo thalamic lesioning study published 
concurrently with the initial neocortical recordings, where bilateral thalamic lesions failed to 
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suppress the appearance of the slow oscillation within the EEG (Steriade et al., 1993c), 
subsequent research focussed on identifying an underlying cortical mechanism. 
Spontaneously occurring slow oscillations have been observed in isolated cortical slabs, with 
the frequency of these oscillations increasing with the size of the isolated slab, consistent 
with the concept that the up states resulted from the summation of spontaneous EPSPs 
(excitatory postsynaptic potentials)  being sufficient to generate an action potential within an 
individual neuron which then induced firing throughout the network (Timofeev et al., 2000). 
Despite the demonstration of this mechanism, in vivo observations of slow oscillations during 
sleep and anaesthesia differ to those seen within this isolated preparation (Crunelli and 
Hughes, 2010). In vivo up states observed within thalamic nuclei have been shown to precede 
cortical up states (Contreras and Steriade, 1995) and hyperpolarisation of thalamic neurons 
that exhibit slow oscillations upon metabatropic glutamate receptor (mGLUR) activation 
produce increases in frequency in line with those observed within the EEG during deepening 
sleep or anaesthesia (Zhu et al., 2006). Thus, the role of the thalamus in the in vivo generation 
of these rhythms has recently come back under scrutiny. Two separate studies within 
anaesthetised and naturally sleeping animals show that pharmacological or physical block of 
ascending thalamic projections to the cortex drastically reduce the slow oscillation frequency 
(David et al., 2013, Lemieux et al., 2014). Additionally, within one of the studies optogenetic 
stimulation of thalamocortical neurons at frequencies below 1.5Hz entrains the observed slow 
oscillation within the EEG (David et al., 2013). 
Delta oscillations are 1-4Hz oscillations observed within the EEG during NREM sleep. As 
sleep progresses following the transition from wake, spindle oscillations become less 
prevalent and are replaced by delta oscillations (Steriade et al., 1993a). Both thalamic and 
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cortical generators of the delta oscillation exist. Thalamic relay neurons can exhibit a 
continuous delta oscillation at sufficiently hyperpolarized membrane potentials. At membrane 
potentials less than -55mV, an inward rectifying current (Ih) consisting of sodium and 
potassium ions is activated, which in turn depolarises the neuron sufficiently to activate low 
threshold calcium currents (It) generating low threshold spikes and action potentials 
(McCormick and Pape, 1990b). Subsequent re-hyperpolarisation of the neuron occurs due to 
Ih being inactivated, and the refractory period of the It (Jahnsen and Llinas, 1984a), thus 
generating an invariant burst-firing rhythmicity in the delta range of frequencies. Distinct 
neocortical delta rhythms have been also observed within frontal and parietal, but not primary 
sensory areas of isolated rat neocortex. This oscillation was generated within layer 5 fast 
spiking interneurons and intrinsic bursting neurons under low cholinergic and dopaminergic 
tones characteristic of NREM sleep (Carracedo et al., 2013). Thus, the appearance of delta 
oscillations within the EEG, nested within the up state of the slow oscillation, is likely due to 
the interaction between intrinsic thalamic and cortical delta oscillation generators, although 
the in vivo relationship between these oscillators is unclear (Contreras and Steriade, 1995, 
Steriade, 2006) . 
Spindles are 7-14Hz oscillations observed during the early stages of NREM sleep. Nested on 
the up state of the slow oscillation (Molle et al., 2002), these oscillations ‘wax and wane’ 
occurring every 3 to 10 seconds and lasting 1 to 3 seconds within the EEG (Steriade et al., 
1993a), and are thought to arise from thalamoreticular interactions. The isolated reticular 
nucleus has been shown to generate spindles (Steriade et al., 1987), and spindle rhythmicity 
is abolished within thalamic and cortical areas deprived of reticular inputs (Steriade et al., 
1985). Thus, the 7-14Hz low threshold spike bursts occurring within reticular neurons cause 
hyperpolarisation of thalamic relay neurons via GABAergic afferents, resulting in the firing 
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of rebound bursts due to de-inactivation of the low threshold calcium
 
current (Ih) (Bentivoglio 
and Spreafico, 1988). These bursts propagate to the cortex, where the rhythmic EPSPs are 
observed within the EEG, before waning during the down state. Although, the primary 
generation point of spindles is within the reticular thalamus, afferents from cortical areas 
instigate synchronised spindle generation during the beginning of the up state of the slow 
oscillation (Contreras et al., 1997, Steriade, 2006). It must be noted however even during the 
early stages of NREM sleep that a spindle is not instigated for every up state, reflected by the 
temporal dynamics of spindles within the EEG (Molle et al., 2002). 
There are two other oscillations within the EEG that are present during the wake state, and 
are worth mentioning. The first oscillation is the theta oscillation (5-9Hz), present during 
REM (rapid eye movement) sleep and locomotor activities, thought to be generated within a 
medial septal- hippocampal pathway. The function of this oscillation is not fully understood, 
but it has been implicated as having a role in spatial memory and other processes involving 
the hippocampus (for reviews see (Buzsaki, 2002, Colgin, 2013)). Within studies of natural 
sleep in rodents, the robustness of the theta oscillation within the EEG is used to accurately 
score wake and transitions into natural sleep, marked by a reduction in the theta/delta ratio 
and a reduction in the amplitude of the electromyogram (EMG), a measure of muscle tone 
(Costa-Miserachs et al., 2003).  
The other oscillation is the gamma oscillation, a spontaneous oscillation of around 40Hz in 
frequency induced following the presentation of a stimulus in both frontal and somatosensory 
areas (Friedman-Hill et al., 2000, Bouyer et al., 1981). As information can be encoded by the 
phase within the gamma cycle at which an individual neuron fires (Fries et al., 2007), phase 
synchronisation between cortical areas, demonstrated in the LFP between parietal and 
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visual/motor cortices in awake cats (Roelfsema et al., 1997), indicates a role in conscious 
perception, with the strength of local synchronisation having a role in selective attention 
(Womelsdorf et al., 2006, Womelsdorf and Fries, 2007). GABAA receptor mediated 
inhibition is thought to underlie the generation of gamma oscillations within two proposed 
cortical models, a self-synchronising network consisting of solely inhibitory interneurons and 
a reciprocal network consisting of excitatory pyramidal and inhibitory interneurons (Buzsaki 
and Wang, 2012). However, gamma oscillations have also been observed in other areas of the 
brain, the hippocampus, thalamus, and brainstem areas (Bragin et al., 1995, Simon et al., 
2010, Kezunovic et al., 2012).  
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1.6 The Thalamocortical System: Anatomy  
The neocortex, which forms a large part of the cerebral cortex, facilitates a whole range of 
processes necessary for consciousness; by integrating external sensory information and 
generating resulting motor commands through processes involving conscious thought and 
knowledge of language. The thalamus has traditionally been thought of as a pure relay to the 
cortex, with nuclei within the thalamus transmitting sensory information to defined 
neocortical areas. The only sensory circuit that does not use a thalamocortical pathway is 
olfaction (Sherman et al., 2006). However, evolving knowledge of input afferents to and 
projections from thalamic nuclei, have led to a range of additional functions, including 
facilitation of long range cortical information transfer (Sherman, 2012), being identified. This 
has resulted in the classification of thalamic nuclei into first or higher-order groups (Guillery 
and Sherman, 2011). 
First-order thalamic nuclei comprise the traditional relays of sensory information to the 
cortex, receiving afferent sensory information and relaying them via a class 1 glutamatergic 
projection innervating layers 4-6 in the relevant primary cortices (Viaene et al., 2011b). 
These class 1 projections, formally known as drivers (Sherman, 2012), typically account for 
the main information transmission. Following cortical processing in the primary region, 
information is transferred to higher-order cortical regions followed by premotor/motor areas. 
This can be done by a corticocortical pathway that consists of reciprocal projections (De 
Pasquale and Sherman, 2011) or an asymmetric corticothalamocortical route that utilises 
higher-order thalamic nuclei.  
Higher-order thalamic nuclei are distinguished by the fact that their class 1 inputs project 
from the primary cortices, typically layer 5 (Reichova and Sherman, 2004). This in turn is 
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projected to the relevant higher-order cortical nucleus. In addition, the higher-order thalamic 
nucleus also projects back to all layers of the primary cortical area (Viaene et al., 2011a), 
however the nature of this projection is a class 2 projection, formally known as a modulator.  
As the former name implies, these cells do not carry the information to be relayed, but can 
modulate the level of transmission from primary areas. This class of glutamatergic cell has 
distinct properties from Class 1 cells (Sherman and Guillery, 1998), and also forms 
corticothalamic projections from layer 6 in both first and higher-order thalamocortical 
circuits. The role of the higher-order nuclei in communication between differing cortical 
areas has been highlighted by Theyal et al (2010) who demonstrated that the class 1 
corticothalamocortical pathway from the barrel field of the primary somatosensory cortex 
(S1BF) could drive activity within the secondary somatosensory cortex (S2), via the posterior 
medial nucleus of the thalamus, following interruption of the direct cortical pathway. Given 
that this route forms a second pathway for cortical communication, the nature of this 
information transfer is debated, however information transfer via the corticothalamocortical 
pathway contains additional motor information, carried by branches to spinal cord motor 
centres. Additionally the thalamic relay neurons can be modulated by GABAergic inputs 
from local interneurons and the reticular thalamus, thus allowing modulation of the 
information transmission, not possible within the corticocortical pathway (Sherman and 
Guillery, 2011).  
In comparison to first-order thalamic nuclei, the ratio of class 2 inputs in comparison to class 
1 inputs has been shown to be significantly larger in higher-order thalamic nuclei (Wang et 
al., 2002). Additionally, higher-order relays have been shown to receive selective 
GABAergic input from the zona incerta (Bartho et al., 2002) , selective dopaminergic inputs 
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(Sanchez-Gonzalez et al., 2005) , and respond differently to cholinergic input (Mooney et al., 
2004), in comparison to first-order relays. These additional modulatory inputs imply that the 
higher-order thalamic nuclei have a more modulatory role in long range cortical information 
transfer, rather than simply facilitating the relay of a duplicate copy of the information sent 
via the corticocortical pathway. One possibility is that these nuclei modulate the synchrony 
between different cortical areas, facilitating the transmission of information requiring 
immediate attention (Saalmann et al., 2012) 
The intralaminar and midline nuclei are a distinct subgroup of higher-order thalamic nuclei. 
Discovered by Dempsey and Morison via electrical stimulation as being able to modulate 
global cortical activity (Morison and Dempsey, 1941), these nuclei were originally described 
as projecting cortically in a nonspecific manner, and formed part of the ascending reticular 
activating system (Moruzzi and Magoun, 1949). Despite having now been shown to project 
to distinct circuits primarily within the prefrontal and motor cortices, their importance as 
having a key role in arousal and cognition remains (Van der Werf et al., 2002). These nuclei 
receive dense innervation from a number of modulatory brainstem centres implicated in 
arousal (Krout et al., 2002), the nuclei of the reticular formation (the brainstem nuclei 
forming part of the reticular activating system) as well as the locus coeruleus (LC), dorsal 
raphe (DR), pedunculopontine (PPN) and laterodorsal tegmental (LDT), brainstem arousal 
nuclei discussed in Section 1.3. 
Crucially, lesioning and manipulation of distinct intralaminar and midline nuclei including 
the centromedian (CM) and central medial thalamus in humans and rodents (CMT) has direct 
effects on levels of consciousness. The CM, a midline nucleus located within the posterior 
intralaminar nuclei, is implicated in the gating attentional effort during visual motor tasks 
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(Schiff et al., 2013), and degeneration has been observed during Parkinson’s disease 
(Henderson et al., 2000). Neuronal loss within the CM and a midline nuclei located within the 
anterior intralaminar nuclei, the CMT) is observed in humans with vegetative state on the 
Glasgow coma scale, whilst lesions of other midline intralaminar nuclei are observed with 
patients exhibiting moderate or severe disabilities on this scale (Maxwell et al., 2006). Finally 
bilateral deep brain stimulation targeting the anterior intralaminar nuclei has been observed to 
improve the behavioural responsiveness of an individual within a minimally conscious state 
(Schiff et al., 2007). In rats, sevoflurane induced LORR can be reversed via administration of 
nicotine or a potassium channel inhibitor directly into the CMT (Alkire et al., 2007, Alkire et 
al., 2009, Lioudyno et al., 2013). Administration of GABAA agonist piperidine-4-sulfonic 
acid into the CMT at concentrations well below the systemic dose induces LORR (Miller and 
Ferrendelli, 1990), also replicated in unpublished experimentation within this lab using 
muscimol. The projections of the CMT in rats have been recently investigated, characterised 
by two subdivisions. In terms of cortical projections, the anterior subdivision of the CMT 
targets the medial anterior regions of the cortex, most specifically the anterior cingulate 
cortex and medial agranular cortex, whilst the posterior subdivision targets anterior lateral 
regions (Vertes et al., 2012). These prefrontal areas are associated with executive functioning 
across species, providing a level of cognition required for a range of complex behaviours 
such as attentional selection, resistance to interference, monitoring, behavioural inhibition, 
task switching, planning, decision making and maintenance of working memory (reviewed by 
(Dalley et al., 2004)). This experimental and anatomical data implicates the CMT as having 
an important role in arousal by facilitating higher-order cognitive processes. Although one 
striking study contradicts this, where near complete lesioning of the thalamus had no 
behavioural nor an EEG effect in rats (Fuller et al., 2011). 
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Figure 1.6.1 Diagram of Thalamocortical Anatomy. Displayed are the first and second order thalamocortical 
loops of the somatosensory system, a higher order thalamocortical loop involving the CMT, and the projections 
between them. 
Figure 1.6.1 summarises the thalamocortical anatomy presented within this chapter. 
Displayed are the interconnected first and second-order thalamocortical loops of the 
somatosensory system, consisting of the ventrobasal complex of the thalamus and the barrel 
field of the primary somatosensory cortex, and the posteromedial complex of the thalamus 
and the secondary somatosensory cortex respectively (Viaene et al., 2011b, Viaene et al., 
2011a, Sherman, 2012, Theyel et al., 2010, Brett-Green et al., 2004). These structures are 
concerned with relay of sensory information from the vibrissae via the trigeminal complex 
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(Jones and Diamond, 1995). Long range cortical connectivity between the S1 barrel cortex 
and the cingulate cortex (Zakiewicz et al., 2014), provides a potential link between this 
system and the higher-order intralaminar thalamic nuclei; as the cingulate receives input to all 
layers from the CMT (Vertes et al., 2012), which is in turn is modulated by the brainstem 
nuclei (Krout et al., 2002). It is of note that the cingulate does not contain layer IV (Vogt et 
al., 2004), which is typically implicated in the receipt of sensory information from the 
thalamus (Miller, 2003). 
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1.7 Mechanisms Underlying Consciousness, Sleep and General Anaesthesia  
The current leading mechanistic description of the unconscious state involves two 
observations. Firstly, an absence of spontaneous oscillations is observed, replaced by 
synchronised global oscillations within the EEG. Secondly, experimental evidence suggests 
that cortical integration is disrupted (Alkire et al., 2008). 
Aside from the aforementioned stereotypic and temporally invariant oscillations of sleep, the 
slow oscillation, delta and spindles, a notable example highlighting the absence of 
spontaneous oscillations is burst suppression observed during deep anaesthesia and coma. 
This consists of a near isoelectric EEG (suppression) being interrupted periodically by large 
voltage activity (bursts). These bursts occur synchronously across the scalp EEG and as 
general anaesthesia deepens, the ratio between the time spent in suppression and bursting 
increases (Ching et al., 2012). This neuronal quiescence has obvious implications for 
information transfer and whilst the bursting can be elicited by mechanical, auditory and 
visual stimuli, its transient, global nature suggests that it is stereotypic and unlikely to 
produce a conscious percept (Alkire et al., 2008). 
Loss of cortical integration is the reduction in functional connectivity (or long range 
information transfer) between distant cortical areas. During anaesthetic-induced LOC, EEG 
coherence in the gamma range of frequencies is disrupted across hemispheres and between 
anterior and posterior regions in humans (John and Prichep, 2005) and coherence reduces in 
evoked gamma oscillations between anterior and posterior regions in rats in a concentration 
dependent manner (Imas et al., 2006). This reduction in gamma coherence occurs in a 
specific manner, with the information flow from higher-order cortical nuclei back to  primary 
cortices disrupted (Imas et al., 2005). Neuroimaging data also suggests a reduction in 
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functional connectivity between cortical areas occurring during propofol and 
dexmedetomidine anaesthesia (Langsjo et al., 2012, Boveroux et al., 2010). This theory is 
further supported by recent data which uses transcranial magnetic stimulation (TMS) to 
induce a localised cortical activation, before observing the subsequent spread of this 
activation across the brain using high density EEG and CSD analysis. During wakefulness, 
aside from the local activation, subsequent activation was observed spreading into connected 
brain regions away from the local site. In contrast, during NREM sleep, although the 
localised activation is greater it does not propagate to connected brain regions and dissipates 
rapidly (Massimini et al., 2005). The same properties are also observed under midazolam 
anaesthesia (Ferrarelli et al., 2010), xenon and propofol anaesthesia (Casali et al., 2013), and 
within vegetative patients (Rosanova et al., 2012). 
As this observation is conserved across sleep, anaesthetic and pathological states, explaining 
the underlying mechanism causing loss of functional cortical connectivity is of great interest 
and revolves around the respective roles of the thalamus and cortex; does the thalamus 
modulate cortical activity, or vice versa?  
Evidence that modulation of thalamic nuclei can control arousal and clinical evidence that 
thalamic lesions within humans cause disruptions to consciousness has been described in 
Section 1.4. Although most neuroimaging studies consistently report a reduction in both 
cortical and thalamic metabolism across transitions into unconsciousness (Portas et al., 2000, 
Kaisti et al., 2002, Alkire et al., 1995). Subsequent increases during awakening from 
anaesthetics reveal that the restoration occurs in a bottom up manner, with minimal cortical 
reactivation (Langsjo et al., 2012). Additionally, recent neuroimaging studies undertaken 
during transitions into NREM sleep and propofol anaesthesia observe a selective reduction in 
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functional connectivity between higher-order thalamic nuclei and their respective cortical 
areas (Liu et al., 2013, Picchioni et al., 2014). Despite this neuroimaging evidence, 
corticothalamic pathways have been implicated in exerting effects on the thalamus under 
anaesthesia (Vahle-Hinz et al., 2007, Nakakimura et al., 1988). Additionally, 
electrophysiological attempts to identify the temporal relationship between cortical and 
thalamic regions during transitions into the unconscious state have produced varying and 
contrary results. Under propofol and sevoflurane anaesthesia in patients with Parkinson’s, 
changes within the cortical EEG, measured using dimensional activation (a measure of signal 
complexity that is reduced during unconsciousness), as well as spectral changes in the delta 
(0.5-3Hz) and beta (13.25-30Hz) frequencies, occurred at the LOC point. In contrast changes 
were not observed until several minutes after LOC within an LFP electrode recording from 
the subthalamic nucleus, which provided a surrogate measure for thalamic activity (Velly et 
al., 2007). In contrast to this, recordings from the medial pulvinar nucleus of the thalamus 
exhibit both spectral and dimensional activation changes that precede those of the cortex by 
several minutes within epileptic patients during transitions into NREM sleep (Magnin et al., 
2010). Finally experiments within rodents recording from the ventrobasal complex of the 
thalamus (VB) and barrel cortex, a well-known primary thalamocortical circuit responsible 
for the relay of sensory information from the vibrissae, conclude that simultaneous changes in 
both nuclei occur during wake-NREM sleep transitions and ketamine-xylazine anaesthesia 
(Gervasoni et al., 2004, Hwang et al., 2010).  
Clarifying these conflicting results and integrating them with proposed mechanisms of 
anaesthetic action forms one of the main motivations for this work. 
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1.8 Project Aims 
The aim of this project is to record LFPs from the first and higher-order thalamocortical 
circuits across wake-NREM transitions, propofol and dexmedetomidine LORR. This is in 
order to investigate the relationship between thalamus and cortex during transitions into 
unconsciousness, observing whether temporal differences between thalamus, cortex or first 
and higher-order circuits exist and aiming to reconcile contrasting data from past 
experiments. Analysis of the data will also seek to identify similarities in the LFP recordings 
that might indicate that anaesthetics exert their effects on endogenous sleep pathways, or that 
a common mechanism underlies transitions into the unconscious state.  
This will be achieved by recording from bipolar electrodes chronically implanted within 
freely moving rats using a Neurologger, a miniature device for the recording of 
electrophysiological signals. The nuclei to be recorded from are the ventrobasal complex of 
the thalamus and barrel cortex representative of a first-order thalamocortical circuit, and the 
central medial thalamus and cingulate cortex, representative of a higher-order thalamocortical 
circuit, as displayed in Figure 1.6.1. ECoG and EMG electrodes will also be used where 
necessary. The data will be analysed using continuous wavelet transforms and cross wavelet 
transforms in order to obtain a high degree of temporal resolution, as well as identify network 
dynamics between the nuclei.  
The project was initially started by Thom Gent (2011), and continued by myself with the 
assistance of Qianzi Yang and Susan Parker. The data presented here are currently in press, 
with a proof copy of the publication included in the Appendix. 
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2 Methods and Materials 
METHODS AND MATERIALS 
47 
 
2.1 Animal Welfare 
Sprague Dawley male rats weighing 300-360gr were housed individually and exposed to a 
12hr light:dark cycle. Surgical procedures and experiments were performed under the United 
Kingdom Home Office Animal Procedures Act (1986) with local ethical approval. Surgical 
procedures were undertaken observing best practices in aseptic technique, anaesthesia and 
analgesia. Rodents experienced a recovery period of at least seven days following delivery to 
the facility and each experiment or surgical procedure. In total 22 rats were used, of which, 
13 were used for more than one experiment (sleep, propofol or dexmedetomidine). 
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2.2 Surgical Methods 
General practice for the surgical procedures described below consisted of 30 minutes of 
premedication with 5mg/Kg SC enrofloxacin (Baytril, Bayer AG, Leverkusen, Germany) and 
15mcg/Kg SC buprenorphine (Temgesic, RB Pharmaceuticals LTD, Slough, UK). Under 
isoflurane anaesthesia (IsoFlo, Abbott Laborotories, Abbott Park, US-IL), the incision sites 
were shaved and prepared using 1% Povidone Iodine solution (Vetasept, Animalcare LTD, 
York, UK), with the animal located away from the surgical area. Depth of anaesthesia was 
assessed using the hind limb reflex, before the rat was relocated to the surgical area with 
maintenance of body temperature achieved using temperature regulating heat pads (Harvard 
Apparatus LTD, Edenbridge, UK). Sterility of the procedure was ensured using autoclaved 
instruments and implantables, and the use of sterile drapes. Following surgery the animal was 
left to recover in a temperature controlled environment before being returned to its cage. 
Post-operative treatment typically consisted of three days of 5mg/Kg/day p.o. enrofloxacin 
and 15mcg/Kg SC buprenorphine administered 12 hourly as required. 
2.2.1 Indwelling Jugular Vein Catheter 
In order to reliably deliver anaesthetics intravenously a permanently indwelling catheter was 
implanted into the right jugular vein of the animal. Following the premedication and 
induction process described, the rat was placed on its back, with isoflurane anaesthesia being 
maintained via a coaxial bain circuit (Harvard Apparatus LTD, Edenbridge, UK). A ~2cm 
anteroposterior stab incision was made above the right clavicle over the jugular vein. Blunt 
dissection of the subcutaneous tissue was performed in order to extract 1 cm of the right 
jugular vein onto a spatula. The vessel was punctured with a 25 gauge needle, and a 31 gauge 
stainless steel guide wire (MicroGroup, Medway, US-MA) inserted into the vein. After the 
tip of the guide wire entered the right atrium of the heart, a 9.5cm PTFE catheter (England 
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Adtech Polymer Engineering Ltd, Stroud, UK) was fed over the guide wire and into the right 
atrium before the guide wire was withdrawn and the catheter aspirated and flushed with 10 
I.U/ml Heparin Sodium solution (Wockhardt UK Limited, Wrexham, UK). The catheter was 
then sutured in place using non-absorbable suture (Ethilon, Ethicon Endo-Surgery (Europe) 
GmBH, Norderstedt, Germany), before the incision was covered with a sterile swab and the 
animal rotated onto its front. A second ~3cm anteroposterior stab incision was then made 
behind the right scapula and using blunt dissection with curved forceps, the free end of the 
catheter was fed over the shoulder such that it protruded from the second incision site. At this 
point, 5mm of a shortened and blunted 25 gauge needle was inserted into the catheter and a 
luer-lock injection cap (Infusion Concepts, Sowerby Bridge, UK) screwed onto the needle. 
Following aspiration and flushing of the complete assembly the needle and injection cap 
assembly was sutured to the underlying spinotrapezius/latissimus dorsi muscles using non-
absorbable suture fed through holes made in the luer connector of the needle. Finally, the two 
incision sites were closed using absorbable suture, (Coated Vicryl, Ethicon Endo-Surgery 
(Europe) GmBH, Norderstedt, Germany).  
2.2.2 Surgical Implantation of LFP, ECoG and EMG Electrodes 
Following recovery from catheterisation the rat underwent stereotaxic surgery to implant the 
electrodes required for in vivo electrophysiological measurements. Following premedication 
and induction a square section of the rat’s head extending from between the eyes to between 
the ears was prepared before the rat was mounted to a stereotaxic frame (Stoelting Co, Wood 
Dale, US-IL) using ear bars with isoflurane anaesthesia maintained via an inhalational mask 
integrated into the frame. The prepared square section of skin was then removed using a 
scalpel and fine tweezers before the periosteum was removed using sterile cotton buds. With 
the sutures exposed, the positions of bregma and lambda were recorded and the drilling 
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coordinates for the relevant electrodes (Figure 2.2.1) calculated using a rat brain atlas 
(Paxinos and Watson, 2005). Holes were drilled into the skull using a drill mounted to a 
frame arm (Stoelting Co, Wood Dale, US-IL) before the bipolar local field potential 
electrodes,  with 125µm tip separation  (WE3ST11.0F5, Microprobes, Gaithersburg, US-
MD), were inserted to the relevant depth and secured to the skull with polycarboxylate 
cement (Henry Schein Dental, Gillingham, UK) and/or ECoG screws (J I Morris Company, 
Southbridge, US-MA) screwed into the skull such that the tip contacted the dura mater. EMG 
wires (Cooner Wire Company, Chatsworth, US-CA) were implanted into the spinotrapezius 
muscles of the neck by firstly threading the wire through a 21 gauge needle and forming a 
hook at the end. This needle was then fed under the posterior section of the incision, 
puncturing the trapezius muscle, before being withdrawn leaving the EMG wire embedded 
within. Finally the LFP, EMG and ECoG wires were soldered to a seven pin header (Harwin 
plc Europe, Portsmouth, UK), which is in turn mounted onto to a rectangular PCB plate 
(Figure 2.3.2) Owing to the number of recording electrodes, up to 3 headers and 
Neurologgers were used. Following soldering, the wound was closed and the electrodes, 
wiring and header/PCB assembly secured in place using dental cement (Orthoresin, Densply 
Intrnational, York, US-PA). The co-ordinates for the bipolar electrodes and ECoG screws are 
recorded in Figure 2.2.1. 
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LFP electrodes 
Co-ordinate w.r.t. Bregma 
AP ML DV 
Central Medial Thalamus 
(CMT) 
-3.2 0.0 -6.5 
Cingulate Cortex 
(CING) 
3.0 -0.8 -2.3 
Ventrobasal Complex 
(VB) 
-3.4 -3.0 -6.0 
Barrel Cortex 
(BARR) 
-2.5 -5.0 -3.0 
 
ECoG electrodes AP ML 
Ground 7.0 1.0 
Reference -6.3 2.0 
1 2.0 2.0 
2 -10.3 0.0 
Figure 2.2.1 Coordinates of the LFP and ECoG recording sites. Derived from Paxinos and Watson (2005) 
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2.3 Neurologger 
2.3.1 Introduction and Specification 
The Neurologger (Figure 2.3.1) is a miniature device for recording in vivo 
electrophysiological signals designed and produced by Alexei Vyssotski (University of 
Zurich, Switzerland). Weighing approximately 3.4 grams including battery holder and 
batteries, it is detachable and can simultaneously sample, digitise and store in memory 4 
signal channels with two references at sampling rates of 200Hz, with 10 bit ADC resolution, 
for 33 hours. The advantage of this system over traditional tethered systems is that the animal 
is relatively uninhibited and can roam its home cage during sleep studies, thus removing 
stress related artefacts. Although other telemetry devices are available that continuously 
stream data via a wireless link; these typically require further surgery to permanently implant 
the device within the animal’s abdomen (Weiergraber et al., 2005). The advantage of the 
Neurologger being detachable is that with the number of devices available being limited on 
cost, multiple animals can be recorded from across a series of different experiments, within a 
short period of time. (Also see Section 8.1). 
Feature Specification 
Number of channels: 4 with 2 ref. inputs 
ADC resolution: 10 bit 
Input range: ± 500 µV 
Size:  22x15x5 mm 
Total weight: 3.42gr 
Battery life time: 33hrs 
256MB memory data filling time: 62hrs 
Figure 2.3.1 Neurologger specification. Adapted from Vyssotski (2014). 
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2.3.2 Device Mounting  
The Neurologgers were attached to the animal using the implanted 7 pin headers, one header 
per Neurologger, prior to the commencement of experiments. Mechanical artefacts can arise 
from the movement of the Neurologger relative to the header. In order to prevent this, the 
Neurologgers were fixed in place using two acrylic screws. On the animal the headers were 
mounted to a rectangular PCB plate with two holes drilled in the posterior corners. Once the 
Neurologgers were connected to their respective headers, the screws were fed through holes 
in the Neurologger battery holders and the PCB plate, securing the Neurologgers in place. 
The PCB plates and Neurologger battery holders were produced in-house by Susan Parker. 
The PCB plate/header assembly and a typical 2 Neurologger setup are shown in Figure 2.3.2. 
 
Figure 2.3.2 Header and Neurologger setup. The 7 pin header was mounted on a rectangular PCB base plate 
with a segregated ground plane. The area denoted by the upper arrow is fixed within the dental cement during 
surgery (A). Once the Neurologger was mounted holes on the battery holder were aligned with holes on the PCB 
plate (B). Mounting headers to both sides of the PCB plate enabled two Neurologgers to be fixed in place (C). 
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2.3.3 Use of Multiple Neurologgers 
For the majority of experiments, at least two Neurologgers were required. To ensure 
simultaneous recordings from both devices, the Neurologgers were connected to a common 
on/off switch. However, to test and align the data correctly, for each recording featuring a 
different Neurologger pair, calibration was undertaken using a circuit that elicited a pulse 
across all channels simultaneously, shown in Figure 2.3.3. Neurologger pairs were attached to 
the device and pulses elicited by the device at multiple time points within a 12 hour 
calibration period. This enabled the identification of potential start up time differences 
between the loggers as well as any minute sampling rate differences. All Neurologger pairs 
exhibited a start-up time difference of 0.015 seconds and sampling differences remained 
consistent across the recording period. The Neurologger pair exhibiting the greatest sampling 
difference had a sampling difference of 1 in 118416 samples. This meant that once the data 
sets were correctly aligned, the maximum time that could be analysed without the 
Neurologgers going out of sync by 0.005 seconds was approximately 592 seconds, well 
above the typical phase analysis time of 60 seconds. 
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Figure 2.3.3 Pulse box circuitry and elicited pulse traces. Synchronous pulses were evoked across all 
Neurologger channels (A) by the circuit in (B). Multiple Neurologgers were attached to the modified potential 
divider circuit (B), and the pulses aligned for calibration purposes. 
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2.4 Experiments 
2.4.1 Loss of Righting Reflex Protocol 
Loss of Righting Reflex (LORR) is used as a surrogate measure of consciousness in rodents 
with the EC50 (half maximal effective concentration) values for LORR corresponding well 
with the EC50 values for LOC in humans (Franks, 2008). Thus, the righting reflex of the rat 
was assessed during anaesthetic infusion experiments by forcing the rat to continually right 
itself within a 15cm plexiglass tube rotating at 3 RPM. After the Neurologgers are fitted, 
switched on and the infusion line connected to the catheter using a 23 gauge needle inserted 
into the injection port, the animal was left to acclimatise to the tube, which rotates for a 
minimum of 5 minutes prior to the commencement of drug infusion. Anaesthetic agents 
Propofol (Propoven, Fresenius Kabi LTD, Cheshire, UK) or Dexmedetomidine (Tocris 
Bioscience, Bristol, UK) were administered using a syringe pump (Harvard Apparatus LTD, 
Edenbridge, UK), with concentrations and infusion rates outlined in Figure 2.4.1. LORR was 
scored as the point at which all four paws of the rat left the surface of the tube as it rolled 
onto its side, with no attempt at righting made. At this point the infusion was stopped for 
most experiments and the animal left undisturbed, with the waking (recovery of spontaneous 
movement) and regain of righting reflex points recorded.  
Anaesthetic Concentration Infusion Rate 
Dexmedetomidine 20µg/ml 20µg/Kg/min 
Propofol 10mg/ml 10mg/kg/min 
Figure 2.4.1 Anaesthetic concentration and infusion rates used in LORR experiments. 
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2.4.2 Recording of Natural Sleep  
In order to record transitions into natural sleep, the animal was fitted with Neurologgers and 
returned to its home cage at least two hours prior to the lights-on phase. Recordings typically 
lasted 15 hours before the Neurologgers were removed for the downloading of data. The 
behavioural state of the animal throughout the lights-on phase was assessed following the 
experiment using a sleep scoring algorithm (described in Section 2.5.1) on recorded 
LFP/ECoG and EMG data. 
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2.5 Data Analysis 
2.5.1 Sleep Scoring 
Following sleep experiments, the downloaded data was displayed in Spike2 (Cambridge 
Electronic Design Limited, Cambridge, UK) and the behavioural state of the rat identified 
using a script based upon the work of Costa Miserachs et al (2003). The script uses 5 second 
segments of ECoG and EMG to score the behaviour of the animal into 3 behavioural states; 
Wake, NREM and REM sleep. In the first step, the delta (0.5-4Hz) and theta (6-10Hz) 
content of the ECoG and magnitude of the EMG was used to score the majority of epochs 
along the following guidelines. Segments with an intermediate theta/delta ratio and large 
EMG power were scored as Wake, a low theta/delta ratio and low EMG amplitude as NREM 
sleep and segments with a large theta delta ratio and minimal EMG power scored as REM 
sleep. Statistics (mean and standard deviation), of the theta/delta ratio, delta power and EMG 
power were then calculated for each of the three states in order to score segments that could 
not be scored initially. This enables the identification and scoring of wake periods containing 
artefacts, and REM and NREM periods that fail the initial arbitrary criteria, but are close to 
the statistical values calculated for these states from the constituent data. 
Twenty second epochs were then constructed from each set of four consecutive 5s segments, 
determined by the most prevalent state. Epochs which contained no prevalent state were 
initially scored as Doubt before a final reassignment of these epochs was undertaken by 
comparing how the epoch content compared to the state scored in the previous epoch. After 
this final refinement 10 ±1% (n=12) of epochs were still scored as Doubt. This may have 
caused problems with circadian studies, but is of limited consequence for these experiments. 
The segment error was only 1.7 ±1% and only periods of data free of any doubt were chosen 
for the wake-NREM transitions and steady state periods analysed. 
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2.5.2 Continuous Wavelet Transform 
In order to visualise changes in frequency and power within the LFP signal with high 
temporal resolution, the continuous wavelet transform (CWT) (Torrence and Compo, 1998) 
was calculated using a modified version of scripts by Aslek Grinsted (2004) in MATLAB 
(MathWorks, Cambridge, UK). The creation of the CWT involves the convolution of the LFP 
signal (𝑥(𝑡)) with a mother wavelet (𝜑(𝑠, 𝜏)): 
𝑊(𝑠, 𝜏) = 𝑥(𝑡) ∗  𝜑(𝑠, 𝜏) 
The wavelet chosen is the Morlet wavelet, which is a plane wave modulated by a Gaussian 
function, In order to satisfy the admissibility criterion, the mother wavelet must have zero 
mean and be localised in time and frequency space (Torrence and Compo, 1998), thus for the 
mother wavelet shown below 𝜔0 = 6.  
𝜑0 (
𝑡
𝑠
) = 𝜋
−1
4 𝑒𝑖𝜔0𝑡/𝑠𝑒−(
𝑡
𝑠)
2
/2
 
By varying the wavelet scale (s) (analogous to period) of the mother wavelet, and translating 
along the time axis, a time varying amplitude value is created for each scale and time point 
(τ). The wavelet power is defined as the square of this value. 
𝑊𝑥(𝑠, 𝜏) =
1
√𝑠
∫ 𝑥(𝑡)𝜑0
∗ (
𝑡 − 𝜏
𝑠
) 𝑑𝑡
∞
−∞
 
𝑃𝑜𝑤𝑒𝑟 =  |𝑊𝑥(𝑠, 𝜏)|
2 
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This method provides advantages over the traditional Fast Fourier Transform, which has a 
frequency resolution proportional to the time sampled. For our data sampled at 200Hz (𝑓𝑠), in 
order to obtain a frequency resolution better than 0.5Hz (𝑑𝑓) restricts the time resolution to 2 
seconds (National-Instruments, 2008). 
∆𝑓 =
1
∆𝑡
=
𝑓𝑠
𝑁
 
𝑁 = 𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑠𝑎𝑚𝑝𝑙𝑒𝑠 
0.5 >
200
𝑁
 
𝑁 > 400 
∴ ∆𝑡 > 2𝑠 
In contrast the frequency and time resolution of the CWT is dependent on the target 
frequency (𝑓𝑖) being analysed. The frequency resolution improves and the time resolution 
decreases as the target frequency reduces (Kijewski and Kareem, 2003). 
∆𝑓𝑖 =
𝑓𝑖
2𝜋√2𝑓0
 
∆𝑡𝑖 =
𝑓0
𝑓𝑖√2
 
𝑤ℎ𝑒𝑟𝑒 𝜔0 = 6 = 2𝜋𝑓𝑜 
For a 2 Hz target frequency this corresponds to ∆𝑓2𝐻𝑧 = 0.24Hz and ∆𝑡2𝐻𝑧 = 0.34s. 
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An additional advantage of the CWT is the ability to define features within the data that are 
not attributable to a background noise source. In this case, a Fourier red noise background 
spectrum for N points is calculated using a lag-1 autoregressive process (Torrence and 
Compo, 1998): 
𝑃𝑘 =  
1 − 𝛼2
1 + 𝛼2 − 2𝛼cos (2𝜋𝑘 𝑁⁄ )
 
where 𝛼 is the lag-1 autocorrelation, k is the fourier frequency index. For a normally 
distributed time series 𝑥(𝑡) with a variance σ2, the magnitude of the Fourier transform will be 
Chi squared distributed with two degrees of freedom 𝜒2
2. Thus the distribution for the local 
wavelet power spectrum is (Torrence and Compo, 1998): 
|𝑊𝑥(𝑠)|
2
𝜎2
⇒
1
2
𝑃𝑘𝜒2
2 
By using the appropriate background spectrum (red noise), and by choosing an appropriate 
confidence level for the chi-square distribution of 95%; the 95% confidence interval  can be 
calculated for the local red noise power spectrum at each wavelet scale (s). By identifying 
where the wavelet power exceeds the upper bound of the red noise 95% confidence interval, 
the data exhibiting 95% confidence above the red noise background could be obtained. All of 
the data presented in the following results chapters exceed the 95% confidence level. 
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2.5.3 Cross Wavelet Transform 
Information from the CWT’s of two LFP recordings can also be combined in a process called 
the Cross Wavelet Transform (XWT) in order to identify the covariant power of the two 
signals at each scale (s) and time (τ) (Grinsted et al., 2004). 
𝑊𝑥
𝑋𝑌(𝑠, 𝜏) = 𝑊𝑥
𝑋(𝑠, 𝜏)𝑊𝑥
𝑌∗(𝑠, 𝜏) 
𝑃𝑜𝑤𝑒𝑟 =  |𝑊𝑥
𝑋𝑌(𝑠, 𝜏)| 
Additionally the phase relationship between the two LFP’s can be deduced by taking the 
complex argument of the result. 
𝜃(𝑠, 𝜏) = 𝑡𝑎𝑛−1 (
ℑ(𝑊𝑥
𝑋𝑌(𝑠, 𝜏))
ℜ(𝑊𝑥𝑋𝑌(𝑠, 𝜏))
) 
Changes in phase across behavioural endpoints may suggest underlying changes in 
connectivity between nuclei corresponding to those timepoints. As with the CWT, the 95% 
confidence level of the XWT can be compared with a red noise distribution given by 
(Grinsted et al., 2004) 
|𝑊𝑥
𝑋(𝑠, 𝜏)𝑊𝑥
𝑌∗(𝑠, 𝜏)|
𝜎𝑋𝜎𝑌
⇒
𝑍𝑣(𝑝)
2
√𝑃𝑘
𝑋𝑃𝑘
𝑌 
where 𝑍𝑣(𝑝) is the confidence level associated with probability 𝑝 for the probability density 
function defined by the square root of two chi-squared distributions. Once again only XWT 
power and phase data exhibiting 95% confidence was used for analysis in the results section. 
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2.6 Verification of LFP Electrode Positions 
Following the completion of all experiments, histological slices of the brain were prepared, 
so that the location of the LFP electrodes could be verified. The majority of the histology was 
performed by Qianzi Yang. Under terminal (100mg/Kg) Ketamine (Ketaset, Zoetis, Florham 
Park, US-NJ) and (20mg/Kg) Xylazine (Rompun, Bayer AG, Leverkusen, Germany) 
anaesthesia (i.p.) and after loss of hind limb reflex, the rat was placed onto its back and a 
medio-lateral incision was made across the diaphragm. Using scissors the ribs were cut 
through on both sides of the midline and peeled back to expose the heart. The left ventricle 
was pierced using a blunted 16 gauge needle, which was then held in place using forceps. 
Initially 150 ml of Phosphate Buffered Saline (PBS) was administered through the needle at a 
rate of 15ml/min with an incision made in the right atrium to allow drainage. Following this 
200ml of 4% Paraformaldehyde (PFA) was perfused before the brain was removed from the 
skull and allowed to rest for 24 hours in 50ml of the 4% PFA solution before being 
dehydrated in 30% sucrose solution. Finally, the brain was frozen in dry ice before 50 µm 
coronal sections were sliced using a cryostat, mounted onto glass slides and examined under 
a microscope. Electrode tracts were located and the most ventral point of the tract, 
corresponding to the electrode tips, recorded and compared to the target using the Paxinos 
Rat Brain Atlas (2005) Representative histological sections and recorded tip locations are 
shown in Figure 2.6.1. 
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Figure 2.6.1 Verification of LFP Electrode Positions. Electrode positions for the experimental group of 
animals (A) and representative sections (B) 
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2.7 Verification of LFP Recording Method 
As discussed in Section 1.4, Bipolar LFP electrodes have been deemed to record changes in 
the extracellular field across small distances. In the experiments performed, the two 
electrodes with the closest spacing were the CMT and VB, with an electrode tip separation of 
3mm. Figure 2.7.1 shows traces from the four electrodes in a single animal under 
dexmedetomidine anaesthesia. With little similarity between the CMT and VB traces, it can 
be concluded that for the purposes of the following experiments, that the LFP’s recorded 
were sufficiently local. 
 
Figure 2.7.1 Example LFP recording. Raw LFP traces from a single animal under dexmedetomidine 
anaesthesia. The pair of LFP electrodes with the smallest distance between them, the CMT and VB, showed 
minimal common features thus indicating that the LFP’s recorded over a sufficiently local volume for these 
experiments. 
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3.1 Comparison of Sleep Scoring with ECoG And LFP Electrodes 
In order to reduce the number of recording electrodes per animal, it could prove useful to 
substitute the ECoG screws, which are predominately used for the purposes of sleep scoring, 
with an appropriate LFP electrode. In order to investigate this, animals equipped with all four 
LFP electrodes and ECoG/EMG electrodes underwent a standard overnight sleep recording. 
Following this, scoring of the animals behavioural state was undertaken with each LFP 
electrode and a common EMG channel. Each 5 second segment scored was compared to the 
corresponding segment scored with the frontal ECoG electrode, the percentage agreement 
between the LFP scoring and ECoG scoring is shown in Figure 3.1.1. 
 
Figure 3.1.1 Comparison of LFP and ECoG sleep scoring. (n=3) Percentage of epochs scored correctly with 
LFP electrodes versus an ECoG benchmark. The data is split into the behavioural states scored by the algorithm. 
With 91 ± 2 % of wake states scored correctly, and 92 ± 1 % of NREM states scored correctly, the CMT LFP 
proved the most accurate. None of the LFP’s are able to score REM sleep accurately. Error bars indicate SEM. 
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Figure 3.1.1 shows that with 91 ± 2 % of wake states scored correctly, and 92 ± 1 % of 
NREM states scored correctly, the CMT LFP proved the most accurate surrogate electrode 
for performing sleep scoring. None of the LFP electrodes were able to score REM sleep 
accurately.  
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3.2 Analysing Wake-NREM Transitions Using a Standardised Method 
 
Figure 3.2.1 Wake-NREM transition: Representative EMG data and ECoG/LFP wavelets. At the Wake- 
NREM transition EMG tone decreases abruptly, and changes occur in the ECoG and all four nuclei. During 
NREM onset, prior to the establishment of global delta oscillations, spectral changes occurred in the CMT and 
ECoG, whereas silence was observed in the cingulate, VB and in most cases the barrel. Areas in white represent 
omitted data that do not exceed the 95% confidence level for the local red noise background. 
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Figure 3.2.1 shows a typical Wake-NREM transition with the sleep scoring, EMG, ECoG and 
LFP recordings from the four nuclei. During the wake state, the theta oscillation can be 
observed globally, as well as sporadic power that varies in frequency around 32Hz. At the 
scored Wake to NREM transition the EMG tone abruptly reduces and is accompanied by a 
profound change in the ECoG and LFP recordings. The CMT and ECoG exhibit a breakup of 
the continuous theta oscillation and a sudden reduction in frequency and increase in power of 
the high frequency component. Relative silence is apparent in the cingulate, VB and most 
barrel recordings. This state, henceforth labelled NREM onset, lasted for approximately 10-
15 seconds before the establishment of a global delta oscillation characteristic of NREM 
sleep in rats (Gervasoni et al., 2004) (Also see Section 3.5) 
The wake- NREM transition (Figure 3.2.1) exhibits changes in 3 distinct frequency bands, 
dynamic changes in a high frequency band between 10 and 64 Hz and changes in the delta (1-
4Hz) and theta (5-9Hz) bands. The methods of analysis described below in conjunction with 
the reporting of the results for the wake-NREM transition will form the basis for all analysis 
used within the thesis. 
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3.3 Wake-NREM: Changes within the 10-64Hz band of frequencies 
In order to characterise the apparent change in the high frequency band of oscillations during 
the Wake-NREM transition period, the CWT of each nuclei was analysed in order to identify 
the frequency exhibiting the largest power at each time point within the 10-64Hz range. To 
prevent effects at the frequency boundaries, the frequency identified had to exhibit a peak in 
power i.e. adjacent frequencies had lower power values. The corresponding frequency and 
normalised power values for each individual animal were then plotted against time. The 
power values were normalised between animals by taking the ratio between the power for the 
second concerned, and the maximum power value for one second obtained for the recording 
period. Averages (n=9) are displayed in Figure 3.3.1. 
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Figure 3.3.1 Wake-NREM 10-64Hz average frequency and power graphs. (n=9) Average peak power & 
frequency at peak power in the 10-64Hz band during Wake-NREM transitions. A general reduction in frequency 
occurs from ~40Hz to~20Hz across the transition accompanied by an increase in relative power. Changes within 
the CMT and ECoG occur more abruptly than the other nuclei, with changes in the CMT occurring first. 
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General trends in the 10-64Hz range of frequencies across the wake-NREM transition were 
for the frequency to reduce in all nuclei from ~40Hz to ~20Hz, with an accompanying 
increase in power (Figure 3.3.1). Most notably the transitions within the ECoG and CMT 
occurred rather abruptly and coincided with the NREM onset point, with the changes in the 
CMT appearing to occur prior to the ECoG. In contrast to this, changes within the other 
nuclei appeared to occur several seconds after the NREM onset point, mirroring the changes 
observed in Figure 3.2.1.  
The power and frequency vs time graphs in Figure 3.3.1 also exhibit a line of best fit for each 
graph, fitted in Origin (OriginLab Corporation, Northampton, US-MA) using a Hill Curve 
(Hill1) fitting function and Levenberg-Marquardt algorithm. 
𝑦 = 𝑆𝑡𝑎𝑟𝑡 + (𝐸𝑛𝑑 − 𝑆𝑡𝑎𝑟𝑡)
𝑥𝑛
𝑘𝑛 + 𝑥𝑛
 
 
Figure 3.3.2 Sample Hill curve and formula. k is the x value at the half maximum point on the curve. 
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In order to characterise the difference in transition timing between the CMT and the other 
nuclei reported in Figure 3.3.1, lines of best fit were plotted onto individual recordings using 
Hill curves and the value at the half time of the transition, k, was obtained. Average half-
times for each of the nuclei are displayed in Figure 3.3.3 for both power and frequency. With 
respect to the NREM onset point the average half-times (n=9) are ECoG: +3.03 ±1.2s, CMT: 
-1.95 ±2.4s, cingulate: +7.93 ±5.5s, VB: +4.89 ±1.5s and barrel: +8.69 ±4.4s for frequency 
and ECoG: +8.72 ±3.8s, CMT: +1.67 ±1.1s, cingulate: +15.12 ±5.5s, VB: +12.40s ±3.2s and 
barrel: +12.80 ±3.2s for power. Thus, changes in the CMT precede those within the ECoG 
and LFP and occur closest to NREM onset, with changes in the three remaining LFPs 
occurring several seconds after the transition. P values were obtained using paired Student’s 
two-tailed t-tests with respect to the CMT and suggest a statistically significant lead of the 
CMT in all cases except against ECoG power. Finally, it is interesting to note that the 
changes in frequency appear to precede the increases in power for all nuclei.  
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Figure 3.3.3 Wake-NREM 10-64Hz average frequency and power half-times. (n=9) Changes in the CMT 
precede all other nuclei. P values are paired, two-tailed Student’s t-tests with respect to the CMT. Error bars 
indicate SEM. 
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3.4 Theta and Delta Power during Wake-NREM Transitions 
 
Figure 3.4.1 Wake and NREM average theta and delta power. (n=9) In NREM there is an increase in both 
theta and delta power in comparison to Wake, however the theta/delta ratio is considerably reduced. Error bars 
indicate SEM 
The other two power bands that show characteristic changes in power across the wake to 
NREM transition are the theta (5-9Hz) and delta (1-4Hz) range of frequencies. In order to 
characterise these changes, a normalised power value for each of the frequency bands was 
calculated for the wake state and the NREM state. To do this for an individual recording, a 
CWT encompassing the wake–NREM transition was first produced, before the power per 
second was calculated for each of the two frequency bands, using the time periods 
corresponding to the relevant state. The NREM period was chosen to be well after the NREM 
onset point. The power per second values for the theta and delta bands were then normalised 
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against the total power per second from 0.5-128Hz during NREM. This period and range of 
frequencies for normalisation was chosen as the NREM period showed the most consistency 
across the four LFP electrodes, with no risk of movement artefacts or observable changes 
across time (See last 20s of Figure 3.2.1 and Figure 3.5.1). These normalised power were 
then averaged across animals (n=9) in order to create the bar charts shown in Figure 3.4.1, 
which shows that the transition from wake to NREM involves an increase in both theta and 
delta power. However during the wake period there is a high theta/delta ratio exhibited within 
all nuclei, which is greatly reduced in NREM. Additionally examination of the Wake-NREM 
wavelets (Figure 3.2.1) suggests that the power within the theta band during NREM sleep is 
not from the same narrowband continuous oscillation exhibited during wake. 
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3.5 NREM Sleep: Phase Relationship within the Delta Band 
 
Figure 3.5.1 NREM sleep: Representative LFP wavelets. A typical example of the CWT’s exhibited during 
NREM sleep, featuring globally occurring temporally sporadic delta oscillations of high power. Other higher 
frequency oscillations can also be observed globally, and are more prevalent in the first-order nuclei. Areas in 
white represent omitted data that do not exceed the 95% confidence level for the local red noise background. 
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The CWT’s of NREM sleep for all nuclei exhibit temporally sporadic oscillations of high 
power within a wide range in frequencies in the delta range (Figure 3.5.1). In addition to this, 
power attributable to higher frequency oscillations in the theta band and above 10Hz were 
also evident, as highlighted previously by Figure 3.3.3 and Figure 3.4.1. Another method of 
analysis involves identifying the delta frequency exhibiting the largest peak power for each 
recording, before averaging across the data set. This results in values of 2.74 ±0.2Hz for the 
CMT, 2.39 ±0.3Hz for the cingulate, 2.78 ±0.3Hz for the VB and 2.95 ±0.2Hz for the barrel 
(n=9). Using this method, no statistically significant difference in the frequency exhibiting 
peak delta power was observed between the nuclei. For this method of recording and 
analysis, significant power was not observed in the sub-1Hz range of frequencies across both 
ECoG and the four LFP nuclei. 
In order to characterise the relationship within the delta range of frequencies between the 4 
nuclei during NREM sleep, the XWT was used in order to establish the phase relationships 
between the CMT and cingulate, cingulate and barrel, VB and barrel, the CMT and VB. 
These pairings were used in order to identify the phase relationships in the first and higher-
order thalamocortical loops, and between the first and higher-order thalamic and cortical 
nuclei. Additionally the phase relationships between the CMT and barrel, and VB and 
cingulate were calculated and are shown in order to check the phase relationships across all 
of the nuclei for consistency. 
For each animal, the phase information from the 1-4Hz band of frequencies was compiled 
from multiple periods of NREM sleep totalling at least 3 minutes for each electrode pair. As 
well as calculating an average value from this constituent data, polar histograms were used in 
order to graphically depict the dispersion of phases for the entire period. The phase 
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relationships between the six combinations exhibit a distribution of phases grouped around a 
single average value, a characteristic which will be referred to as phase locking. Figure 3.5.2 
shows the phases attributable to an individual animal represented with the grey shaded area. 
The average phase angle for the animals used (n=9), is denoted by the red arrow with the 
error bar representing the standard error of the mean. The thalamocortical relationships 
exhibit a phase difference of 112 ±11
o 
between the higher-order pair, the CMT-cingulate, and 
77 ±19
o
 between the first-order pair, the VB-barrel. In contrast the cortical pair, the cingulate-
barrel are in phase at 354 ±13
o
 and the thalamic pair, the CMT-VB are in phase at 359 ±8
o
. 
As can be seen by the CMT-barrel and VB-cingulate values of 64 ±15
o
 and 68 ±28
o
 
respectively, the phase averages calculated are self-consistent; the phase relationship between 
any nuclei pair can be correctly calculated using any combination of nuclei pairings. 
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Figure 3.5.2 Delta frequency phase relationships during NREM sleep. (n=9) Phase histograms from a 
representative animal (grey shaded area) with average angles for the group represented by the red arrow. Error 
bars indicate SEM. The thalamic nuclei exhibit a phase advantage over cortical nuclei, whilst the thalamic and 
cortical pairs are in phase with each other. 
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3.6 Fixing of LFP Electrode Polarities  
Although all electrodes were implanted using an identical protocol, the possibility existed 
that the two poles of the same electrode may, in different animals, be oriented differently 
with respect to the electric dipole within the nuclei. Thus, the polarity of the electrode may be 
reversed in one animal in comparison to another, which results in a phase value difference for 
the same electrode pair of 180
o
. This occurred in a small number of animals, and in order to 
overcome this, the phase relationship in the delta range of frequencies during steady state 
NREM sleep was used as a control. The polarities of the electrodes were oriented such that 
the higher frequency oscillations were nested on the peaks of the slower frequency 
oscillations, resulting in phase values that were in agreement between animals. Once the 
orientation of electrodes had been decided for each animal, this orientation was then fixed for 
phase experiments involving dexmedetomidine and propofol anaesthesia. 
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4 Characterisation of Dexmedetomidine 
Anaesthesia 
CHARACTERISATION OF DEXMEDETOMIDINE ANAESTHESIA 
84 
 
4.1 Dexmedetomidine LORR 
 
Figure 4.1.1 Dexmedetomidine LORR: Representative EMG data and LFP wavelets. Prior to LORR, high 
delta power was exhibited in all nuclei bar the VB. An abrupt reduction in EMG tone and reduction in delta 
frequency occurs at the LORR point. In addition to this, changes appear to occur in the high frequency 
components of the wavelets, a sudden change in frequency can be seen in the CMT, VB and barrel at LORR. 
Areas in white represent omitted data that do not exceed the 95% confidence level for the local red noise 
background. 
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Rats placed within the rotating tube and infused with 20µg/Kg/min Dexmedetomidine lost 
righting reflex after 116 ±14s (n=7). The period of sedation prior to LORR was marked by 
the establishment of a prominent continuous delta oscillation within the CMT, cingulate and 
barrel (Figure 4.1.1). At LORR, a sudden loss in EMG power occurred and the frequency of 
the continuous delta oscillation abruptly reduced. Additionally changes in the 10-64Hz band 
of oscillations can clearly be seen within the CMT, VB and barrel occurring at LORR.  
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4.2 Dexmedetomidine LORR: Changes in the 10-64Hz Band of Frequencies 
 
Figure 4.2.1 Dexmedetomidine LORR 10-64Hz average frequency and power graphs. (n=7) Average peak 
power & frequency at peak power in the 10-64Hz band across dexmedetomidine LORR. A Wake period, prior 
to infusion is also included. Dexmedetomidine has an effect on frequency and power prior to LORR. However 
in a similar fashion to the Wake to NREM transition, the LORR point is marked by an increase in power and 
decrease in frequency from ~40 to ~20Hz. However these changes all appear to occur simultaneously across the 
nuclei, and the changes in frequency are more sudden than changes in power, and occur just prior to LORR. 
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A change in the high frequency (10-64Hz) component of the CWT’s occurred in all nuclei 
both prior to and across LORR (Figure 4.2.1). Figure 4.2.1 also includes a section of wake 
data prior to the infusion of dexmedetomidine where the animal is continuously righting itself 
in the rotating cylinder. During this period the frequency of the identified peaks averages 
40Hz and exhibits the lowest normalised power. Following the infusion of dexmedetomidine, 
but prior to LORR, the average frequency reduces slightly to ~35Hz and an increase in 
relative power occurs across all nuclei. In a similar fashion to the Wake to NREM transitions 
(Figure 3.3.1), a further reduction in frequency and increase in power occurs at the point of 
dexmedetomidine LORR. The frequency reduction occurs simultaneously across all nuclei 
across a short period of time just prior to LORR. In contrast the power increase is, on 
average, gradual across the whole LORR period, again with no observable differences 
between the nuclei.  
 
Figure 4.2.2 Dexmedetomidine LORR 10-64Hz average frequency half-times. (n=7) The average frequency 
half-times occur prior to LORR in all nuclei with no significant difference in timing between them. 
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Attempting to characterise the relative timing of the power increase, by fitting hill curves to 
the individual recordings as previously described, did not work owing to the inconsistency of 
the individual recordings. However, the individual frequency transitions could be fitted on a 
more consistent basis. Thus the average half-times for the frequency reduction were 
calculated and are displayed in Figure 4.2.2. With respect to LORR these are CMT: -3.57 
±0.9s, cingulate: -2.16 ±3.6s, VB: -4.67 ±2.4s and barrel: -5.04 ±1.1s. The average half-times 
in all nuclei occur prior to LORR with no significant difference between them. Large 
standard errors, particularly for the cingulate and VB highlight the variability of the 
constituent data. 
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4.3 Theta and Delta Power during Dexmedetomidine LORR 
 
Figure 4.3.1 Wake and dexmedetomidine average theta and delta power. (n=7) During wake the delta 
power is minimal or has a large standard error attributable to it, whereas power within the theta band is small but 
more consistent across the nuclei. Following dexmedetomidine LORR the delta band contained a larger 
proportion of total power, with an accompanying increase in power within the theta band. Error bars indicate 
SEM. 
The changes in theta and delta power between the wake period and dexmedetomidine 
anaesthesia are characterised in Figure 4.3.1 (n=7). During the wake period prior to drug 
infusion, there is minimal power within the delta range of frequencies with the exception of 
the CMT and barrel, whose average values feature large standard errors. There is also power 
within the theta band, which is more consistent across the four nuclei. Following 
dexmedetomidine LORR there is a large increase in delta power in all four nuclei such that 
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the delta oscillation contains up to half of the total power within the 0.5-128Hz spectrum. 
There is also a modest increase in power within the theta range of frequencies. 
One of the main characteristics of the dexmedetomidine LORR period is the establishment of 
a high power, continuous, narrow band delta oscillation prior to LORR (Figure 4.1.1). The 
average frequency of the peak power of this oscillation was 2.87 ±0.2Hz in the CMT, 2.62 
±0.2Hz in the cingulate, 2.92 ±0.2 in the barrel (n=7). The appearance of continuous delta 
power within the VB was not present in 2 animals, but averaged 2.67 ±0.3Hz for the 
remainder. At LORR the delta oscillation abruptly reduced in frequency. The magnitude of 
the reduction was of the order of 0.5Hz; 0.51 ±0.2Hz in the CMT, 0.44 ±0.2Hz in the 
cingulate, 0.57 ±0.2Hz in the barrel and 0.60 ±0.45Hz in the VB. Using one sample Student’s 
two-tailed t-tests, all of the nuclei except for the VB exhibited a statistically significant 
reduction in frequency at the p=0.05 level (Figure 4.3.2)  
 
Figure 4.3.2 Dexmedetomidine Delta Frequency And Reduction across LORR. (n=7) Average peak delta 
frequency in each nuclei prior to LORR (white bars) and the magnitude of the delta frequency reduction at 
LORR (grey bars). The average delta frequency prior to LORR is ~2.5-3Hz. At LORR this reduces by ~0.5Hz. 
Stars represent significant changes in frequency at p<0.05 using a one sample Student’s two-tailed t-tests. Only 
the VB does not exhibit a significant change in frequency at LORR. Error bars indicate SEM. 
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The appearance of prominent delta oscillations prior to dexmedetomidine induced LORR and 
the sudden reduction in frequency occurring at LORR warranted further investigation using 
the XWT. Using the thalamocortical, thalamothalamic and corticocortical pairings used for 
the NREM phase analysis, the phase relationships between the nuclei within the delta range 
of frequencies were analysed for two periods of ten seconds either side of the loss of righting 
reflex point, in order to observe whether a change in phase between the nuclei accompanied 
the observed change in frequency across LORR. 
Figure 4.3.3 shows an example of the pre and post LORR phase relationships, shown by the 
grey shaded areas, and the averages for the experimental group (n=7), given by the red 
arrows with error bars representing the standard errors. In the two periods phase locked 
relationships exist between all nuclei pairs. Prior to LORR, the thalamocortical relationships 
were CMT-cingulate: 136 ±26˚ and VB-barrel: 100 ±34˚, with the corticocortical and 
thalamothalamic relationships in phase; cingulate-barrel: 348 ±27˚ and CMT-VB: 15 ±19˚. 
For completeness the other phase relationships were CMT-barrel: 90 ±20˚ and VB-cingulate: 
126 ±13˚. At LORR the phase relationships involving the CMT all reduce in phase by 30-60˚. 
The new phase relationships were CMT-cingulate: 89 ±18˚, CMT-VB: 318 ±18˚ and CMT-
barrel: 61 ±21˚. p values, shown in Figure 4.3.3 are from paired, two-tailed Student’s t-tests 
between the phase before and after LORR and suggest high levels of significance.  
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Figure 4.3.3 Delta frequency phase relationships across dexmedetomidine LORR. (n=7) A comparison of 
phase angles for the 10 second periods immediately prior to and following dexmedetomidine LORR. Polar 
histograms from an individual animal are displayed by the grey shaded areas and the group averages denoted by 
red arrows. A reduction in phase angle occurs between the CMT and Cingulate, and the CMT and VB at LORR. 
No other pair displays a phase shift. This implicates the relationship between the CMT and the other nuclei 
changing at the LORR point. p values are from paired t tests between the phase before and after LORR, and are 
shown where significant differences occurred. Error bars indicate SEM. 
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4.4 Comparison of Dexmedetomidine Anaesthesia and NREM Sleep 
 
Figure 4.4.1 Dexmedetomidine anaesthesia: Representative LFP wavelets. In all 4 wavelets there appears to 
be a high-power delta oscillation of around 2Hz. However, there is also power in the theta band and high 
frequencies. This occurs to a lesser extent within the CMT, with the cingulate only exhibiting large power 
continuously at 2Hz. Areas in white represent omitted data that do not exceed the 95% confidence level for the 
local red noise background. 
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Figure 4.4.1 shows typical wavelets observed during steady state dexmedetomidine 
anaesthesia. These all exhibit large delta power at around 2Hz. Noticeably the first-order 
nuclei and CMT exhibit power in the theta band, the cingulate contains the highest power 
within the delta band and exhibits minimal power within the theta range. This has previously 
been characterised in Sections 4.2 and 4.3, and although subtle differences exist, the range of 
frequencies exhibited during dexmedetomidine anaesthesia is similar to NREM sleep (Figure 
3.4.1 and Figure 4.3.1). The more continuous and larger delta power (Figure 4.4.1 & Figure 
3.5.1) during dexmedetomidine anaesthesia seems to be the main difference between the two 
states.  
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 Dexmedetomidine Anaesthesia NREM 
 Before LORR After LORR  
CMT - CING 136 ± 26˚ 89 ± 18˚ 112 ± 11˚ 
VB - BARR 100 ± 34˚
 91 ± 32˚ 77 ± 19˚ 
CING - BARR 348 ± 27˚ 338 ± 23˚ 354 ± 13˚ 
CMT - VB 15 ± 19˚ 318 ± 18˚ 359 ± 8˚ 
CMT - BARR 90 ± 20˚ 61 ± 21˚ 64 ± 15˚ 
VB - CING 126 ± 13˚ 112 ± 29˚ 68 ± 28˚ 
Figure 4.4.2 Delta band phase comparison between dexmedetomidine and NREM sleep. The two states 
exhibit similar phase relationships. 
Further examination of the phase relationships in the delta range, highlights the similarity 
between dexmedetomidine and NREM sleep. Figure 4.4.2 contains all of the average phases 
calculated across the dexmedetomidine LORR period and NREM sleep Here it can be seen 
that the phase relationships are similar between the two states, with the thalamic nuclei 
exhibiting a phase advancement of roughly 90
o 
over the cortical nuclei and the 
thalamothalamic and corticocortical relationships being in phase. Although there is no 
connectivity between the CMT and VB, CMT and barrel and the VB and cingulate, these are 
listed such that the consistency of results can be confirmed. 
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5 Characterisation of Propofol Anaesthesia 
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5.1 Propofol LORR 
 
Figure 5.1.1 Propofol LORR: Representative EMG data and LFP wavelets. Approximately 25s prior to 
LORR an increase in high frequency oscillations are observed at ~40Hz. These oscillations appear to increase in 
power and reduce in frequency approaching LORR. At LORR the EMG loses tone and the high frequency 
oscillations stabilise at approximately 20Hz. Additionally, a continuous oscillation of approximately 8 Hz 
appears globally. This oscillation appears to be unrelated to the theta oscillation, which is absent immediately 
prior to LORR. Areas in white represent omitted data that do not exceed the 95% confidence level for the local 
red noise background. 
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Rats placed within the rotating tube were infused with propofol at (10mg/Kg/min) and lost 
righting reflex after 48 ±3s (n=11). The LFP’s (Figure 5.1.1), all show similar behaviour 
across this transition, approximately 25s prior to LORR, the high frequency oscillations 
began to increase in power and reduce in frequency, from approximately 40Hz to ~20Hz at 
the loss of righting reflex point. At LORR, an abrupt reduction in muscle tone occurred, and 
the now 20 Hz oscillations stabilised in frequency and power. Strikingly a high power 
oscillation of approximately 8 Hz in frequency was established at the LORR point, unrelated 
to the theta oscillation, which was absent immediately prior to LORR. 
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5.2 Propofol LORR: Changes in the 10-64Hz Band of Frequencies 
The average frequency and power vs time graphs for the identified peak power in the 10-
64Hz band of frequencies is shown in Figure 5.2.1 (n=11). Here it can be seen that in all 
nuclei, there is an average frequency that oscillates around 40Hz until roughly 25 seconds 
prior to LORR, where this frequency reduces at a near constant rate to 20Hz at LORR. 
Following LORR the frequency stabilises at just below 20Hz, with much less variation in 
average frequency from second to second. The power increase noted in the wavelets (Figure 
5.1.1) is confirmed in Figure 5.2.1, which shows the power in the cingulate, barrel and VB 
increasing from a low stable baseline, commencing approximately 25 seconds before LORR 
and stabilising immediately prior to LORR, where the subsequent power values display a 
higher variability from second to second. A different relationship with respect to time is 
observed with the CMT, although the period prior to LORR involves a low power baseline 
followed by an increase in power commencing approximately 25 seconds prior to LORR, the 
increase in power is much greater, forming a peak at LORR. Following LORR the power 
decreases to a relative level similar to the other nuclei before remaining constant. 
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Figure 5.2.1 Propofol LORR 10-64Hz average frequency and power graphs. (n=11) Average peak power & 
frequency at peak power in the 10-64Hz band across propofol LORR. A reduction in frequency occurs from 
~40Hz to ~20Hz in all nuclei, commencing ~25 seconds prior to LORR and stabilising at LORR. This is 
accompanied by an increase in relative power, again commencing prior to LORR and stabilising just prior to the 
transition point. In contrast to the other nuclei, the power within the CMT rises to a much larger relative power 
at the transition point, before reducing and stabilising at a lower level. 
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With the power within the CMT showing a characteristically different shape, both on average 
(Figure 5.2.1) and with individual recordings, the line of best fit for power was plotted using 
a modified function combining a Hill1 curve with a Gaussian (Figure 5.2.2). This enabled the 
calculation of the half-times for the CMT power. Once again, in order to characterise any 
temporal differences between the nuclei, half-times for the frequency reduction and power 
increase were calculated for individual recordings, with the results shown in Figure 5.2.3. 
𝑦 = 𝐶 + (𝐵 − 𝐶) ∗  
𝑥𝑛
(𝑘𝑛 + 𝑥𝑛)
+ (𝐴 − 𝐶) ∗ 𝑒
−(𝑥−𝑡0)
2
2𝜎2   
 
Figure 5.2.2 Example Hill + Gaussian curve. Used to fit the CMT power data, A is the Gaussian height, B the 
Hill1 curve height, C the baseline, t0 the Gaussian peak position, k is the Hill1 time at half maximum, σ the 
Gaussian standard deviation and n the Hill coefficient. 
 
  
CHARACTERISATION OF PROPOFOL ANAESTHESIA 
102 
 
 
Figure 5.2.3 Propofol LORR 10-64Hz average frequency and power half-times. (n=11) Half-times for both 
frequency and power occur prior to the LORR point in all nuclei. Changes in the CMT precede all other nuclei. 
P values are paired, two-tailed Student’s t-tests with respect to the CMT. Error bars are standard errors. 
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The average half-time value for each of the nuclei is shown in Figure 5.2.3, which clearly 
shows that the frequency half-times for the higher-order thalamocortical nuclei, precede the 
first-order nuclei. These are -11.46 ±1.4s for the CMT, -10.76 ±1.7s for the cingulate, -7.87 
±1.5s for the VB and -5.72 ±1.3s for the barrel. Using paired students two-tailed t-tests, a 
significant difference was identified between the half-time values for the CMT and the first-
order nuclei, but not the cingulate cortex. The time at half maximum power for the CMT 
(Figure 5.2.3), also precedes all other nuclei. The half time value for the CMT is 16.27 ±1.7s 
prior to LORR in contrast to 9.15 ±1.5s, 9.01 ±3.7s and 8.81 ±2.4s prior to LORR in the 
cingulate, VB and barrel respectively. Using paired Student’s two-tailed t-tests on the 
constituent data confirmed that the difference between the CMT and each of the other nuclei 
were significant at the p<0.05 level.  
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5.3 Theta and Delta Power during Propofol LORR 
In addition to the changes observed in the high frequency oscillations at LORR, a prominent 
increase in power occurred in the theta range of frequencies, although this is unlikely to be a 
manifestation of the theta oscillation, which was absent immediately prior to LORR (Figure 
5.1.1). Additionally, following propofol LORR, increases in delta power were temporally 
sporadic and large increases occurred in some animals, but not in others.  
 
Figure 5.3.1 Wake and Propofol average theta and delta power. (n=11) Average theta and delta power 
during wake and following propofol LORR. It can be seen that there is a large, global, increase in theta power 
following LORR and a modest increase in delta power. Unlike dexmedetomidine and NREM sleep, during 
propofol anaesthesia the theta band contains more power than the delta band in all nuclei. Error bars indicate 
SEM 
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In order to characterise this, power in the theta and delta bands were calculated using the 
method outlined in Section 3.4 for a period of wake and a period of 10 seconds following 
LORR, before being averaged (n=11). The results, shown in Figure 5.3.1, confirm a large 
increase in power in all nuclei across LORR in the theta band and a modest increase in delta 
power. Unlike dexmedetomidine and NREM sleep, the power within the theta band is greater 
than that within the delta band in all nuclei. 
As an increase in delta power does occur following propofol LORR. An attempt was made to 
characterise the phase relationship within the delta band of frequencies. However, this phase 
relationship did not appear to remain consistent across time. Figure 5.3.2 shows an example 
of phase within the delta band changing across time following propofol LORR.  
 
Figure 5.3.2 Example of phase variability following propofol LORR. Here, 45 seconds of CMT-CING data 
in two consecutive segments following LORR is compared, showing a random distribution of phases. 
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5.4 Surgical Levels of Propofol Anaesthesia Result in Burst Suppression 
 
Figure 5.4.1 Propofol LOHLR: representative LFP wavelets. Representative LFP’s during transitions from 
wake to surgical levels of propofol anaesthesia, indicated by Loss of Hind Limb Reflex (LOHLR). Following 
LORR the power below 10Hz decreases until burst suppression, global bursts of high frequency power, 
interspersed by silence, occurs. The interburst frequency reduces to a minimum at the LOHLR point. Areas in 
white represent omitted data that do not exceed the 95% confidence level for the local red noise background. 
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In a variant of the propofol LORR protocol carried out in a small number of animals, an 
infusion of propofol at 5mg/kg/min continued past LORR until the hind limb reflex of the 
animal, a widely used test of anaesthetic depth used during rodent surgery, was lost (Loss of 
Hind Limb Reflex- LOHLR). The hind limb reflex was assessed every 15 seconds 
commencing one minute after LORR and the propofol infusion stopped at the LOHLR point. 
LFP recordings from the four nuclei are displayed in Figure 5.4.1. As the anaesthetic depth 
increases, the power below 10Hz reduces in all of the nuclei. Above 10Hz, the continuous 
high frequency oscillations described previously appear to become more intermittent with 
increasing anaesthetic depth, until discrete broadband bursts of high frequency can be 
observed. The interburst frequency decreases to a minimum at the LOHLR point, where the 
infusion of propofol was halted. Following this, a subsequent increase in the interburst 
frequency and the re-establishment of power below 10Hz occurred. This restoration appeared 
to occur much earlier within the cingulate, VB and barrel nuclei in comparison to the CMT. 
The recovery phase in investigated further in Section 5.5. 
 
 
 
 
 
  
CHARACTERISATION OF PROPOFOL ANAESTHESIA 
108 
 
5.5 Recovery from Propofol Anaesthesia Involves A NREM Sleep-Like Period 
 
Figure 5.5.1 Recovery from Propofol LOHLR: representative LFP wavelets. During recovery from 
propofol LOHLR a stage involving global low-frequency delta oscillations resembling NREM sleep occurs 
during the recovery phase. The oscillation is disrupted when the animal moves a paw (~750s), although RORR 
does not occur until several minutes later. Areas in white represent omitted data that do not exceed the 95% 
confidence level for the local red noise background. 
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A complete recording from a propofol LOHLR experiment is displayed in Figure 5.5.1 where 
it can be seen that following LOHLR, the recovery of power across the entire spectrum 
occurs rapidly in the cingulate, barrel and VB in contrast to the CMT. When power is 
regained within the CMT, it contains a low frequency delta oscillation resembling NREM 
sleep which is also established within the other nuclei. This global NREM sleep-like phase 
typically lasts for several minutes until the animal makes its first spontaneous movements. 
Whilst undisturbed, the animal may rouse briefly a number of times, indicated by 
spontaneous whisker and paw movements, before fully regaining righting reflex, as shown in 
Figure 5.5.1. These periods between movements also appear to have similarities with NREM 
sleep, with global sporadically occurring delta. At the wake point it is interesting to note that 
in addition to the reestablishment of the theta oscillation within the thalamic nuclei, the 
frequency of oscillations within the 10-64Hz range of frequencies abruptly increases in all 
nuclei. 
In order to further compare the NREM like period observed with previously characterised 
NREM sleep, 90s of phase within the delta band was extracted for comparison from each 
recording. Owing to a lack of recordings including the VB electrode, only the phases 
calculated between the CMT, cingulate and barrel nuclei are displayed in Figure 5.5.2 (n=5). 
Firstly, the phase during the 90s period exhibits phase locking, unlike the 90s period 
following propofol LORR described in Section 5.3. Additionally the average phase angles 
between the CMT and cingulate, cingulate and barrel and CMT and barrel are similar to those 
reported during NREM sleep (Section 3.5). This indicates that during unstimulated recovery 
from surgical doses of propofol, a transition occurs from the propofol induced state into a 
natural sleep-like state, before the animal regains righting reflex. 
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Figure 5.5.2 Delta phase relationships during recovery from propofol LOHLR. (n=5) Phase were obtained 
during the NREM like stage during propofol recovery, and resemble those observed during NREM sleep. The 
grey shaded area is from 90s of data from one animal, whilst averages are indicated by red arrows. Error bars 
indicate SEM. 
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6 Discussion 
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6.1 Overview 
In this series of experiments simultaneous recordings of ECoG, LFP and EMG data were 
obtained from freely moving animals during transitions into natural sleep or anaesthetic 
induced LORR using dexmedetomidine, an α2 adrenergic receptor agonist and propofol, 
which exerts its effects on GABAA receptors. Four recording sites were chosen; the VB and 
barrel cortex and the CMT and cingulate cortex, representative of both first-order and higher-
order thalamocortical circuits respectively. Data collected were then analysed offline using a 
combination of continuous wavelet and cross wavelet transforms in order to obtain high 
degrees of temporal resolution.  
The experiments were performed in order to gain insight into the mechanisms disrupting 
consciousness and the similarities between natural sleep and the reversible loss of 
consciousness induced by anaesthetics. Firstly, although it is widely believed that a loss of 
long range cortical connectivity and the inability to sustain spontaneous neuronal firing 
results in the unconscious state, there is little agreement as to whether thalamic deactivation 
instigates this state or occurs as a result of it (Alkire et al., 2008). Secondly, although the 
understanding of anaesthetic effects at the molecular level is progressing rapidly, relatively 
little is known as to how these effects cause sufficient changes at the level of neuronal 
networks to cause reversible loss of consciousness (Franks, 2008). Finally, are the neuronal 
pathways harnessed by anaesthetics similar to those used during natural sleep, and to what 
extent are the two states; anaesthetic induced LOC and NREM sleep, similar? 
The majority of previous experiments within the field have been performed using imaging 
techniques or EEG recordings resulting in temporal and spatial compromises respectively. 
Although imaging studies are extremely useful at identifying differences in neuronal activity 
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between the wake, sedated and unconscious state (Liu et al., 2013, Langsjo et al., 2012); they 
lack sufficient temporal resolution to identify which of the observed nuclei are important at 
the point of LOC. Additionally, data from EEG and LFP studies that do record from the 
thalamus do not distinguish between the differing orders of thalamocortical circuits and 
report conflicting results (Gervasoni et al., 2004, Magnin et al., 2010, Velly et al., 2007).  
In brief, our results indicate that common changes, a reduction in frequency exhibiting peak 
power and an increase in power, occur in the band of frequencies from 10-64Hz under 
anaesthetic-induced LORR and wake-NREM transitions. In both propofol LORR and wake-
NREM transitions, these changes occur in the CMT before the other nuclei. In the case of 
dexmedetomidine anaesthesia, although the high frequency changes occur simultaneously, 
the phase relationship within the delta band of frequencies observed between the CMT and 
other nuclei abruptly change at LORR. These data suggest that the higher-order thalamic 
nuclei play an important role in initiating natural sleep and general anaesthesia.  
Despite some aforementioned similarities, the LFP signatures of propofol and 
dexmedetomidine during LORR experiments showed characteristic differences in both 
spectral content and temporal progression, consistent with the concept that anaesthetics with 
differing molecular targets could exert effects on different neuronal pathways. In contrast 
dexmedetomidine anaesthesia and NREM sleep were found to share common features in 
terms of temporal progression at the LOC point, spectral content and phase relationships. The 
following will examine these conclusions in further detail by discussing each experiment 
separately, before providing some concluding remarks. 
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6.2 Transitions into Natural Sleep 
An attempt was made to investigate whether the number of recording electrodes per animal 
could be reduced by scoring its behavioural state with an appropriate LFP electrode, thus 
negating the need for multiple ECoG electrodes. The CMT had the highest percentage 
agreement with the standard ECoG scoring method, correct for over 90% of wake and NREM 
states. Given that the ECoG data consists of a bipolar montage of cortical activity, one might 
expect that one of the cortical LFPs would’ve been more appropriate. However, it appears 
that local field potentials recorded from the cingulate and barrel cortices do not match the 
frequency spectra exhibited by the ECoG as closely as the CMT. A lack of wake accuracy 
can be explained by the lack of continuous high power theta power observable in cortical 
LFP recordings (Figure 3.2.1), which has also been reported in previous LFP recordings from 
the cingulate cortex (Remondes and Wilson, 2013). In contrast, none of the nuclei were able 
to score REM sleep with great accuracy, with the highest percentage agreement of roughly 
25% achieved using the CMT electrode. 
 It is established that within rats the continuous type 1 theta oscillations observed in the EEG 
during waking and REM sleep are hippocampally generated (Buzsaki, 2002). Despite the 
CMT having projections to and from a wide variety of cortical and subcortical structures 
(Van der Werf et al., 2002), there are no direct projections to the hippocampus proper from 
the CMT (Vertes et al., 2012), and although there is evidence of weak axonal projections 
from CA1 to midline thalamic nuclei, no projections were recorded within the CMT 
(Cenquizca and Swanson, 2006). However the CMT does form projections to the perirhinal 
and to a lesser extent entorhinal cortices (Vertes et al., 2012). These nuclei form part of the 
parahippocampal region (van Strien et al., 2009) from which parasubicular and presubicular 
projections terminate within the anterior thalamic nuclei (Aggleton et al., 2010) with 
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presubiclar projections also terminating within the CMT in cats (Kaitz and Robertson, 1981). 
Thus the appearance of continuous theta within the CMT during wake is most likely due to a 
hippocampal pathway that is disrupted during natural sleep. 
Wake to NREM transitions were typified by a unique period, starting at and immediately 
following the transition point, called NREM onset, which was characterised by the CMT LFP 
recordings displaying an abrupt reduction in frequency and increase in power of the 
oscillation exhibiting peak power within the 10-64Hz range of frequencies. In contrast, these 
changes were not fully established in the other LFP recordings until several seconds after 
NREM onset. Following this period, which lasted roughly 10-15 seconds, thalamocortical 
oscillations typical of NREM sleep, such as the delta oscillation, were established 
simultaneously in all LFP’s.  
This temporal progression indicates that the higher-order thalamic nuclei are involved in the 
regulation of cortical arousal and transitions into NREM sleep. This is in agreement with a 
wide variety of experimental data. As well as recordings of single neurons in intralaminar 
thalamic nuclei by Glenn and Steriade (1982) showing that cortical arousal can be directly 
maintained via cortically projecting intralaminar neurons; fMRI data comparing connectivity 
between the centromedian thalamic nucleus and the neocortex in humans identified 
significant reductions in functional connectivity from wakefulness to NREM sleep (Picchioni 
et al., 2014). A first-order thalamocortical loop, the lateral geniculate nucleus of the thalamus 
and calcarine cortex, was used as a control and showed no such changes, thus highlighting 
that the changes in functional connectivity between the thalamus and neocortex were specific 
to the higher-order circuits. Direct comparison with two aforementioned in vivo LFP/EEG 
studies of transitions into sleep also yield similarities. Magnin et al. (2010) recorded from the 
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medial pulvinar nucleus of the thalamus in conjunction with ECoG of humans, and noted that 
thalamic deactivation precedes that of the cerebral cortex by several minutes. The medial 
pulvinar nucleus, whilst not an anterior midline thalamic nuclei by definition, is regarded as a 
higher-order thalamic nucleus, important for corticocortical communication (Sherman, 2007) 
and with diverse projections suggesting a possible role in integrating different types of 
sensory information with motor movements in primates (Cappe et al., 2009). Additionally, 
the time difference of several minutes between thalamic and subsequent cortical changes 
reported by Magnin, might be reconciled with the differences of a few seconds reported here 
by taking species differences into account. For example, establishment of slow wave sleep, 
akin to the NREM sleep reported in our results, has been reported to occur several minutes 
after sleep onset in humans (Aeschbach and Borbely, 1993), whilst transitions from the 
waking state to slow wave sleep in other rodents (mice) have been characterised on the 
second scale (Takahashi et al., 2010). Finally, one other experimental recording of LFP data 
during transitions into sleep from the same first-order thalamocortical loop studied here, the 
VB and barrel cortex in rats, also concluded that changes occurring across the wake to 
NREM transition occur simultaneously for these nuclei (Gervasoni et al., 2004). Thus, it is 
crucial to discern between first and higher-order thalamocortical nuclei when discussing the 
temporal dynamics of the thalamocortical system during transitions into natural sleep. 
The observation that changes in the LFP of higher-order thalamic nuclei occur prior to the 
neocortex during transitions into natural sleep is also consistent with current hypotheses 
proposing sub-cortical interplay between wake active and sleep active circuits regulating 
control of waking and sleep (Saper et al., 2010). There are a number of brainstem nuclei that 
project to the intralaminar nuclei of the thalamus (Krout et al., 2002) and exhibit increased 
firing rates during the wake state (for review see (Saper et al., 2010)). Of these nuclei, the 
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Locus Coeruleus (LC), is known to exhibit significantly reduced firing rates a few seconds 
prior to sleep onset, determined in this case by measurement of cortical eeg in mice 
(Takahashi et al., 2010, Takahashi et al., 2006). This is in contrast with measured sleep active 
nuclei in the basal forebrain and pre-optic area of the hypothalamus, whose firing rates only 
increase after the reductions in activity of the aforementioned wake active nuclei (Takahashi 
et al., 2010, Takahashi et al., 2009). Additionally, only the LC neurons were observed to have 
increased firing rates prior to the reverse transition from NREM sleep to wake. However, it 
cannot definitively be said that only the wake active brainstem nuclei such as the LC wholly 
mediate wake-NREM transitions. Another nucleus, the median pre optic nucleus (MnPO), 
contains sleep active neurons that fire in advance of sleep (Suntsova et al., 2002). 
Additionally, this nuclei projects to the LC (Uschakov et al., 2007), although it is not known 
whether these projections consist of the sleep active neurons or not (Saper et al., 2010), nor is 
there any direct comparison of the temporal relationship between changes in the wake active 
LC firing and the sleep active MnPO neuronal firing at transitions into natural sleep. 
Nevertheless, the possibility exists that the reduction in ascending wake active input from 
brainstem nuclei, such as the LC, into the higher-order thalamic nuclei, specifically the 
anterior midline intralaminar nuclei, possibly mediated by sleep active hypothalamic nuclei 
such as the MnPO, affects the ability of those higher-order nuclei to perform their primary 
role of integrating and facilitating corticocortical communication (Sherman and Guillery, 
2011). The result of which is a break up in functional connectivity between different parts of 
the cortex, a proposed mechanism underlying a lack of consciousness (Alkire et al., 2008), 
supported by experimental data during natural sleep (Massimini et al., 2005). Thus, the 
involvement of the higher-order thalamic nuclei, highlighted by the data reported here, 
provide a potential link between the changes in brainstem and hypothalamic firing thought to 
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regulate transitions into sleep (Saper et al., 2010) and the functional description of the 
unconscious state (Alkire et al., 2008).  
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6.3 Dexmedetomidine  
Experiments with dexmedetomidine, an α2 adrenergic agonist, were performed with loss of 
righting reflex (LORR) serving as the rodent correlate for human unconsciousness. In a 
similar fashion to transitions into NREM sleep, high frequency oscillations of 40Hz were 
observed to reduce in frequency to around 20Hz and increase in power across the LORR 
point, although in this case the abrupt transition in frequency and more gradual increase in 
power occurred simultaneously across LORR in both thalamic and cortical nuclei. 
Interestingly, prior to LORR, the LFP’s of both thalamic and cortical nuclei contained a 
continuous delta oscillation of high power, these oscillations also simultaneously and 
abruptly reduce in frequency at loss of righting reflex, from ~3 Hz to ~2Hz. No temporal 
progression between the nuclei was observable across this period. However analysis of the 
phase relationships in the delta range of frequencies between the four LFPs revealed that 
thalamic signals preceded those from the cortex by ~90 degrees, with both cortical and 
thalamic recordings in phase prior to LORR. At LORR, simultaneous to the drop in delta 
frequency, the phase advancement between the CMT and all other nuclei reduces by roughly 
45 degrees. Apart from this phase change involving the CMT at LORR, all nuclei appeared to 
behave in a similar manner. Thus, an attempt will be made to explain the significance of this 
change with respect to LORR. 
A discrete drop in delta frequency accompanied by a change in phase between the CMT and 
other nuclei, marked dexmedetomidine LORR. These effects need to be explained within the 
context of dexmedetomidine anaesthesia. Dexmedetomidine exerts its sedative effects via the 
α2A receptor (Lakhlani et al., 1997) and can cause LORR in rats in a dose dependent fashion 
via direct administration into the LC (Correa-Sales et al., 1992). Dose dependent inhibitions 
of LC neurons have also been reported in vitro (Chiu et al., 1995). As postulated with NREM 
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transitions, inhibition of LC firing could result in a reduction of noradrenergic input to the 
CMT. This would have a direct effect on the delta oscillations which arise from a rebound 
bursting caused by the hyperpolarisation of thalamic relay neurons. Hyperpolarisation of the 
neurons results in the activation of the inwardly rectifying Ih current (McCormick and Pape, 
1990b), which is upregulated by noradrenergic action on β adrenoceptors (McCormick and 
Pape, 1990a). This potentiation of the Ih current has effects on the interburst frequency, which 
is increased and when upregulated sufficiently will disrupt the delta oscillation (Yue and 
Huguenard, 2001). In this case, downregulation, brought about by a reduction in 
noradrenergic input to the thalamus following dexmedetomidine administration, as 
hypothesised here, increases the likelihood of the establishment of the delta oscillation with a 
direct relationship between noradrenaline concentration and delta frequency (Yue and 
Huguenard, 2001).  
Hypothetically, one might expect that in our experiments, the increasing concentration of 
dexmedetomidine, which induces a concentration-dependent reduction in LC firing (Chiu et 
al., 1995), would be depicted by a more continuous reduction in delta frequency. However, 
the delta frequency observed prior to LORR is stable with an abrupt reduction only occurring 
at LORR. This can be explained by the work of Yue and Huguenard (2001) using in vitro 
recordings of rat VB neurons. At high levels of noradrenaline (1µM), the delta oscillation 
was nearly abolished, but exhibited a frequency of 3.1Hz, lower levels of noradrenaline 
produced more robust delta oscillations with a slightly lower frequency of ~2.9Hz with the 
0.1µM and 0.3µM concentrations exhibiting near indistinguishable delta frequencies. 
However without noradrenaline, the delta frequency was ~2.6Hz. In the results reported here, 
a well-established delta oscillation was observable prior to LORR, which suddenly reduced at 
LORR. Thus, the CMT may be going from a slowly reducing amount of low noradrenergic 
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input, to no noradrenergic input, consistent with a reduction and cessation of LC firing due to 
inhibition by dexmedetomidine. 
Whilst the reduction in delta frequency can be explained by the reduction in noradrenergic 
input to the CMT explained above, the change in phase relationship, which highlights the 
CMT as changing in its connectivity with the other nuclei, requires explanation. Thalamic-
specific reductions in phase advancement in relation to the cortical LFP have previously been 
reported to correlate with reductions in frequency. Additionally the higher-order, but not 
primary, thalamic nuclei exhibit a phase advancement proportional to the number of spikes 
per burst (Slezia et al., 2011). Thus, a change in phase of the CMT, but not the VB, can occur 
with respect to other nuclei. Whether this phase change is functionally significant for LORR, 
or happens as a consequence of it also requires examination. The phase of a single neuron 
firing with respect to the LFP is a proposed method of information encoding (Fries et al., 
2007). Additionally, although tonic firing has traditionally been focused on as a method of 
thalamocortical information transfer, there is also a potential role for burst firing as well, 
which has been observed to be more prevalent in higher-order than first-order thalamic nuclei 
in awake rhesus monkeys (Ramcharan et al., 2005) , although the nature of information is less 
certain given the prevalence of burst firing during sleep (Sherman, 2001). Despite this, the 
phase change accompanying the reduction in delta frequency during LORR specific to the 
higher-order thalamic nuclei may play a role in disrupting their ability to facilitate 
information transfer via a corticothalomocortical pathway. 
Finally, steady state dexmedetomidine anaesthesia and NREM sleep share spectral and (delta 
specific) phase similarities. Given the proposed role of the brainstem nuclei in instigating the 
transition in both, this is not hugely surprising. Dexmedetomidine has long been thought of as 
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being able to induce a sleep like state owing to the ability to rouse patients from sedation 
(Venn and Grounds, 2001) and the similarity between dexmedetomidine EEG and the EEG of 
natural sleep (Huupponen et al., 2008). Additionally the effects of dexmedetomidine in the 
LC have been reported to cause downstream effects in VLPO and the TMN similar to those 
observed during sleep (Nelson et al., 2003). The LFP data presented here concurs with these 
ideas. 
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6.4 Propofol  
During propofol LORR experiments, the most prominent features of the LFP recordings were 
the increase in power and decrease in frequency of an oscillation in the 10-64Hz range of 
frequencies. These changes in power and frequency occurred over a very different timescale 
in comparison to NREM sleep and dexmedetomidine LORR; commencing ~25 seconds prior 
to LORR and progressing in a continuous manner. The frequency of the identified peak 
power stabilised at the LORR point and was preceded marginally by stabilisation of the 
power. The exception was the CMT, which exhibited a peak in power at the LORR point 
before decreasing to a constant relative power value in line with the other nuclei. Crucially, 
examination of the temporal progression of the power increase identified changes in the CMT 
preceding those within the other nuclei. With frequency, changes within the CMT preceded 
all other nuclei except for the cingulate, which was not deemed significant under paired 
Student’s t-tests. With changes in the gamma band of frequencies occurring prior to LORR, 
an explanation of these changes, particularly with reference to the CMT will be discussed 
under that the presumption that these changes underlie LORR. 
Firstly, although intrinsic gamma oscillations can occur within the cortex (Whittington et al., 
2011), and despite the CMT and Cingulate reducing in frequency simultaneously, the delayed 
changes observed within the barrel cortex precludes direct action by propofol on the cortex as 
a primary explanation for the gamma frequency reduction (Angel and LeBeau, 1992). As 
previously described, propofol exhibits its effects on GABAA receptors. With multiple 
GABAergic projections from inhibitory centres in the POA of the hypothalamus to the 
arousal centres in the brainstem (Saper et al., 2010), one potential target of propofol could be 
at the GABAergic synapses projecting onto the brainstem arousal nuclei, inhibiting them 
(Brown et al., 2011). Bilateral injections of endogenous GABAA enhancers (pentobarbital) 
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and direct agonists (muscimol) into the mesopontine tegmental anaesthesia area (MPTA), a 
brainstem region, caused reversible and deep anaesthesia, with sleep like EEG (Devor and 
Zalkind, 2001). The MPTA contains projections to other brainstem arousal nuclei and the 
intralaminar thalamic nuclei including the CMT (Sukhotinsky et al., 2007) .  
Gamma oscillations have been induced in an intralaminar thalamic nucleus (the 
parafascicular nucleus), which when maximally depolarised, averages 31.5 Hz in developing 
rats, with the trend suggesting that this frequency increases with age. As the level of 
depolarisation decreases in these neurons so does the average gamma frequency exhibited 
(Kezunovic et al., 2012). These oscillations could be driven by ascending cholinergic input 
from the brainstem nuclei such as the Pedunculopontine Nucleus (PPN) (Simon et al., 2010), 
shown to exhibit gamma oscillations during waking and REM sleep and minimal firing in 
other states (Datta and Siwek, 2002). Like other gamma oscillation generating networks, such 
as those within the neocortex (Economo and White, 2012), the frequency of gamma 
oscillations within the PPN also correlate with the degree of depolarisation (Simon et al., 
2010). Additionally, with in vivo high frequency activity (>10Hz) in cortical LFPs being 
removed by thalamic inactivation (Lemieux et al., 2014), the changes observed within the 
cingulate cortex could be partially driven by the effects of propofol on the brainstem coupled 
with effects on intralaminar thalamic nuclei. Thus causing a simultaneous reduction in 
gamma oscillation frequency in the PPN, its downstream target, the intralaminar nuclei of the 
thalamus such as the CMT, and owing to a reduction in arousal from diffuse projections from 
both brainstem nuclei, (Mesulam et al., 1983) more specific projections from intralaminar 
thalamic nuclei (Vertes et al., 2012) and the effects on cortical GABAergic interneurons 
(Markram et al., 2004), the cingulate cortex.  
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The unique power vs time behaviour displayed by the CMT can be also be explained by the 
simultaneous changes in frequency described above. With dense innervation of the CMT 
from the brainstem, as well as reciprocal connectivity with the cingulate cortex (Van der 
Werf et al., 2002), the CMT LFP can measure synchronised input from both nuclei. The 
convergence of frequencies within the cortical and subcortical structures could thus result in a 
high power resonance observed within the CMT LFP. The reduction in power following 
LORR could be as a result of complete inhibition and cessation of firing of the brainstem 
nuclei, such as the PPN, which is already known to cease firing during transitions from wake 
to natural sleep (Datta and Siwek, 2002).  
At the point of LORR a continuous oscillation of high power at ~8Hz is established in all 
LFP’s. This alpha rhythm is observed in EEG propofol studies in humans (Feshchenko et al., 
2004) and the basis of both the occipital alpha and propofol induced alpha oscillation is 
thought to result from thalamocortical interactions (Ching et al., 2010, Hughes and Crunelli, 
2005). Similar to occipital alpha rhythms observed in the primary thalamocortical circuits of 
cats (Chatila et al., 1993) and dogs (da Silva et al., 1973). Propofol-induced alpha rhythms 
were observed within both cortical and thalamic LFP’s. The alpha rhythm establishes itself at 
the point of LORR and at the reported LOC point in humans (Purdon et al., 2013) and thus 
thalamocortical coherence of the alpha rhythm has been proposed as a mechanism underlying 
the unconscious state by removing the ability of the thalamus to relay sensory information to 
the cortex (Ching et al., 2010). This is plausible, but it is important to separate this functional 
description of unconsciousness, with the changes in the high frequency oscillations (10-
64Hz) that appear to precede LORR and the appearance of the alpha oscillation. 
DISCUSSION 
126 
 
Alpha oscillations observed within the waking state arise within a subset of thalamocortical 
(TC) neurons, that exhibit burst firing behaviour occurring at depolarised membrane 
potentials (>-55mV) (Hughes et al., 2004), called high threshold bursting thalamocortical 
neurons (HTC). These bursts are also mediated by T-type calcium channels (Jahnsen and 
Llinas, 1984b) which are responsible for the low threshold calcium spikes observed during 
delta oscillations. Crucially, low threshold spikes and bursting at delta frequencies only occur 
in TC cells with hyperpolarised membrane potentials (< -65mV) (Coulter et al., 1989, 
McCormick and Pape, 1990b). As the reduction in gamma frequency prior to LORR suggests 
hyperpolarisation of the same neurons, and the conscious, occipital alpha rhythms are 
diminished under propofol anaesthesia (Purdon et al., 2013), another mechanism for the 
generation of alpha oscillations at hyperpolarised membrane potentials is required. A model 
by Vijayan et al (2013), explains the reduction of occipital alpha by hyperpolarising the HTC 
neurons below their operating window. Crucially, the model also hypothesises the emergence 
of alpha oscillations within hyperpolarised TC cells. The potentiation of GABAA and its 
hyperpolarising effects result in a reverberation between TC cells and cells within the 
reticular thalamus (RE); hyperpolarisation induced burst firing (due to It and Ih currents) 
induce RE spiking, which in effect hyperpolarises and thus re-induces burst firing in TC cells 
at alpha frequencies. Additionally, input to cortical areas by ascending TC neurons, helps to 
reinforce the thalamic reverberation with alpha instigated within the cortex by GABAA 
potentiation of interneurons. Thus, providing a potential explanation for the high power of the 
alpha oscillation observed in our LFP data. This mechanism may also explain why the power 
within the delta band of frequencies was temporally sporadic post LORR and did not exhibit 
phase locking between the nuclei, unlike NREM sleep and dexmedetomidine. Additionally, 
unlike previous studies (Ni Mhuircheartaigh et al., 2013, Purdon et al., 2013), we were unable 
to observe power in the <1Hz band of frequencies following propofol LORR.  
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Prolonged infusion of propofol up to the point of loss of hind limb reflex (LOHLR), 
indicating the establishment of a surgical plane of anaesthesia within rats, coincided with the 
establishment of global burst-suppression activity within the LFP, a commonly seen feature 
during deep anaesthesia, but not observed during natural sleep (Brown et al., 2010). 
Interestingly, recovery from LOHLR without any stimulation of the rat was marked by a 
period that exhibited similar spectra and phase locked delta oscillations to those observed 
during NREM sleep. Cases of propofol emergence delirium in adults are well-characterised 
(Thomson and Knight, 1988) but statistically of lower occurrence under propofol anaesthesia, 
than inhalational methods (Lepouse et al., 2006). Both doses of propofol administered 
continuously during sevoflurane anaesthesia and as a bolus following sevoflurane anaesthesia 
(before emergence) were effective against emergence delirium in children. As administration 
of dexmedetomidine had similar effects (for review see (Dahmani et al., 2010)), and reduced 
emergence agitation is attributable to recovery from a sleep like state (Martin et al., 2014). It 
is probable that propofol administration reduces the occurrence of emergence delirium by 
inducing a sleep-like period prior to emergence.  
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6.5 Lack of Sub 1Hz Power within Recordings 
Slow (<1Hz) oscillations are hallmarks of both sleep (Crunelli and Hughes, 2010) and 
propofol anaesthesia (Lewis et al., 2012). However, power within this band was not observed 
in either ECoG recordings or LFP data in any experiment. 
In the case of ECoG recordings, we used a bipolar montage ECoG configuration, recording 
the fluctuations in potential between the frontal and parietal cortices. In hindsight, this limited 
our ability to observe oscillations occurring synchronously across the cortex (Amzica and 
Steriade, 2002). Although slow oscillations are observed to propagate across the cortex 
(Massimini et al., 2004), the speed of propagation is high (1.2-7.0m/sec), thus slow 
oscillations are observed near simultaneously at different ECoG screw locations and are not 
represented within the differential recording. 
Slow oscillations are cortically generated (Timofeev et al., 2000), however we did not 
observe these within our cortical LFP recordings. The two poles of the bipolar electrodes 
record a potential generated across the cortical layers. This is possible due to a reversal in 
polarity from deep layers in comparison to superficial cortical layers and has been 
demonstrated through LFP recordings from individual layers. This property is preserved 
across the slow (Chauvette et al., 2010), neocortical delta (Carracedo et al., 2013) and evoked 
potentials (Kajikawa and Schroeder, 2011b). Thus it is more likely that the high pass -3dB 
frequency of the Neurologger, of 1 Hz (Robledo, 2008), impinges on the ability to record 
slow oscillations of significant power. 
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7 Conclusions 
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The results reported here clearly implicate the CMT, a higher-order anterior intralaminar 
midline nucleus of the thalamus, as having a role in both anaesthetic induced and natural 
transitions into the unconscious state. For both wake-NREM sleep transitions and propofol 
LORR, changes within the LFP of this nucleus preceded the other nuclei recorded, the 
cingulate cortex, barrel cortex and ventrobasal complex of the thalamus, whereas with 
dexmedetomidine LORR, an abrupt change in phase relationship across LORR implicated the 
CMT. The conclusion that the CMT, and higher-order anterior midline thalamic nuclei have a 
role in the maintenance and breakdown of consciousness supports a number of experiments 
involving natural sleep (Picchioni et al., 2014), propofol (Liu et al., 2013), dexmedetomidine 
(Langsjo et al., 2012), sevoflurane (Alkire et al., 2007) and clinical observations (Giacino et 
al., 2014). Given that the higher-order thalamic nuclei are thought to facilitate long range 
cortical communication (Sherman et al., 2006), with the anterior midline nuclei having 
important interactions with cortical areas related to attention, orienting and memory 
(Saalmann, 2014). Our data would indicate that a loss of functional connectivity between 
higher-order cortical areas involved in integrating multimodal sensory information, a 
mechanism underlying unconsciousness (Alkire, 2008), could be mediated by changes in the 
intralaminar thalamic nuclei, thus disrupting a proposed consciousness network involving the 
cortical regions involved in higher-order function and the intralaminar thalamus (Hudetz, 
2012). 
As observation of the cortical LFP’s did not reveal any unique or temporally advanced 
behaviour over the natural sleep and anaesthetic-induced LORR experiments, it was deemed 
that the changes in CMT behaviour are instigated subcortically, supporting proposed actions 
of dexmedetomidine (Nelson et al., 2003), and GABAergic agents on brainstem nuclei (Devor 
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and Zalkind, 2001), with transitions into natural sleep being regulated by interactions 
between the brainstem and nuclei of the hypothalamus (Saper et al., 2010). 
Our experimental results with the primary thalamocortical loops, where cortical and thalamic 
changes occur synchronously, are in agreement with previous results recording from the 
ventrobasal complex of the thalamus and barrel cortex in rodents across natural sleep 
(Gervasoni et al., 2004) and ketamine/xylazine (Hwang et al., 2010). Additionally some 
primary circuits have been reported to continue relaying external stimuli following 
anaesthetic induced LOC (Liu et al., 2012), further highlighting differences with higher-order 
thalamic nuclei across consciousness transitions.  
Another common feature across the anaesthetic induced LORR and wake-NREM 
experiments was the reduction in gamma frequency from ~40 - ~20Hz across the transition 
point. In the two transitions showing temporal differences between the CMT and the other 
nuclei, propofol LORR and the wake-NREM transition, the temporal differences were 
characterised via observation of changes in the gamma frequency band. Gamma oscillations 
have been implicated in processes relating to arousal and attention (Engel and Singer, 2001) 
and have been proposed as a prerequisite for consciousness (Crick and Koch, 1990, John and 
Prichep, 2005). Although gamma power above 30Hz is observed during NREM sleep and 
some anaesthetics (Vanderwolf, 2000), research suggests that it is the gamma synchrony 
across cortical areas that is indicative of the conscious state of the subject and not the 
presence or lack of power (Hwang et al., 2013, Imas et al., 2005, John et al., 2001). 
Gamma oscillations within the cortex are removed following the ablation of thalamic 
afferents in an in-vivo system (Lemieux et al., 2014). As the intralaminar thalamic nuclei 
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have also been implicated in modulating attention in the awake state (Kinomura et al., 1996), 
and during tasks requiring attentional effort changes within the gamma band are specifically 
observed within these nuclei (Schiff et al., 2013). Our results would suggest that disruptions 
to cortical gamma synchrony may be mediated by the higher-order thalamic nuclei across 
loss of consciousness transitions. 
Another observation from this study is the similarity between dexmedetomidine anaesthesia 
and NREM sleep, due to dexmedetomidine exerting its effects on a shared neuronal pathway. 
However, propofol anaesthesia exhibited different spectral and phase characteristics 
following LORR and at LOHLR, indicating that GABAA agonists do not solely exert their 
effects on sleep promoting pathways. It was interesting to note that following propofol 
anaesthesia of surgical depth, a sleep like state occurred during the recovery period. With 
emergence related delirium reduced in patients administered propofol and dexmedetomidine 
in contrast to sevoflurane (Dahmani et al., 2010, Lepouse et al., 2006). It is likely that this 
reduction is attributable to emergence from the sleep-like state as opposed to anaesthesia. A 
concept recently confirmed (Martin et al., 2014). 
Future work is required in order to evaluate the main hypotheses generated by the results of 
experiments presented within this thesis. The first avenue is to probe the relationship between 
the brainstem nuclei and the central medial thalamus across wake-NREM transitions and 
anaesthetic-induced LORR in order to confirm that the proposed brainstem mechanisms of 
transitions into natural sleep (Saper et al., 2010) and anaesthetic-induced LOC (Devor and 
Zalkind, 2001, Nelson et al., 2003) exert their effects via higher-order intralaminar nuclei 
such as the CMT. The second set of experiments should examine the phase relationship 
within the gamma range of frequencies between the CMT and the multiple rat equivalents of 
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cortical areas (posterior cingulate cortex, medial prefrontal cortex, anterior cingulate cortex, 
lateral parietal cortex) that make up a commonly proposed consciousness network in humans 
(Alkire et al., 2008, Hudetz, 2012). This would investigate the extent to which gamma 
oscillation synchrony is a true correlate of the level of consciousness and whether the level of 
synchrony is controlled by the intralaminar nuclei. With the current set of data, analysis of 
the CMT and cingulate can be performed as a preliminary investigation. Finally, a short 
series of experiments examining recovery from sevoflurane anaesthesia should be 
undertaken. Based on our limited experimental data, the hypothesis behind these experiments 
is that the recurring natural sleep-like period during dexmedetomidine anaesthesia and during 
recovery from surgical levels of propofol anaesthesia results in a comparative lack of 
emergence agitation/delirium in comparison to sevoflurane, which exhibits rapid onset and 
recovery characteristics (Behne et al., 1999). Thus, the aim of this experiment is to 
investigate the factors affecting the erratic appearance of a sleep-like state during recovery 
period following a surgical plane of sevoflurane anaesthesia, recently reported to reduce 
emergence delirium in children (Martin et al., 2014). 
This series of experiments has successfully recorded simultaneous local field potentials from 
two cortical and two thalamic regions representing first-order and higher-order 
thalamocortical loops in freely moving rats across wake to natural sleep transitions and 
anaesthetic-induced LORR. We have been able to conclude that a temporal progression exists 
during propofol LORR and wake-NREM transitions and that the changes observed under 
dexmedetomidine LORR also converge on the same nucleus, the CMT, as behaving in a 
unique manner in comparison to the other nuclei. Additionally we have been able to confirm 
the validity of, and explain vastly differing results from previous work in other laboratories 
(Gervasoni et al., 2004, Hwang et al., 2010, Magnin et al., 2010). If the experiment were to 
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be repeated, one area that could be improved is the filtering profile of the Neurologgers, 
identified as having a first-order high pass filter with a -3dB point at 1Hz (Robledo, 2008). 
This would enable us to unequivocally observe whether the bipolar LFP electrodes could 
record sub-1Hz oscillations during natural sleep and propofol as reported previously 
(Massimini et al., 2004, Ni Mhuircheartaigh et al., 2013). It is to this end, as well as the 
desire to improve the reliability of the current recording equipment, that development of a 
miniature device for wireless transmission of electrophysiological signals is being undertaken 
in-house as explained in the self-contained Section 8. 
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Acquisition System  
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8.1 Introduction and Principles of EEG Instrumentation 
Recording EEG and LFP from small rodents is commonplace within laboratories. As outlined 
in Chapter 2.5.1, the measurements of muscle tone (EMG) and EEG change in a well 
characterised manner according to the behavioural state of the rodent. Thus, these recordings 
are commonly used during circadian and sleep-wake studies in order to score the rodent’s 
sleep pattern (Pang et al., 2009). As in this thesis, recordings of EEG and more specifically 
LFP are also used to understand the underlying neuronal behaviour occurring during 
observed behaviours and transitions between conscious states. All of these experiments 
typically involve the simultaneous recording of multiple EEG/LFP/EMG channels which 
requires complex instrumentation, something made all the more difficult by the physical 
constraints imposed when recording from rodents.  
In order to record from an individual EEG/LFP electrode, the following process is applied to 
the signal. Firstly the signal requires amplification, as the input signal from EEG/LFP usually 
exhibits peak to peak amplitude in the millivolt range. This is typically done using a 
differential amplifier, and thus the resulting signal is the difference between the recording 
signal and ground or a reference electrode amplified by a chosen factor (typically 1000). 
Following this the signal is the band pass filtered, with a typical band pass having -3dB 
points at 0.1-125Hz. The high pass -3dB point needs to be as low as possible in order to 
observe the slow oscillation, but prevent the observation of changes in direct current over 
time. The low pass boundary depends on the experiments; circadian studies rarely observe 
changes outside of the 0.1-30Hz band yet studies in the gamma band observe typical 
frequencies of up to 90 Hz (Buzsaki and Wang, 2012). Following amplification and filtering 
modern EEG systems typically digitise the signal using an analogue to digital convertor 
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(ADC) with a minimum sampling frequency given by the Nyquist rate for the low pass -3dB 
frequency. The data is then stored in memory or sent to a receiving computer for analysis. 
Attempts to create the most suitable instrumentation for recording from rodents has led to the 
emergence of three main methods, tethered, implantable, and detachable head mounted 
systems, each with differing benefits and drawbacks in terms of experimental limitations and 
signal quality. 
Tethered systems place minimal instrumentation on the rodents head; instead signal leads are 
suspended vertically from the top of the recording area and are connected to the head of the 
rodent during the experiment. The tether typically hangs from a swivelling arm and 
commutator system, such that the movement of the rodent is as unimpeded as possible 
(Bertram et al., 1997). In some systems amplification occurs on the head of the rodent to 
minimise artefacts generated within the tether (Pinnacle Technology, 2014). However, the 
majority of the required instrumentation is located outside of the recording area, thus this 
instrumentation can be as large and as heavy as required and several stages of amplification, 
signal filtering and processing can be undertaken before the data is sent directly to a 
computer for observation, storage and analysis. The major disadvantage of this system is that 
there is still restriction of the rodents head motion and overall movement via the tether. 
Restraint stress has been reported to cause a variety of negative physiological and 
behavioural effects (Kramer and Kinter, 2003). Additionally, behavioural studies using 
rotating tubes to assess LORR or within an extended recording arena such as a T maze, 
cannot be undertaken without significant modification of this recording method.  
In contrast, implantable systems pose minimal behavioural impairment during recording. 
These devices, which for mice typically weigh less than 4 grams (Lapray et al., 2008), are 
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implanted into the abdomen of the rodent, with the leads to the skull electrodes routed 
subcutaneously (Weiergraber et al., 2005). During experiments the device is activated and 
transmits data to a receiving station via radio transmission. Except for the additional surgical 
procedure, other drawbacks of these devices arise from the volume constraints associated 
with abdominal implantation, typically restricted to under 2cc in mice (Lapray et al., 2008). 
Thus, mice specific devices typically only record from 2 EEG channels and do not feature 
induction charging, limiting the use of the device and experimental rodent to the battery life 
of 1.5 months (Data Sciences International, 2014). Additionally, with the device only being 
able to record from the rodent in which it is implanted, it is less cost efficient than detachable 
methods.  
The final method of EEG recording is the detachable head mounted device, attached to the 
rodent at the commencement of an experiment via a connector that is surgically implanted 
onto the rodents skull during electrode implantation. In order to prevent stress artefacts from 
the weight and device size, dummy devices are attached to the rodent several days prior to the 
recording for acclimatisation (Zecharia et al., 2012). Like implantable telemetry methods, this 
allows the rodent a relatively free range of movement within the recording arena. In 
experiments where the physical recording time from the rodent is short, and the frequency of 
recording limited, for example anaesthetic-induced LORR experiments; a large set of 
experimental rodents can be consecutively recorded from using a single device. 
In mice, head mounted devices are weight limited to ~3 grams. One of the best examples of 
this type of device is the Neurologger (see Section 2.3), a device measuring 22x15mm and 
weighing 3.4grams including battery holder and batteries. The Neurologger is able to record 
from 4 EEG channels with two references, and is powered by replaceable two zinc-air cells 
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providing a stated 33 hours of battery life (Vyssotski, 2014), although with no inbuilt low 
battery protection, the use of the Neurologger within this lab is limited to a maximum of 30 
hours.. The compromise with this device is that the data is stored within flash memory as 
opposed to wirelessly transmitted, and requires downloading following each experiment. The 
main drawback with this method of data acquisition is that there is no physical way of 
checking the integrity of the data and correcting poor recordings during the experiment itself. 
Failed recordings are problematic as the animal typically requires a rest period of 7 days 
before repeating the experiment or the experiment was undertaken at a defined time point and 
cannot be repeated.  
  
DATENSENDER - RODENT EEG & EMG ACQUISITION SYSTEM 
140 
 
8.2 Project outline and responsibilities 
The aim of this project is to produce a detachable head mounted EEG and EMG recording 
device for use on rodents. The end device should have the following capabilities; firstly it 
must weigh less than 3 grams and have an appropriate size for use on mice. It should have a 
recording setup of equal to the current Neurologgers- a minimum of 4 channels and 2 
references and the device should be capable of saving the data within local storage, 
transmitting it wirelessly to an external system, or both, for a minimum of 48 hours. This 
additional wireless capability should also enable interactive control and monitoring on 
demand via computer. Finally the interface must be usable without the experimenter needing 
any specialist knowledge of the technical aspects of the device.  
The first stage was to produce a slightly larger prototype on a single printed circuit board 
(PCB), in order to test the selected analogue electronics configuration and integrate this with 
the development on the digital electronics side (the programming of a microcontroller). We 
are coming towards the end of this stage. Given that there are no major circuit or component 
changes currently envisaged, the final device will use the same integrated circuit components 
supplied in smaller packages, and the PCB routing will made more efficient to reduce size 
and weight. 
This project is led by Susan Parker, who specified the components, tested them using 
simulation tools, and designed and built the first stage prototype. My role was to liaise with 
Susan during the definition phase of the project from a laboratory based perspective, having 
developed a crude proof of principle device previously. Following this we both carried out 
development of the software for the microcontroller and tested the prototype device. 
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8.3 Prototype device overview 
 
Figure 8.3.1 Prototype DatenSender and circuit block diagram. Photographs of prototype  DatenSender (A), 
Panel (B) is a circuit block diagram for the prototype, showing the constituent analogue and digital electronics. 
Figures provided by Susan Parker 
The first prototype, shown in Figure 8.3.1, measures 34mm x 22mm and weighs 3.42 grams 
excluding, and 5 grams with, batteries. It is powered by two 1.4V size 13 zinc air batteries, 
which are ~0.3gr heavier than the current batteries, but contain more charge. Panel B depicts 
the system components on the PCB. The analogue front end receives 6 input channels as well 
as a ground signal, following filtering and amplification the data is digitised by a 12-bit ADC 
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on-board a EFM32 Leopard Gecko 32-bit ARM microcontroller (EFM32LG990F256, Silicon 
Labs, Austin, USA-TX) and can be stored in flash memory or sent via an infrared data 
association (IrDA) transceiver. Other circuits on the board include a micro USB interface, a 
serial wire debug (SWD) interface for programming, as well as the voltage regulation 
circuitry regulating power from button cells. 
The analogue front end consists of 6 identical input channels designed for signals of 
±1.26mV peak to peak amplitude, utilising two operational amplifier (op-amp) stages, which 
provide a combined amplification of 54dB and a band pass filtering with -3dB points of 0.15-
250Hz. The low pass filter is second order, through the use of two consecutive first-order 
resistor capacitor (R-C) circuits whilst capacitive coupling between the two op-amp stages 
provides the high pass filter. The circuitry for a single channel and a gain and frequency 
response simulation is shown in Figure 8.3.2. Instead of hardwiring a differential stage, this 
configuration allows flexibility with the reference configurations and the differential 
calculation either being done within the microcontroller or in software prior to analysis. 
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Figure 8.3.2 DatenSender single channel circuit and simulation. A single channel of the analogue front end 
with two filtering and gain stages is shown along with the DC offset circuitry (A). Simulation data showing the 
input voltage (green) and gain and frequency response stages is shown in (B). The colour of the lines correspond 
to the coloured arrows in (A), indicating the first (blue) and second (red) gain and filtering stages. 
On the digital electronics side initial development occurred using Atollic TrueSTUDIO for 
ARM (Atollic AB, Jönköping, Sweden) for code development, in conjunction with the 
EFM32 Leopard Gecko starter kit (EFMLG32-STK3600, Silicon Labs, Austin, USA-TX.). 
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Once running, the code was ported onto the prototype device using SEGGER J-Link EDU 
(SEGGER Microcontroller GmbH & Co. KG, Hilden, Germany) and the SWD interface.  
At this stage the microcontroller has been programmed to sample from each of the inputs at a 
frequency of 192Hz using a 12-bit ADC, providing 1 in 4096 level voltage resolution. Once 
sampled, the data is encoded using ASCII characters before being output to the on-board 
IrDA transceiver (Vishay TFBS4711-TT1, Vishay Components, Magarpatta City, India) 
sending single 10 bit messages. This is received by an IrDA receiving station (Microchip 
MCP2120 developer board, Microchip Technology Inc, Chandler, USA-AZ), which transmits 
to a PC via a serial (RS232) connection. RealTerm (http://realterm.sourceforge.net) is being 
used to store the incoming data into text for offline analysis, which currently consists of a 
conversion in excel into numeric data, followed by analysis using the labs standard tools. The 
system is outlined in Figure 8.3.3. 
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Figure 8.3.3 Flowchart showing the DatenSender system constituents. Flow of the EEG information is 
signified by the hollow arrows whilst system processes are indicated by the standard arrows. 
In order to manage the power consumption of the microcontroller, a low power mode, Energy 
Mode 2 (EM2) is implemented between sample cycles, keeping a low power 32kHz crystal 
oscillator and its associated real time clock (RTC) running whilst all other processes are 
dormant. A 192Hz interrupt running on the RTC is used instigate a sample cycle with the 
microcontroller back in its highest performance setting, Energy Mode 0 (EM0), with Energy 
Mode 1 (EM1) implemented during each ADC data acquisition and EM2 reselected 
following IrDA transmission. To quantify the effect this has EM0 runs at 5.06mA for ~24% 
of the total run time, with EM1 used for ~6% at 1.2mA, whilst the remainder is run under 
EM2, rated at 1.1 µA (Silicon Labs, 2014).  
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8.4 Prototype characterisation 
8.4.1 Signal quality 
 
Figure 8.4.1 Neurologger and  DatenSender Signal to Noise ratio comparison. Power spectra of 8Hz 
recordings in the NeuroLogger (NL) and DatenSender (DS). In the DS recording the 16Hz peak is a signal 
generator harmonic of the 8Hz oscillation in the FFT.  
In order to test signal quality an 8Hz peak to peak sinusoid produced by a signal generator 
(TTi TG2000, Thurlby Thandar Instruments Limited, Huntingdon, UK) connected to a 
potential divider, was used to compare the signal to noise ratio (SNR) of the DatenSender and 
Neurologger. The Fast Fourier Transforms (FFT) of the recordings in Figure 8.4.1 show that 
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the power within the noise is attenuated evenly across all frequencies with the DatenSender at 
~-90dB, the power of the noise attenuates from ~-60dB to ~-80dB as frequency increases 
with the Neurologger. The 16Hz harmonic within the DatenSender FFT may be present 
within the Neurologger data, but masked by the increased noise at that frequency. Using the 
signal to noise ratio function in MATLAB, which ignores the first 6 harmonics, the calculated 
SNR for the DatenSender was 48.53dB and 40.17dB for the Neurologger. One minor 
observation was that with the DatenSender the peak power was observed at 8.0625Hz, 
meaning that real time clock oscillator or sampling rate calibration is required when the final 
sampling rate is chosen. 
8.4.2 Battery Performance 
To test the battery performance with the current configuration the supply voltage was 
monitored by the microcontroller for each sample cycle. Once the voltage level fell below 2 
volts, the microcontroller was shut down by being placed into shutoff mode (Energy Mode 
4). This monitoring will remain on the device, in order to protect the flash memory when it is 
implemented, as insufficient voltage supply can permanently damage the storage array, 
rendering the memory unusable (Hung-Wei et al., 2011). This function is not on the 
Neurologger which requires careful battery management. With constant IrDA streaming of 
the data, and a total of 8 ADC inputs sampled at 192Hz, the total time before shutdown was 
25hrs 9 minutes using 2 Duracell DA13 batteries rated at 290mAh each. In comparison the 
Neurologger can run for ~ 50 Hours on equivalent batteries. However, the DatenSender code 
has not yet been fully optimised for energy efficiency. For example we are currently 
sampling from all 8 ADC input channels, with an LED flash to indicate correct operation and 
a supply voltage check within each sample. In future versions we will reduce this by 
sampling and transmitting 4 channels differentially, the same configuration as the 
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Neurologger, and only flashing the LED and performing supply voltage tests periodically. 
Optimising the code for this purpose would have a large effect on battery life, as currently the 
digital electronics draw current in the milliamp range, whilst the analogue circuits draw 
~100µA.  
Additionally the need to continuously stream the data will be limited to short behavioural 
studies typically of less than 2 hours in duration. On the final device, for longer studies, once 
the data integrity has been confirmed via IrDA streaming, the IrDA stream can be halted via a 
command sent from the PC and the data stored onto flash memory, which is expected to 
reduce power consumption. For example to write at current data rates to the flash memory 
draws ~14µA, whereas IrDA consumes a theoretical maximum of 10.8mA (Micron 
Technology, 2012, Vishay Semiconductors, 2010). 
8.4.3 Test Recordings from anaesthetised rats. 
Following bench top characterisation, ECoG recordings from isoflurane and 
dexmedetomidine-anaesthetised rats were undertaken. The ECoG recordings are displayed in 
Figure 8.4.2 with representative Neurologger recordings, taken from a different set of 
experiments, but under the same experimental conditions. The isoflurane recordings using the 
Neurologger were provided by Ed Harding. An increase in sub-1Hz power in the isoflurane 
recordings is observed. As a power increase in this frequency range is not observable in the 
dexmedetomidine recordings, and the results in Section 8.4.1 suggest that there is little noise 
at low frequencies, this power increase is biological, which is expected owing to the differing 
high-pass filter characteristics of the DatenSender. Overall, the DatenSender and Neurologger 
data are similar for a variety of differing experimental situations and waveforms, burst-
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suppression under isoflurane anaesthesia, subsequent recovery, and steady state 
dexmedetomidine anaesthesia.  
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Figure 8.4.2 DatenSender vs Neurologger data comparison. ECoG recordings from the  DatenSender with 
representative Neurologger recordings from separate sessions. Aside from some additional power at low 
frequencies under isoflurane. DatenSender recordings are comparable to those from the Neurologger. Power 
exhibiting 95% significance above the red noise background is within the black outlines. Isoflurane Neurologger 
recordings courtesy of Ed Harding.  
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8.5  Current Status and Future Development 
Currently, the DatenSender prototype can record EEG signals and wirelessly transmit them to 
a PC using IrDA. The raw signal with a maximum amplitude of 1.26mV peak to peak, 
undergoes an initial amplification and filtering stage with a gain of 500 and band pass of 
0.15-250Hz (-3dB points). Digitisation and IrDA transmission occurs at 192Hz and the 
current battery life of the device is 25 hours, which is promising given the current lack of 
optimisation. The data recorded exhibits a signal to noise ratio of 48.53dB in comparison to 
40.17dB with the Neurologger. Additionally the noise recorded on the DatenSender is 
attenuated evenly across all frequencies, whilst the noise recorded by the Neurologger 
attenuates as the frequency increases. ECoG recordings in rats under isoflurane and 
dexmedetomidine anaesthesia with the DatenSender are indistinguishable from recordings 
made by the Neurologger, with the exception of increased biological power at sub-1Hz 
frequencies attributable to the lower high pass cut-off frequency. Thus, the signals recorded 
and transmitted are suitable for the intended application. Further development is now needed 
to finalise the device specification and produce a system appropriate for recording from mice. 
Firstly, at a total weight of 5 grams and plan size of 34mm x 22mm, the current prototype is 
too large to record from mice, but can be used to record from rats. In order to do this, further 
development of the IrDA transceiver setup on the PC side is required, multiple IrDA 
acquisition transceivers will need to be placed within the recording area, such that line of 
sight with the IrDA transceiver on the device is maintained at all times. The process of 
integrating the data together when it is received from multiple acquisition points should be 
simple through time stamping the incoming data as it is received, and using code to merge the 
data accordingly, however experimentation is required in order to identify the number of 
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IrDA acquisition points required, and where they are best placed within the possible 
recording areas, the home cage or rotating tube.  
The next stage is to find a suitable configuration in order to hit the battery life, weight and 
size targets. The weight and size of the device will depend on its final hardware 
configuration, which in turn is dependent on the progress made with the optimisation of 
battery life through improving the current microcontroller software. The first stage in 
improving the software will be to implement the differential ADC mode as a user 
configurable option, in order to reduce the number of ADC conversions per sample to 4 from 
the current 8. A subsequent reduction in the amount of data streamed via IrDA will result, 
further prolonging the battery life. Additionally, the on board red LED pulses, to signify 
device operation, and supply voltage checks, will be implemented such that they occur every 
few seconds, instead of every sample. 
Battery life is also heavily dependent on the sampling rate of the device. High sampling rates 
of 200Hz or above are preferred, so that the device is capable of measuring the gamma range 
of frequencies, typically between 30-90Hz (Buzsaki and Wang, 2012). The sampling rate 
should also set the upper limit for the low pass filter, which at its maximum should be half 
the sampling rate. Sampling at frequencies greater than double the low pass -3dB frequency 
reduces the possibility of aliasing artefacts (National Instruments, 2006), although the 
possibility of aliasing with ECoG/LFP signals is alleviated by their 1/f
n
 power distribution 
(Buzsaki et al., 2012). Thus, if in vivo experimentation to be undertaken can confirm that that 
aliasing artefacts do not occur, the sampling rate could be made user adjustable such that 
lower rates can be used in order to maximise battery life. At these lower sampling rates, the 
ability to record gamma oscillations may be compromised. However given that these long 
DATENSENDER - RODENT EEG & EMG ACQUISITION SYSTEM 
153 
 
recordings of over 24 hours are typically used for sleep scoring, which relies on the 
observance of frequencies below 10Hz (Chapter 2.5.1), this should be of little consequence.  
Should the battery life target be met satisfactorily, the USB connectivity and flash memory 
capability could be sacrificed in order to minimise the size and weight of the final device, 
however, having these features means that the device can run in a standalone mode without 
requiring equipment for IrDA acquisition, act as a backup if the IrDA link were to fail, or can 
be used to prolong the battery life as flash is predicted to be less energy intensive. 
Additionally the design currently being drafted for the final device contains these elements, 
and is projected to be of comparable size and weight to the Neurologger. 
 
 
 
 
 
 
  
 154 
 
 
References 
  
REFERENCES 
155 
 
AESCHBACH, D. & BORBELY, A. A. 1993. All-night dynamics of the human sleep EEG. J Sleep 
Res, 2, 70-81. 
AGGLETON, J. P., O'MARA, S. M., VANN, S. D., WRIGHT, N. F., TSANOV, M. & ERICHSEN, 
J. T. 2010. Hippocampal-anterior thalamic pathways for memory: uncovering a network of direct and 
indirect actions. Eur J Neurosci, 31, 2292-307. 
ALKIRE, M. T. 2008. Loss of effective connectivity during general anesthesia. Int Anesthesiol Clin, 
46, 55-73. 
ALKIRE, M. T., ASHER, C. D., FRANCISCUS, A. M. & HAHN, E. L. 2009. Thalamic 
microinfusion of antibody to a voltage-gated potassium channel restores consciousness during 
anesthesia. Anesthesiology, 110, 766-73. 
ALKIRE, M. T., HAIER, R. J., BARKER, S. J., SHAH, N. K., WU, J. C. & KAO, Y. J. 1995. 
Cerebral metabolism during propofol anesthesia in humans studied with positron emission 
tomography. Anesthesiology, 82, 393-403; discussion 27A. 
ALKIRE, M. T., HUDETZ, A. G. & TONONI, G. 2008. Consciousness and anesthesia. Science, 322, 
876-80. 
ALKIRE, M. T., MCREYNOLDS, J. R., HAHN, E. L. & TRIVEDI, A. N. 2007. Thalamic 
microinjection of nicotine reverses sevoflurane-induced loss of righting reflex in the rat. 
Anesthesiology, 107, 264-72. 
AMZICA, F. & STERIADE, M. 2002. The functional significance of K-complexes. Sleep Med Rev, 
6, 139-49. 
ANGEL, A. & LEBEAU, F. 1992. A comparison of the effects of propofol with other anaesthetic 
agents on the centripetal transmission of sensory information. Gen Pharmacol, 23, 945-63. 
ASTON-JONES, G. & BLOOM, F. E. 1981. Activity of norepinephrine-containing locus coeruleus 
neurons in behaving rats anticipates fluctuations in the sleep-waking cycle. J Neurosci, 1, 876-86. 
BARTHO, P., FREUND, T. F. & ACSADY, L. 2002. Selective GABAergic innervation of thalamic 
nuclei from zona incerta. Eur J Neurosci, 16, 999-1014. 
BEHNE, M., WILKE, H. J. & HARDER, S. 1999. Clinical pharmacokinetics of sevoflurane. Clin 
Pharmacokinet, 36, 13-26. 
BENTIVOGLIO, M. & SPREAFICO, R. 1988. Cellular thalamic mechanisms : based on 
contributions to the symposium held in Verona, Italy, 22-25 August 1987, New York, NY, USA, 
Elsevier Science Pub. Co. 
BERGER, H. 1929. Über das Elektrenkephalogramm des Menschen. Archiv für Psychiatrie und 
Nervenkrankheiten, 87, 527-570. 
REFERENCES 
156 
 
BERTRAM, E. H., WILLIAMSON, J. M., CORNETT, J. F., SPRADLIN, S. & CHEN, Z. F. 1997. 
Design and construction of a long-term continuous video-EEG monitoring unit for simultaneous 
recording of multiple small animals. Brain Res Brain Res Protoc, 2, 85-97. 
BIGELOW, H. J. 1846. Insensibility during Surgical Operations Produced by Inhalation. The Boston 
Medical and Surgical Journal, 35, 309-317. 
BLAKELY, T., MILLER, K. J., RAO, R. P. N., HOLMES, M. D. & OJEMANN, J. G. Localization 
and classification of phonemes using high spatial resolution electrocorticography (ECoG) grids.  
Engineering in Medicine and Biology Society, 2008. EMBS 2008. 30th Annual International 
Conference of the IEEE, 20-25 Aug. 2008 2008. 4964-4967. 
BOL, C., DANHOF, M., STANSKI, D. R. & MANDEMA, J. W. 1997. Pharmacokinetic-
pharmacodynamic characterization of the cardiovascular, hypnotic, EEG and ventilatory responses to 
dexmedetomidine in the rat. J Pharmacol Exp Ther, 283, 1051-8. 
BOLLIMUNTA, A., CHEN, Y., SCHROEDER, C. E. & DING, M. 2008. Neuronal mechanisms of 
cortical alpha oscillations in awake-behaving macaques. J Neurosci, 28, 9976-88. 
BOUYER, J. J., MONTARON, M. F. & ROUGEUL, A. 1981. Fast fronto-parietal rhythms during 
combined focused attentive behaviour and immobility in cat: cortical and thalamic localizations. 
Electroencephalogr Clin Neurophysiol, 51, 244-52. 
BOVEROUX, P., VANHAUDENHUYSE, A., BRUNO, M. A., NOIRHOMME, Q., LAUWICK, S., 
LUXEN, A., DEGUELDRE, C., PLENEVAUX, A., SCHNAKERS, C., PHILLIPS, C., BRICHANT, 
J. F., BONHOMME, V., MAQUET, P., GREICIUS, M. D., LAUREYS, S. & BOLY, M. 2010. 
Breakdown of within- and between-network resting state functional magnetic resonance imaging 
connectivity during propofol-induced loss of consciousness. Anesthesiology, 113, 1038-53. 
BRAGIN, A., JANDO, G., NADASDY, Z., HETKE, J., WISE, K. & BUZSAKI, G. 1995. Gamma 
(40-100 Hz) oscillation in the hippocampus of the behaving rat. J Neurosci, 15, 47-60. 
BRETT-GREEN, B., PAULSEN, M., STABA, R. J., FIFKOVÁ, E. & BARTH, D. S. 2004. Two 
distinct regions of secondary somatosensory cortex in the rat: topographical organization and 
multisensory responses. J Neurophysiol, 91, 1327-36. 
BROWN, E. N., LYDIC, R. & SCHIFF, N. D. 2010. General anesthesia, sleep, and coma. N Engl J 
Med, 363, 2638-50. 
BROWN, E. N., PURDON, P. L. & VAN DORT, C. J. 2011. General anesthesia and altered states of 
arousal: a systems neuroscience analysis. Annu Rev Neurosci, 34, 601-28. 
BUZSAKI, G. 2002. Theta oscillations in the hippocampus. Neuron, 33, 325-40. 
BUZSAKI, G., ANASTASSIOU, C. A. & KOCH, C. 2012. The origin of extracellular fields and 
currents--EEG, ECoG, LFP and spikes. Nat Rev Neurosci, 13, 407-20. 
REFERENCES 
157 
 
BUZSAKI, G. & WANG, X. J. 2012. Mechanisms of gamma oscillations. Annu Rev Neurosci, 35, 
203-25. 
CAPPE, C., MOREL, A., BARONE, P. & ROUILLER, E. M. 2009. The thalamocortical projection 
systems in primate: an anatomical support for multisensory and sensorimotor interplay. Cereb Cortex, 
19, 2025-37. 
CARRACEDO, L. M., KJELDSEN, H., CUNNINGTON, L., JENKINS, A., SCHOFIELD, I., 
CUNNINGHAM, M. O., DAVIES, C. H., TRAUB, R. D. & WHITTINGTON, M. A. 2013. A 
neocortical delta rhythm facilitates reciprocal interlaminar interactions via nested theta rhythms. J 
Neurosci, 33, 10750-61. 
CARTER, A. J. 1995. Antagonists of the NMDA receptor-channel complex and motor coordination. 
Life Sciences, 57, 917-929. 
CASALI, A. G., GOSSERIES, O., ROSANOVA, M., BOLY, M., SARASSO, S., CASALI, K. R., 
CASAROTTO, S., BRUNO, M. A., LAUREYS, S., TONONI, G. & MASSIMINI, M. 2013. A 
theoretically based index of consciousness independent of sensory processing and behavior. Sci 
Transl Med, 5, 198ra105. 
CENQUIZCA, L. A. & SWANSON, L. W. 2006. Analysis of direct hippocampal cortical field CA1 
axonal projections to diencephalon in the rat. J Comp Neurol, 497, 101-14. 
CHAE, Y. J., ZHANG, J., AU, P., SABBADINI, M., XIE, G. X. & YOST, C. S. 2010. Discrete 
change in volatile anesthetic sensitivity in mice with inactivated tandem pore potassium ion channel 
TRESK. Anesthesiology, 113, 1326-37. 
CHATILA, M., MILLERET, C., ROUGEUL, A. & BUSER, P. 1993. Alpha rhythm in the cat 
thalamus. C R Acad Sci III, 316, 51-8. 
CHAUVETTE, S., VOLGUSHEV, M. & TIMOFEEV, I. 2010. Origin of active states in local 
neocortical networks during slow sleep oscillation. Cereb Cortex, 20, 2660-74. 
CHING, S., CIMENSER, A., PURDON, P. L., BROWN, E. N. & KOPELL, N. J. 2010. 
Thalamocortical model for a propofol-induced alpha-rhythm associated with loss of consciousness. 
Proc Natl Acad Sci U S A, 107, 22665-70. 
CHING, S., PURDON, P. L., VIJAYAN, S., KOPELL, N. J. & BROWN, E. N. 2012. A 
neurophysiological-metabolic model for burst suppression. Proc Natl Acad Sci U S A, 109, 3095-100. 
CHIU, T. H., CHEN, M. J., YANG, Y. R., YANG, J. J. & TANG, F. I. 1995. Action of 
dexmedetomidine on rat locus coeruleus neurones: intracellular recording in vitro. Eur J Pharmacol, 
285, 261-8. 
CHOU, T. C., BJORKUM, A. A., GAUS, S. E., LU, J., SCAMMELL, T. E. & SAPER, C. B. 2002. 
Afferents to the ventrolateral preoptic nucleus. J Neurosci, 22, 977-90. 
COLGIN, L. L. 2013. Mechanisms and functions of theta rhythms. Annu Rev Neurosci, 36, 295-312. 
REFERENCES 
158 
 
CONTRERAS, D., DESTEXHE, A., SEJNOWSKI, T. J. & STERIADE, M. 1997. Spatiotemporal 
patterns of spindle oscillations in cortex and thalamus. J Neurosci, 17, 1179-96. 
CONTRERAS, D. & STERIADE, M. 1995. Cellular basis of EEG slow rhythms: a study of dynamic 
corticothalamic relationships. J Neurosci, 15, 604-22. 
CORREA-SALES, C., RABIN, B. C. & MAZE, M. 1992. A hypnotic response to dexmedetomidine, 
an alpha 2 agonist, is mediated in the locus coeruleus in rats. Anesthesiology, 76, 948-52. 
COSTA-MISERACHS, D., PORTELL-CORTES, I., TORRAS-GARCIA, M. & MORGADO-
BERNAL, I. 2003. Automated sleep staging in rat with a standard spreadsheet. J Neurosci Methods, 
130, 93-101. 
COULTER, D. A., HUGUENARD, J. R. & PRINCE, D. A. 1989. Calcium currents in rat 
thalamocortical relay neurones: kinetic properties of the transient, low-threshold current. J Physiol, 
414, 587-604. 
CRICK, F. & KOCH, C. Towards a neurobiological theory of consciousness.  Seminars in the 
Neurosciences, 1990. Saunders Scientific Publications, 263-275. 
CRUNELLI, V. & HUGHES, S. W. 2010. The slow (<1 Hz) rhythm of non-REM sleep: a dialogue 
between three cardinal oscillators. Nat Neurosci, 13, 9-17. 
DA SILVA, F. H., VAN LIEROP, T. H., SCHRIJER, C. F. & VAN LEEUWEN, W. S. 1973. 
Organization of thalamic and cortical alpha rhythms: spectra and coherences. Electroencephalogr 
Clin Neurophysiol, 35, 627-39. 
DAHMANI, S., STANY, I., BRASHER, C., LEJEUNE, C., BRUNEAU, B., WOOD, C., NIVOCHE, 
Y., CONSTANT, I. & MURAT, I. 2010. Pharmacological prevention of sevoflurane- and desflurane-
related emergence agitation in children: a meta-analysis of published studies. Br J Anaesth, 104, 216-
23. 
DALLEY, J. W., CARDINAL, R. N. & ROBBINS, T. W. 2004. Prefrontal executive and cognitive 
functions in rodents: neural and neurochemical substrates. Neurosci Biobehav Rev, 28, 771-84. 
DATA SCIENCES INTERNATIONAL. 2014. Miniature Telemetry [Online]. Available: 
http://www.datasci.com/products/implantable-telemetry/mouse-(miniature) [Accessed 23.09. 2014]. 
DATTA, S. & SIWEK, D. F. 2002. Single cell activity patterns of pedunculopontine tegmentum 
neurons across the sleep-wake cycle in the freely moving rats. J Neurosci Res, 70, 611-21. 
DAVID, F., SCHMIEDT, J. T., TAYLOR, H. L., ORBAN, G., DI GIOVANNI, G., UEBELE, V. N., 
RENGER, J. J., LAMBERT, R. C., LERESCHE, N. & CRUNELLI, V. 2013. Essential thalamic 
contribution to slow waves of natural sleep. J Neurosci, 33, 19599-610. 
DE PASQUALE, R. & SHERMAN, S. M. 2011. Synaptic properties of corticocortical connections 
between the primary and secondary visual cortical areas in the mouse. J Neurosci, 31, 16494-506. 
REFERENCES 
159 
 
DE SOUSA, S. L., DICKINSON, R., LIEB, W. R. & FRANKS, N. P. 2000. Contrasting synaptic 
actions of the inhalational general anesthetics isoflurane and xenon. Anesthesiology, 92, 1055-66. 
DE ZWART, J. A., SILVA, A. C., VAN GELDEREN, P., KELLMAN, P., FUKUNAGA, M., CHU, 
R., KORETSKY, A. P., FRANK, J. A. & DUYN, J. H. 2005. Temporal dynamics of the BOLD fMRI 
impulse response. Neuroimage, 24, 667-77. 
DEVOR, M. & ZALKIND, V. 2001. Reversible analgesia, atonia, and loss of consciousness on 
bilateral intracerebral microinjection of pentobarbital. Pain, 94, 101-12. 
DUYN, J. H. 2012. EEG-fMRI Methods for the Study of Brain Networks during Sleep. Front Neurol, 
3, 100. 
ECONOMO, M. N. & WHITE, J. A. 2012. Membrane Properties and the Balance between Excitation 
and Inhibition Control Gamma-Frequency Oscillations Arising from Feedback Inhibition. PLoS 
Comput Biol, 8, e1002354. 
EDELMAN, G. M. 2003. Naturalizing consciousness: a theoretical framework. Proc Natl Acad Sci U 
S A, 100, 5520-4. 
ENGEL, A. K. & SINGER, W. 2001. Temporal binding and the neural correlates of sensory 
awareness. Trends Cogn Sci, 5, 16-25. 
FERRARELLI, F., MASSIMINI, M., SARASSO, S., CASALI, A., RIEDNER, B. A., ANGELINI, 
G., TONONI, G. & PEARCE, R. A. 2010. Breakdown in cortical effective connectivity during 
midazolam-induced loss of consciousness. Proc Natl Acad Sci U S A, 107, 2681-6. 
FESHCHENKO, V. A., VESELIS, R. A. & REINSEL, R. A. 2004. Propofol-induced alpha rhythm. 
Neuropsychobiology, 50, 257-66. 
FLOHR, H., GLADE, U. & MOTZKO, D. 1998. The role of the NMDA synapse in general 
anesthesia. Toxicol Lett, 100-101, 23-9. 
FOOTE, S. L., BLOOM, F. E. & ASTON-JONES, G. 1983. Nucleus locus ceruleus: new evidence of 
anatomical and physiological specificity. Physiol Rev, 63, 844-914. 
FRANKS, N. P. 2006. Molecular targets underlying general anaesthesia. Br J Pharmacol, 147 Suppl 
1, S72-81. 
FRANKS, N. P. 2008. General anaesthesia: from molecular targets to neuronal pathways of sleep and 
arousal. Nat Rev Neurosci, 9, 370-86. 
FRANKS, N. P. & LIEB, W. R. 1982. Molecular mechanisms of general anaesthesia. Nature, 300, 
487-93. 
FRANKS, N. P. & LIEB, W. R. 1984. Do general anaesthetics act by competitive binding to specific 
receptors? Nature, 310, 599-601. 
REFERENCES 
160 
 
FRANKS, N. P. & LIEB, W. R. 1988. Volatile general anaesthetics activate a novel neuronal K+ 
current. Nature, 333, 662-4. 
FRANKS, N. P. & LIEB, W. R. 1991. Stereospecific effects of inhalational general anesthetic optical 
isomers on nerve ion channels. Science, 254, 427-30. 
FRANKS, N. P. & LIEB, W. R. 1994. Molecular and cellular mechanisms of general anaesthesia. 
Nature, 367, 607-14. 
FRIEDMAN-HILL, S., MALDONADO, P. E. & GRAY, C. M. 2000. Dynamics of striate cortical 
activity in the alert macaque: I. Incidence and stimulus-dependence of gamma-band neuronal 
oscillations. Cereb Cortex, 10, 1105-16. 
FRIES, P., NIKOLIC, D. & SINGER, W. 2007. The gamma cycle. Trends Neurosci, 30, 309-16. 
FULLER, P. M., SHERMAN, D., PEDERSEN, N. P., SAPER, C. B. & LU, J. 2011. Reassessment of 
the structural basis of the ascending arousal system. J Comp Neurol, 519, 933-56. 
GALLOPIN, T., FORT, P., EGGERMANN, E., CAULI, B., LUPPI, P. H., ROSSIER, J., AUDINAT, 
E., MUHLETHALER, M. & SERAFIN, M. 2000. Identification of sleep-promoting neurons in vitro. 
Nature, 404, 992-5. 
GALLOPIN, T., LUPPI, P. H., RAMBERT, F. A., FRYDMAN, A. & FORT, P. 2004. Effect of the 
wake-promoting agent modafinil on sleep-promoting neurons from the ventrolateral preoptic nucleus: 
an in vitro pharmacologic study. Sleep, 27, 19-25. 
GENT, T. C. 2011. Thalamocortical Oscillations in Sleep and Anaesthesia. Doctor of Philosophy, 
Imperial College London. 
GERVASONI, D., LIN, S. C., RIBEIRO, S., SOARES, E. S., PANTOJA, J. & NICOLELIS, M. A. 
2004. Global forebrain dynamics predict rat behavioral states and their transitions. J Neurosci, 24, 
11137-47. 
GIACINO, J. T., FINS, J. J., LAUREYS, S. & SCHIFF, N. D. 2014. Disorders of consciousness after 
acquired brain injury: the state of the science. Nat Rev Neurol, 10, 99-114. 
GLENN, L. L. & STERIADE, M. 1982. Discharge rate and excitability of cortically projecting 
intralaminar thalamic neurons during waking and sleep states. J Neurosci, 2, 1387-404. 
GOLDSTEIN, S. A., BAYLISS, D. A., KIM, D., LESAGE, F., PLANT, L. D. & RAJAN, S. 2005. 
International Union of Pharmacology. LV. Nomenclature and molecular relationships of two-P 
potassium channels. Pharmacol Rev, 57, 527-40. 
GOLDSTEIN, S. A., BOCKENHAUER, D., O'KELLY, I. & ZILBERBERG, N. 2001. Potassium 
leak channels and the KCNK family of two-P-domain subunits. Nat Rev Neurosci, 2, 175-84. 
REFERENCES 
161 
 
GRINSTED, A., MOORE, J. C. & JEVREJEVA, S. 2004. Application of the cross wavelet transform 
and wavelet coherence to geophysical time series. Nonlinear Processes in Geophysics, 11, 561-566. 
GUILLERY, R. W. & SHERMAN, S. M. 2011. Branched thalamic afferents: What are the messages 
that they relay to the cortex? Brain Research Reviews, 66, 205-219. 
GVILIA, I., XU, F., MCGINTY, D. & SZYMUSIAK, R. 2006. Homeostatic regulation of sleep: a 
role for preoptic area neurons. J Neurosci, 26, 9426-33. 
HALLANGER, A. E., LEVEY, A. I., LEE, H. J., RYE, D. B. & WAINER, B. H. 1987. The origins of 
cholinergic and other subcortical afferents to the thalamus in the rat. The Journal of Comparative 
Neurology, 262, 105-124. 
HARRIS, B., MOODY, E. & SKOLNICK, P. 1992. Isoflurane anesthesia is stereoselective. European 
Journal of Pharmacology, 217, 215-216. 
HARRIS, K., ARMSTRONG, S. P., CAMPOS-PIRES, R., KIRU, L., FRANKS, N. P. & 
DICKINSON, R. 2013. Neuroprotection against traumatic brain injury by xenon, but not argon, is 
mediated by inhibition at the N-methyl-D-aspartate receptor glycine site. Anesthesiology, 119, 1137-
48. 
HENDERSON, J. M., CARPENTER, K., CARTWRIGHT, H. & HALLIDAY, G. M. 2000. 
Degeneration of the centre median-parafascicular complex in Parkinson's disease. Ann Neurol, 47, 
345-52. 
HEURTEAUX, C., GUY, N., LAIGLE, C., BLONDEAU, N., DUPRAT, F., MAZZUCA, M., 
LANG-LAZDUNSKI, L., WIDMANN, C., ZANZOURI, M., ROMEY, G. & LAZDUNSKI, M. 
2004. TREK-1, a K+ channel involved in neuroprotection and general anesthesia. EMBO J, 23, 2684-
95. 
HOFLE, N., PAUS, T., REUTENS, D., FISET, P., GOTMAN, J., EVANS, A. C. & JONES, B. E. 
1997. Regional cerebral blood flow changes as a function of delta and spindle activity during slow 
wave sleep in humans. J Neurosci, 17, 4800-8. 
HUDETZ, A. G. 2012. General anesthesia and human brain connectivity. Brain Connect, 2, 291-302. 
HUGHES, S. W. & CRUNELLI, V. 2005. Thalamic mechanisms of EEG alpha rhythms and their 
pathological implications. Neuroscientist, 11, 357-72. 
HUGHES, S. W., LORINCZ, M., COPE, D. W., BLETHYN, K. L., KEKESI, K. A., PARRI, H. R., 
JUHASZ, G. & CRUNELLI, V. 2004. Synchronized oscillations at alpha and theta frequencies in the 
lateral geniculate nucleus. Neuron, 42, 253-68. 
HUNG-WEI, T., GRUPP, L. & SWANSON, S. Understanding the impact of power loss on flash 
memory.  Design Automation Conference (DAC), 2011 48th ACM/EDAC/IEEE, 5-9 June 2011 2011. 
35-40. 
REFERENCES 
162 
 
HUUPPONEN, E., MAKSIMOW, A., LAPINLAMPI, P., SARKELA, M., SAASTAMOINEN, A., 
SNAPIR, A., SCHEININ, H., SCHEININ, M., MERILAINEN, P., HIMANEN, S. L. & 
JAASKELAINEN, S. 2008. Electroencephalogram spindle activity during dexmedetomidine sedation 
and physiological sleep. Acta Anaesthesiol Scand, 52, 289-94. 
HWANG, E., KIM, S., SHIN, H. S. & CHOI, J. H. 2010. The forced walking test: a novel test for 
pinpointing the anesthetic-induced transition in consciousness in mouse. J Neurosci Methods, 188, 14-
23. 
HWANG, E., MCNALLY, J. M. & CHOI, J. H. 2013. Reduction in cortical gamma synchrony during 
depolarized state of slow wave activity in mice. Front Syst Neurosci, 7, 107. 
IMAS, O. A., ROPELLA, K. M., WARD, B. D., WOOD, J. D. & HUDETZ, A. G. 2005. Volatile 
anesthetics disrupt frontal-posterior recurrent information transfer at gamma frequencies in rat. 
Neurosci Lett, 387, 145-50. 
IMAS, O. A., ROPELLA, K. M., WOOD, J. D. & HUDETZ, A. G. 2006. Isoflurane disrupts anterio-
posterior phase synchronization of flash-induced field potentials in the rat. Neurosci Lett, 402, 216-21. 
JAHNSEN, H. & LLINAS, R. 1984a. Electrophysiological properties of guinea-pig thalamic 
neurones: an in vitro study. J Physiol, 349, 205-26. 
JAHNSEN, H. & LLINAS, R. 1984b. Ionic basis for the electro-responsiveness and oscillatory 
properties of guinea-pig thalamic neurones in vitro. J Physiol, 349, 227-47. 
JOHN, E. R. & PRICHEP, L. S. 2005. The anesthetic cascade: a theory of how anesthesia suppresses 
consciousness. Anesthesiology, 102, 447-71. 
JOHN, E. R., PRICHEP, L. S., KOX, W., VALDES-SOSA, P., BOSCH-BAYARD, J., AUBERT, E., 
TOM, M., DI MICHELE, F. & GUGINO, L. D. 2001. Invariant reversible QEEG effects of 
anesthetics. Conscious Cogn, 10, 165-83. 
JONES, E. G. & DIAMOND, I. T. 1995. The Barrel Cortex of Rodents: Volume 11: The Barrel 
Cortex of Rodents, Springer. 
JURD, R., ARRAS, M., LAMBERT, S., DREXLER, B., SIEGWART, R., CRESTANI, F., ZAUGG, 
M., VOGT, K. E., LEDERMANN, B., ANTKOWIAK, B. & RUDOLPH, U. 2002. General anesthetic 
actions in vivo strongly attenuated by a point mutation in the GABAA receptor β3 subunit. The 
FASEB Journal. 
KAISTI, K. K., METSAHONKALA, L., TERAS, M., OIKONEN, V., AALTO, S., 
JAASKELAINEN, S., HINKKA, S. & SCHEININ, H. 2002. Effects of surgical levels of propofol 
and sevoflurane anesthesia on cerebral blood flow in healthy subjects studied with positron emission 
tomography. Anesthesiology, 96, 1358-70. 
KAITZ, S. S. & ROBERTSON, R. T. 1981. Thalamic connections with limbic cortex. II. 
Corticothalamic projections. The Journal of Comparative Neurology, 195, 527-545. 
REFERENCES 
163 
 
KAJIKAWA, Y. & SCHROEDER, CHARLES E. 2011a. How Local Is the Local Field Potential? 
Neuron, 72, 847-858. 
KAJIKAWA, Y. & SCHROEDER, C. E. 2011b. How local is the local field potential? Neuron, 72, 
847-58. 
KAMIBAYASHI, T. & MAZE, M. 2000. Clinical uses of alpha2 -adrenergic agonists. 
Anesthesiology, 93, 1345-9. 
KEZUNOVIC, N., HYDE, J., SIMON, C., URBANO, F. J., WILLIAMS, D. K. & GARCIA-RILL, E. 
2012. Gamma band activity in the developing parafascicular nucleus. J Neurophysiol, 107, 772-84. 
KIJEWSKI, T. & KAREEM, A. 2003. Wavelet Transforms for System Identification in Civil 
Engineering. Computer-Aided Civil and Infrastructure Engineering, 18, 339-355. 
KINOMURA, S., LARSSON, J., GULYAS, B. & ROLAND, P. E. 1996. Activation by attention of 
the human reticular formation and thalamic intralaminar nuclei. Science, 271, 512-5. 
KOCSIS, B., VARGA, V., DAHAN, L. & SIK, A. 2006. Serotonergic neuron diversity: identification 
of raphe neurons with discharges time-locked to the hippocampal theta rhythm. Proc Natl Acad Sci U 
S A, 103, 1059-64. 
KRAMER, K. & KINTER, L. B. 2003. Evaluation and applications of radiotelemetry in small 
laboratory animals. Physiol Genomics, 13, 197-205. 
KRASOWSKI, M. D., KOLTCHINE, V. V., RICK, C. E., YE, Q., FINN, S. E. & HARRISON, N. L. 
1998. Propofol and other intravenous anesthetics have sites of action on the gamma-aminobutyric acid 
type A receptor distinct from that for isoflurane. Mol Pharmacol, 53, 530-8. 
KROUT, K. E., BELZER, R. E. & LOEWY, A. D. 2002. Brainstem projections to midline and 
intralaminar thalamic nuclei of the rat. J Comp Neurol, 448, 53-101. 
LAKHLANI, P. P., MACMILLAN, L. B., GUO, T. Z., MCCOOL, B. A., LOVINGER, D. M., 
MAZE, M. & LIMBIRD, L. E. 1997. Substitution of a mutant alpha2a-adrenergic receptor via "hit 
and run" gene targeting reveals the role of this subtype in sedative, analgesic, and anesthetic-sparing 
responses in vivo. Proc Natl Acad Sci U S A, 94, 9950-5. 
LANGSJO, J. W., ALKIRE, M. T., KASKINORO, K., HAYAMA, H., MAKSIMOW, A., KAISTI, 
K. K., AALTO, S., AANTAA, R., JAASKELAINEN, S. K., REVONSUO, A. & SCHEININ, H. 
2012. Returning from oblivion: imaging the neural core of consciousness. J Neurosci, 32, 4935-43. 
LAPRAY, D., BERGELER, J., DUPONT, E., THEWS, O. & LUHMANN, H. J. 2008. A novel 
miniature telemetric system for recording EEG activity in freely moving rats. J Neurosci Methods, 
168, 119-26. 
LAZARENKO, R. M., WILLCOX, S. C., SHU, S., BERG, A. P., JEVTOVIC-TODOROVIC, V., 
TALLEY, E. M., CHEN, X. & BAYLISS, D. A. 2010. Motoneuronal TASK channels contribute to 
immobilizing effects of inhalational general anesthetics. J Neurosci, 30, 7691-704. 
REFERENCES 
164 
 
LEMIEUX, M., CHEN, J. Y., LONJERS, P., BAZHENOV, M. & TIMOFEEV, I. 2014. The impact 
of cortical deafferentation on the neocortical slow oscillation. J Neurosci, 34, 5689-703. 
LEPOUSE, C., LAUTNER, C. A., LIU, L., GOMIS, P. & LEON, A. 2006. Emergence delirium in 
adults in the post-anaesthesia care unit. Br J Anaesth, 96, 747-53. 
LEWIS, L. D., WEINER, V. S., MUKAMEL, E. A., DONOGHUE, J. A., ESKANDAR, E. N., 
MADSEN, J. R., ANDERSON, W. S., HOCHBERG, L. R., CASH, S. S., BROWN, E. N. & 
PURDON, P. L. 2012. Rapid fragmentation of neuronal networks at the onset of propofol-induced 
unconsciousness. Proc Natl Acad Sci U S A, 109, E3377-86. 
LINDEN, H., TETZLAFF, T., POTJANS, T. C., PETTERSEN, K. H., GRUN, S., DIESMANN, M. 
& EINEVOLL, G. T. 2011. Modeling the spatial reach of the LFP. Neuron, 72, 859-72. 
LINGENHÖHL, K. & POZZA, M. F. 1998. Reevaluation of ACEA 1021 as an antagonist at the 
strychnine-insensitive glycine site of the N-methyl-d-aspartate receptor. Neuropharmacology, 37, 
729-737. 
LIOUDYNO, M. I., BIRCH, A. M., TANAKA, B. S., SOKOLOV, Y., GOLDIN, A. L., CHANDY, 
K. G., HALL, J. E. & ALKIRE, M. T. 2013. Shaker-related potassium channels in the central medial 
nucleus of the thalamus are important molecular targets for arousal suppression by volatile general 
anesthetics. J Neurosci, 33, 16310-22. 
LIU, X., LAUER, K. K., WARD, B. D., LI, S. J. & HUDETZ, A. G. 2013. Differential effects of deep 
sedation with propofol on the specific and nonspecific thalamocortical systems: a functional magnetic 
resonance imaging study. Anesthesiology, 118, 59-69. 
LIU, X., LAUER, K. K., WARD, B. D., RAO, S. M., LI, S. J. & HUDETZ, A. G. 2012. Propofol 
disrupts functional interactions between sensory and high-order processing of auditory verbal 
memory. Hum Brain Mapp, 33, 2487-98. 
LOGOTHETIS, N. K. 2008. What we can do and what we cannot do with fMRI. Nature, 453, 869-
878. 
LOW, P. 2012. Consciousness in human and non-human animals. In: PANKSEPP J, E. A. (ed.) The 
Francis Crick Memorial Conference. Cambridge, UK. 
LU, J., JHOU, T. C. & SAPER, C. B. 2006. Identification of wake-active dopaminergic neurons in the 
ventral periaqueductal gray matter. J Neurosci, 26, 193-202. 
MACDONALD, R. & BARKER, J. 1978. Different actions of anticonvulsant and anesthetic 
barbiturates revealed by use of cultured mammalian neurons. Science, 200, 775-777. 
MAGNIN, M., REY, M., BASTUJI, H., GUILLEMANT, P., MAUGUIERE, F. & GARCIA-
LARREA, L. 2010. Thalamic deactivation at sleep onset precedes that of the cerebral cortex in 
humans. Proc Natl Acad Sci U S A, 107, 3829-33. 
REFERENCES 
165 
 
MARKRAM, H., TOLEDO-RODRIGUEZ, M., WANG, Y., GUPTA, A., SILBERBERG, G. & WU, 
C. 2004. Interneurons of the neocortical inhibitory system. Nat Rev Neurosci, 5, 793-807. 
MARTIN, J. C., LILEY, D. T., HARVEY, A. S., KUHLMANN, L., SLEIGH, J. W. & DAVIDSON, 
A. J. 2014. Alterations in the Functional Connectivity of Frontal Lobe Networks Preceding 
Emergence Delirium in Children. Anesthesiology. 
MASHOUR, G. A. & ALKIRE, M. T. 2013. Evolution of consciousness: phylogeny, ontogeny, and 
emergence from general anesthesia. Proc Natl Acad Sci U S A, 110 Suppl 2, 10357-64. 
MASSIMINI, M., FERRARELLI, F., HUBER, R., ESSER, S. K., SINGH, H. & TONONI, G. 2005. 
Breakdown of cortical effective connectivity during sleep. Science, 309, 2228-32. 
MASSIMINI, M., HUBER, R., FERRARELLI, F., HILL, S. & TONONI, G. 2004. The sleep slow 
oscillation as a traveling wave. J Neurosci, 24, 6862-70. 
MAXWELL, W. L., MACKINNON, M. A., SMITH, D. H., MCINTOSH, T. K. & GRAHAM, D. I. 
2006. Thalamic nuclei after human blunt head injury. J Neuropathol Exp Neurol, 65, 478-88. 
MCCORMICK, D. A. & PAPE, H. C. 1990a. Noradrenergic and serotonergic modulation of a 
hyperpolarization-activated cation current in thalamic relay neurones. J Physiol, 431, 319-42. 
MCCORMICK, D. A. & PAPE, H. C. 1990b. Properties of a hyperpolarization-activated cation 
current and its role in rhythmic oscillation in thalamic relay neurones. J Physiol, 431, 291-318. 
MESULAM, M. M., MUFSON, E. J., WAINER, B. H. & LEVEY, A. I. 1983. Central cholinergic 
pathways in the rat: an overview based on an alternative nomenclature (Ch1-Ch6). Neuroscience, 10, 
1185-201. 
MEYER, H. 1899. Zur Theorie der Alkoholnarkose. Archiv für experimentelle Pathologie und 
Pharmakologie, 42, 109-118. 
MICRON TECHNOLOGY. 2012. NAND Flash Memory MT29F4G08ABADAH4, 
MT29F4G08ABADAWP, MT29F4G08ABBDAH4,MT29F4G08ABBDAHC, MT29F4G16ABADAH4, 
MT29F4G16ABADAWP, MT29F4G16ABBDAH4, MT29F4G16ABBDAHC, MT29F8G08ADADAH4, 
MT29F8G08ADBDAH4, MT29F8G16ADADAH4, MT29F8G16ADBDAH4, MT29F16G08AJADAWP 
Datasheet [Online]. Boise,  USA-ID: Micron Technology Inc. 
MIHALEK, R. M., BANERJEE, P. K., KORPI, E. R., QUINLAN, J. J., FIRESTONE, L. L., MI, Z. 
P., LAGENAUR, C., TRETTER, V., SIEGHART, W., ANAGNOSTARAS, S. G., SAGE, J. R., 
FANSELOW, M. S., GUIDOTTI, A., SPIGELMAN, I., LI, Z., DELOREY, T. M., OLSEN, R. W. & 
HOMANICS, G. E. 1999. Attenuated sensitivity to neuroactive steroids in gamma-aminobutyrate type 
A receptor delta subunit knockout mice. Proc Natl Acad Sci U S A, 96, 12905-10. 
MILLER, J. W. & FERRENDELLI, J. A. 1990. Characterization of gabaergic seizure regulation in 
the midline thalamus. Neuropharmacology, 29, 649-655. 
REFERENCES 
166 
 
MILLER, K. D. 2003. Understanding layer 4 of the cortical circuit: a model based on cat V1. Cereb 
Cortex, 13, 73-82. 
MILLER, K. W., PATON, W. D., SMITH, E. B. & SMITH, R. A. 1972. Physicochemical approaches 
to the mode of action of general anesthetics. Anesthesiology, 36, 339-51. 
MITZDORF, U. 1985. Current source-density method and application in cat cerebral cortex: 
investigation of evoked potentials and EEG phenomena. Physiol Rev, 65, 37-100. 
MOLLE, M., MARSHALL, L., GAIS, S. & BORN, J. 2002. Grouping of spindle activity during slow 
oscillations in human non-rapid eye movement sleep. J Neurosci, 22, 10941-7. 
MOONEY, D. M., ZHANG, L., BASILE, C., SENATOROV, V. V., NGSEE, J., OMAR, A. & HU, 
B. 2004. Distinct forms of cholinergic modulation in parallel thalamic sensory pathways. Proc Natl 
Acad Sci U S A, 101, 320-4. 
MORISON, R. S. & DEMPSEY, E. W. 1941. A STUDY OF THALAMO-CORTICAL RELATIONS. 
MORUZZI, G. & MAGOUN, H. W. 1949. Brain stem reticular formation and activation of the EEG. 
Electroencephalography and Clinical Neurophysiology, 1, 455-473. 
MULLINS, L. J. 1954. Some Physical Mechanisms in Narcosis. Chemical Reviews, 54, 289-323. 
NAKAKIMURA, K., SAKABE, T., FUNATSU, N., MAEKAWA, T. & TAKESHITA, H. 1988. 
Metabolic Activation of Intercortical and Corticothalamic Pathways during Enflurane Anesthesia in 
Rats. Anesthesiology, 68, 777-782. 
NATIONAL INSTRUMENTS. 2006. Aliasing and Sampling at Frequencies Above the Nyquist 
Frequency [Online]. Available: http://www.ni.com/white-paper/3000/en/ [Accessed 23.09 2014]. 
NATIONAL-INSTRUMENTS 2008. Sound and Vibration Measurement Suite 7.0 Help. 
NELSON, L. E., LU, J., GUO, T., SAPER, C. B., FRANKS, N. P. & MAZE, M. 2003. The alpha2-
adrenoceptor agonist dexmedetomidine converges on an endogenous sleep-promoting pathway to 
exert its sedative effects. Anesthesiology, 98, 428-36. 
NI MHUIRCHEARTAIGH, R., WARNABY, C., ROGERS, R., JBABDI, S. & TRACEY, I. 2013. 
Slow-wave activity saturation and thalamocortical isolation during propofol anesthesia in humans. Sci 
Transl Med, 5, 208ra148. 
OGATA, J., SHIRAISHI, M., NAMBA, T., SMOTHERS, C. T., WOODWARD, J. J. & HARRIS, R. 
A. 2006. Effects of anesthetics on mutant N-methyl-D-aspartate receptors expressed in Xenopus 
oocytes. J Pharmacol Exp Ther, 318, 434-43. 
OVERTON, E. 1901. Studien ueber die Narkose zugleich ein Beitrag zur allgemeinen Pharmakologie. 
REFERENCES 
167 
 
PANG, D. S., ROBLEDO, C. J., CARR, D. R., GENT, T. C., VYSSOTSKI, A. L., CALEY, A., 
ZECHARIA, A. Y., WISDEN, W., BRICKLEY, S. G. & FRANKS, N. P. 2009. An unexpected role 
for TASK-3 potassium channels in network oscillations with implications for sleep mechanisms and 
anesthetic action. Proc Natl Acad Sci U S A, 106, 17546-51. 
PANULA, P., PIRVOLA, U., AUVINEN, S. & AIRAKSINEN, M. S. 1989. Histamine-
immunoreactive nerve fibers in the rat brain. Neuroscience, 28, 585-610. 
PAOLETTI, P., BELLONE, C. & ZHOU, Q. 2013. NMDA receptor subunit diversity: impact on 
receptor properties, synaptic plasticity and disease. Nat Rev Neurosci, 14, 383-400. 
PAXINOS, G. & WATSON, C. 2005. The rat brain in stereotaxic coordinates, Amsterdam ; Boston, 
Elsevier Academic Press. 
PICCHIONI, D., PIXA, M. L., FUKUNAGA, M., CARR, W. S., HOROVITZ, S. G., BRAUN, A. R. 
& DUYN, J. H. 2014. Decreased connectivity between the thalamus and the neocortex during human 
nonrapid eye movement sleep. Sleep, 37, 387-97. 
PINNACLE TECHNOLOGY. 2014. 4-Channel EEG/EMG Tethered Rat System [Online]. Available: 
http://www.pinnaclet.com/4-channel-eeg-emg-systems-rats.html [Accessed 23.09. 2014]. 
PORTAS, C. M., KRAKOW, K., ALLEN, P., JOSEPHS, O., ARMONY, J. L. & FRITH, C. D. 2000. 
Auditory processing across the sleep-wake cycle: simultaneous EEG and fMRI monitoring in humans. 
Neuron, 28, 991-9. 
PURDON, P. L., PIERCE, E. T., MUKAMEL, E. A., PRERAU, M. J., WALSH, J. L., WONG, K. F., 
SALAZAR-GOMEZ, A. F., HARRELL, P. G., SAMPSON, A. L., CIMENSER, A., CHING, S., 
KOPELL, N. J., TAVARES-STOECKEL, C., HABEEB, K., MERHAR, R. & BROWN, E. N. 2013. 
Electroencephalogram signatures of loss and recovery of consciousness from propofol. Proc Natl 
Acad Sci U S A, 110, E1142-51. 
QUINLAN, J. J., HOMANICS, G. E. & FIRESTONE, L. L. 1998. Anesthesia sensitivity in mice that 
lack the beta3 subunit of the gamma-aminobutyric acid type A receptor. Anesthesiology, 88, 775-80. 
RAMCHARAN, E. J., GNADT, J. W. & SHERMAN, S. M. 2005. Higher-order thalamic relays burst 
more than first-order relays. Proc Natl Acad Sci U S A, 102, 12236-41. 
REES, G., KREIMAN, G. & KOCH, C. 2002. Neural correlates of consciousness in humans. Nat Rev 
Neurosci, 3, 261-70. 
REICHOVA, I. & SHERMAN, S. M. 2004. Somatosensory corticothalamic projections: 
distinguishing drivers from modulators. J Neurophysiol, 92, 2185-97. 
REMONDES, M. & WILSON, M. A. 2013. Cingulate-hippocampus coherence and trajectory coding 
in a sequential choice task. Neuron, 80, 1277-89. 
REYNOLDS, D. S., ROSAHL, T. W., CIRONE, J., O'MEARA, G. F., HAYTHORNTHWAITE, A., 
NEWMAN, R. J., MYERS, J., SUR, C., HOWELL, O., RUTTER, A. R., ATACK, J., MACAULAY, 
REFERENCES 
168 
 
A. J., HADINGHAM, K. L., HUTSON, P. H., BELELLI, D., LAMBERT, J. J., DAWSON, G. R., 
MCKERNAN, R., WHITING, P. J. & WAFFORD, K. A. 2003. Sedation and anesthesia mediated by 
distinct GABA(A) receptor isoforms. J Neurosci, 23, 8608-17. 
RIES, C. R. & PUIL, E. 1999. Mechanism of anesthesia revealed by shunting actions of isoflurane on 
thalamocortical neurons. J Neurophysiol, 81, 1795-801. 
ROBLEDO, C. J. 2008. The role of two-pore domain potassium channels in anaesthesia and sleep. 
Doctor of Philosophy, Imperial College London. 
ROELFSEMA, P. R., ENGEL, A. K., KONIG, P. & SINGER, W. 1997. Visuomotor integration is 
associated with zero time-lag synchronization among cortical areas. Nature, 385, 157-161. 
ROSANOVA, M., GOSSERIES, O., CASAROTTO, S., BOLY, M., CASALI, A. G., BRUNO, M. 
A., MARIOTTI, M., BOVEROUX, P., TONONI, G., LAUREYS, S. & MASSIMINI, M. 2012. 
Recovery of cortical effective connectivity and recovery of consciousness in vegetative patients. 
Brain, 135, 1308-20. 
RUDOLPH, U. & ANTKOWIAK, B. 2004. Molecular and neuronal substrates for general 
anaesthetics. Nat Rev Neurosci, 5, 709-20. 
RUDOLPH, U. & MOHLER, H. 2004. Analysis of GABAA receptor function and dissection of the 
pharmacology of benzodiazepines and general anesthetics through mouse genetics. Annu Rev 
Pharmacol Toxicol, 44, 475-98. 
SAALMANN, Y. B. 2014. Intralaminar and medial thalamic influence on cortical synchrony, 
information transmission and cognition. Front Syst Neurosci, 8, 83. 
SAALMANN, Y. B., PINSK, M. A., WANG, L., LI, X. & KASTNER, S. 2012. The pulvinar 
regulates information transmission between cortical areas based on attention demands. Science, 337, 
753-6. 
SANCHEZ-GONZALEZ, M. A., GARCIA-CABEZAS, M. A., RICO, B. & CAVADA, C. 2005. The 
primate thalamus is a key target for brain dopamine. J Neurosci, 25, 6076-83. 
SAPER, C. B., FULLER, P. M., PEDERSEN, N. P., LU, J. & SCAMMELL, T. E. 2010. Sleep state 
switching. Neuron, 68, 1023-42. 
SAPER, C. B. & LEVISOHN, D. 1983. Afferent connections of the median preoptic nucleus in the 
rat: anatomical evidence for a cardiovascular integrative mechanism in the anteroventral third 
ventricular (AV3V) region. Brain Res, 288, 21-31. 
SAPER, C. B. & LOEWY, A. D. 1980. Efferent connections of the parabrachial nucleus in the rat. 
Brain Res, 197, 291-317. 
SATOH, K. & FIBIGER, H. C. 1986. Cholinergic neurons of the laterodorsal tegmental nucleus: 
efferent and afferent connections. J Comp Neurol, 253, 277-302. 
REFERENCES 
169 
 
SCHIFF, N. D., GIACINO, J. T., KALMAR, K., VICTOR, J. D., BAKER, K., GERBER, M., FRITZ, 
B., EISENBERG, B., BIONDI, T., O'CONNOR, J., KOBYLARZ, E. J., FARRIS, S., MACHADO, 
A., MCCAGG, C., PLUM, F., FINS, J. J. & REZAI, A. R. 2007. Behavioural improvements with 
thalamic stimulation after severe traumatic brain injury. Nature, 448, 600-3. 
SCHIFF, N. D., SHAH, S. A., HUDSON, A. E., NAUVEL, T., KALIK, S. F. & PURPURA, K. P. 
2013. Gating of attentional effort through the central thalamus. J Neurophysiol, 109, 1152-63. 
SETH, A. K. 2010. The grand challenge of consciousness. Front Psychol, 1, 5. 
SHERIN, J. E., ELMQUIST, J. K., TORREALBA, F. & SAPER, C. B. 1998. Innervation of 
histaminergic tuberomammillary neurons by GABAergic and galaninergic neurons in the ventrolateral 
preoptic nucleus of the rat. J Neurosci, 18, 4705-21. 
SHERMAN, S. M. 2001. Tonic and burst firing: dual modes of thalamocortical relay. Trends 
Neurosci, 24, 122-6. 
SHERMAN, S. M. 2007. The thalamus is more than just a relay. Curr Opin Neurobiol, 17, 417-22. 
SHERMAN, S. M. 2012. Thalamocortical interactions. Curr Opin Neurobiol, 22, 575-9. 
SHERMAN, S. M. & GUILLERY, R. W. 1998. On the actions that one nerve cell can have on 
another: distinguishing "drivers" from "modulators". Proc Natl Acad Sci U S A, 95, 7121-6. 
SHERMAN, S. M. & GUILLERY, R. W. 2011. Distinct functions for direct and transthalamic 
corticocortical connections. J Neurophysiol, 106, 1068-77. 
SHERMAN, S. M., GUILLERY, R. W. & SHERMAN, S. M. 2006. Exploring the thalamus and its 
role in cortical function, Cambridge, Mass., MIT Press. 
SHMUEL, A., YACOUB, E., CHAIMOW, D., LOGOTHETIS, N. K. & UGURBIL, K. 2007. Spatio-
temporal point-spread function of fMRI signal in human gray matter at 7 Tesla. Neuroimage, 35, 539-
52. 
SILICON LABS. 2014. EFM32LG990 Datasheet [Online]. Online. Available: 
http://www.silabs.com/Support%20Documents/TechnicalDocs/EFM32LG990.pdf [Accessed 23.09. 
2014]. 
SIMON, C., KEZUNOVIC, N., YE, M., HYDE, J., HAYAR, A., WILLIAMS, D. K. & GARCIA-
RILL, E. 2010. Gamma band unit activity and population responses in the pedunculopontine nucleus. 
J Neurophysiol, 104, 463-74. 
SIROIS, J. E., LEI, Q., TALLEY, E. M., LYNCH, C., 3RD & BAYLISS, D. A. 2000. The TASK-1 
two-pore domain K+ channel is a molecular substrate for neuronal effects of inhalation anesthetics. J 
Neurosci, 20, 6347-54. 
REFERENCES 
170 
 
SLEZIA, A., HANGYA, B., ULBERT, I. & ACSADY, L. 2011. Phase advancement and nucleus-
specific timing of thalamocortical activity during slow cortical oscillation. J Neurosci, 31, 607-17. 
SONNER, J. M., WERNER, D. F., ELSEN, F. P., XING, Y., LIAO, M., HARRIS, R. A., 
HARRISON, N. L., FANSELOW, M. S., EGER, E. I., 2ND & HOMANICS, G. E. 2007. Effect of 
isoflurane and other potent inhaled anesthetics on minimum alveolar concentration, learning, and the 
righting reflex in mice engineered to express alpha1 gamma-aminobutyric acid type A receptors 
unresponsive to isoflurane. Anesthesiology, 106, 107-13. 
STEINBERG, E. A., WAFFORD, K. A., BRICKLEY, S. G., FRANKS, N. P. & WISDEN, W. in 
press. The role of K2P channels in anaesthesia and sleep. European Journal of Physiology. 
STERIADE, M. 2006. Grouping of brain rhythms in corticothalamic systems. Neuroscience, 137, 
1087-106. 
STERIADE, M., DESCHENES, M., DOMICH, L. & MULLE, C. 1985. Abolition of spindle 
oscillations in thalamic neurons disconnected from nucleus reticularis thalami. J Neurophysiol, 54, 
1473-97. 
STERIADE, M., DOMICH, L., OAKSON, G. & DESCHENES, M. 1987. The deafferented reticular 
thalamic nucleus generates spindle rhythmicity. J Neurophysiol, 57, 260-73. 
STERIADE, M., MCCORMICK, D. A. & SEJNOWSKI, T. J. 1993a. Thalamocortical oscillations in 
the sleeping and aroused brain. Science, 262, 679-85. 
STERIADE, M., NUNEZ, A. & AMZICA, F. 1993b. A novel slow (< 1 Hz) oscillation of neocortical 
neurons in vivo: depolarizing and hyperpolarizing components. J Neurosci, 13, 3252-65. 
STERIADE, M., NUNEZ, A. & AMZICA, F. 1993c. Intracellular analysis of relations between the 
slow (< 1 Hz) neocortical oscillation and other sleep rhythms of the electroencephalogram. J 
Neurosci, 13, 3266-83. 
SUKHOTINSKY, I., ZALKIND, V., LU, J., HOPKINS, D. A., SAPER, C. B. & DEVOR, M. 2007. 
Neural pathways associated with loss of consciousness caused by intracerebral microinjection of 
GABA A-active anesthetics. Eur J Neurosci, 25, 1417-36. 
SUNTSOVA, N., SZYMUSIAK, R., ALAM, M. N., GUZMAN-MARIN, R. & MCGINTY, D. 2002. 
Sleep-waking discharge patterns of median preoptic nucleus neurons in rats. J Physiol, 543, 665-77. 
SZYMUSIAK, R., ALAM, N., STEININGER, T. L. & MCGINTY, D. 1998. Sleep-waking discharge 
patterns of ventrolateral preoptic/anterior hypothalamic neurons in rats. Brain Res, 803, 178-88. 
TAKAHASHI, K., KAYAMA, Y., LIN, J. S. & SAKAI, K. 2010. Locus coeruleus neuronal activity 
during the sleep-waking cycle in mice. Neuroscience, 169, 1115-26. 
TAKAHASHI, K., LIN, J. S. & SAKAI, K. 2006. Neuronal activity of histaminergic 
tuberomammillary neurons during wake-sleep states in the mouse. J Neurosci, 26, 10292-8. 
REFERENCES 
171 
 
TAKAHASHI, K., LIN, J. S. & SAKAI, K. 2009. Characterization and mapping of sleep-waking 
specific neurons in the basal forebrain and preoptic hypothalamus in mice. Neuroscience, 161, 269-
92. 
THEYEL, B. B., LLANO, D. A. & SHERMAN, S. M. 2010. The corticothalamocortical circuit drives 
higher-order cortex in the mouse. Nat Neurosci, 13, 84-8. 
THOMSON, K. D. & KNIGHT, A. B. 1988. Hallucinations after propofol. Anaesthesia, 43, 170-171. 
TIMOFEEV, I., GRENIER, F., BAZHENOV, M., SEJNOWSKI, T. J. & STERIADE, M. 2000. 
Origin of slow cortical oscillations in deafferented cortical slabs. Cereb Cortex, 10, 1185-99. 
TORRENCE, C. & COMPO, G. P. 1998. A practical guide to wavelet analysis. Bulletin of the 
American Meteorological Society, 79, 61-78. 
USCHAKOV, A., GONG, H., MCGINTY, D. & SZYMUSIAK, R. 2007. Efferent projections from 
the median preoptic nucleus to sleep- and arousal-regulatory nuclei in the rat brain. Neuroscience, 
150, 104-20. 
UUSI-OUKARI, M. & KORPI, E. R. 2010. Regulation of GABA(A) receptor subunit expression by 
pharmacological agents. Pharmacol Rev, 62, 97-135. 
VAHLE-HINZ, C., DETSCH, O., SIEMERS, M. & KOCHS, E. 2007. Contributions of GABAergic 
and glutamatergic mechanisms to isoflurane-induced suppression of thalamic somatosensory 
information transfer. Exp Brain Res, 176, 159-72. 
VAN DER WERF, Y. D., WITTER, M. P. & GROENEWEGEN, H. J. 2002. The intralaminar and 
midline nuclei of the thalamus. Anatomical and functional evidence for participation in processes of 
arousal and awareness. Brain Res Brain Res Rev, 39, 107-40. 
VAN STRIEN, N. M., CAPPAERT, N. L. & WITTER, M. P. 2009. The anatomy of memory: an 
interactive overview of the parahippocampal-hippocampal network. Nat Rev Neurosci, 10, 272-82. 
VANDERWOLF, C. H. 2000. Are neocortical gamma waves related to consciousness? Brain Res, 
855, 217-24. 
VELLY, L. J., REY, M. F., BRUDER, N. J., GOUVITSOS, F. A., WITJAS, T., REGIS, J. M., 
PERAGUT, J. C. & GOUIN, F. M. 2007. Differential dynamic of action on cortical and subcortical 
structures of anesthetic agents during induction of anesthesia. Anesthesiology, 107, 202-12. 
VENN, R. M. & GROUNDS, R. M. 2001. Comparison between dexmedetomidine and propofol for 
sedation in the intensive care unit: patient and clinician perceptions†. British Journal of Anaesthesia, 
87, 684-690. 
VERTES, R. P., HOOVER, W. B. & RODRIGUEZ, J. J. 2012. Projections of the central medial 
nucleus of the thalamus in the rat: node in cortical, striatal and limbic forebrain circuitry. 
Neuroscience, 219, 120-36. 
REFERENCES 
172 
 
VIAENE, A. N., PETROF, I. & SHERMAN, S. M. 2011a. Properties of the thalamic projection from 
the posterior medial nucleus to primary and secondary somatosensory cortices in the mouse. Proc 
Natl Acad Sci U S A, 108, 18156-61. 
VIAENE, A. N., PETROF, I. & SHERMAN, S. M. 2011b. Synaptic properties of thalamic input to 
the subgranular layers of primary somatosensory and auditory cortices in the mouse. J Neurosci, 31, 
12738-47. 
VIJAYAN, S., CHING, S., PURDON, P. L., BROWN, E. N. & KOPELL, N. J. 2013. 
Thalamocortical mechanisms for the anteriorization of alpha rhythms during propofol-induced 
unconsciousness. J Neurosci, 33, 11070-5. 
VIRTANEN, R., SAVOLA, J. M., SAANO, V. & NYMAN, L. 1988. Characterization of the 
selectivity, specificity and potency of medetomidine as an alpha 2-adrenoceptor agonist. Eur J 
Pharmacol, 150, 9-14. 
VISHAY SEMICONDUCTORS. 2010. TFBS4711 Datasheet [Online]. Online. Available: 
http://www.vishay.com/docs/82633/tfbs4711.pdf [Accessed 23.09. 2014]. 
VOGT, B. A., VOGT, L. & FARBER, N. B. 2004. Chapter 22 - Cingulate Cortex and Disease 
Models. In: PAXINOS, G. (ed.) The Rat Nervous System (Third Edition). Burlington: Academic 
Press. 
VYAZOVSKIY, V. V., OLCESE, U., HANLON, E. C., NIR, Y., CIRELLI, C. & TONONI, G. 2011. 
Local sleep in awake rats. Nature, 472, 443-7. 
VYSSOTSKI, A. 2014. Neurologger 2/2A [Online]. Available: http://www.vyssotski.ch/neurologger2 
[Accessed 23.09. 2014]. 
WANG, R., MACMILLAN, L. B., FREMEAU, R. T., JR., MAGNUSON, M. A., LINDNER, J. & 
LIMBIRD, L. E. 1996. Expression of alpha 2-adrenergic receptor subtypes in the mouse brain: 
evaluation of spatial and temporal information imparted by 3 kb of 5' regulatory sequence for the 
alpha 2A AR-receptor gene in transgenic animals. Neuroscience, 74, 199-218. 
WANG, S., EISENBACK, M. A. & BICKFORD, M. E. 2002. Relative distribution of synapses in the 
pulvinar nucleus of the cat: implications regarding the "driver/modulator" theory of thalamic function. 
J Comp Neurol, 454, 482-94. 
WEIERGRABER, M., HENRY, M., HESCHELER, J., SMYTH, N. & SCHNEIDER, T. 2005. 
Electrocorticographic and deep intracerebral EEG recording in mice using a telemetry system. Brain 
Res Brain Res Protoc, 14, 154-64. 
WEIR, C. J. 2006. The molecular mechanisms of general anaesthesia: dissecting the GABAA 
receptor. Continuing Education in Anaesthesia, Critical Care & Pain, 6, 49-53. 
WESTPHALEN, R. I., KRIVITSKI, M., AMAROSA, A., GUY, N. & HEMMINGS, H. C., JR. 2007. 
Reduced inhibition of cortical glutamate and GABA release by halothane in mice lacking the K+ 
channel, TREK-1. Br J Pharmacol, 152, 939-45. 
REFERENCES 
173 
 
WHITTINGTON, M. A., CUNNINGHAM, M. O., LEBEAU, F. E., RACCA, C. & TRAUB, R. D. 
2011. Multiple origins of the cortical gamma rhythm. Dev Neurobiol, 71, 92-106. 
WILKINSON, D. J. 2014. The History of Anaesthesia [Online]. London: The Royal College of 
Anaesthetists. Available: http://www.rcoa.ac.uk/about-the-college/history-of-anaesthesia [Accessed 
22.08. 2014]. 
WOMELSDORF, T. & FRIES, P. 2007. The role of neuronal synchronization in selective attention. 
Curr Opin Neurobiol, 17, 154-60. 
WOMELSDORF, T., FRIES, P., MITRA, P. P. & DESIMONE, R. 2006. Gamma-band 
synchronization in visual cortex predicts speed of change detection. Nature, 439, 733-6. 
YUE, B. W. & HUGUENARD, J. R. 2001. The role of H-current in regulating strength and frequency 
of thalamic network oscillations. Thalamus Relat Syst, 1, 95-103. 
ZAKIEWICZ, I. M., BJAALIE, J. G. & LEERGAARD, T. B. 2014. Brain-wide map of efferent 
projections from rat barrel cortex. Frontiers in Neuroinformatics, 8. 
ZECHARIA, A. Y., YU, X., GOTZ, T., YE, Z., CARR, D. R., WULFF, P., BETTLER, B., 
VYSSOTSKI, A. L., BRICKLEY, S. G., FRANKS, N. P. & WISDEN, W. 2012. GABAergic 
inhibition of histaminergic neurons regulates active waking but not the sleep-wake switch or propofol-
induced loss of consciousness. J Neurosci, 32, 13062-75. 
ZELLER, A., ARRAS, M., JURD, R. & RUDOLPH, U. 2007. Identification of a molecular target 
mediating the general anesthetic actions of pentobarbital. Mol Pharmacol, 71, 852-9. 
ZHU, L., BLETHYN, K. L., COPE, D. W., TSOMAIA, V., CRUNELLI, V. & HUGHES, S. W. 
2006. Nucleus- and species-specific properties of the slow (<1 Hz) sleep oscillation in thalamocortical 
neurons. Neuroscience, 141, 621-36. 
 
  
 174 
 
 
Appendix 
APPENDIX 
175 
 
 
APPENDIX 
176 
 
 
APPENDIX 
177 
 
 
APPENDIX 
178 
 
  
APPENDIX 
179 
 
 
APPENDIX 
180 
 
 
APPENDIX 
181 
 
 
APPENDIX 
182 
 
 
APPENDIX 
183 
 
  
APPENDIX 
184 
 
 
